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Abstract
The innate immune system responds to infection or injury by initiating nonspecific 
inflammation, which functions to limit the spread of harmful microbes or the damage 
caused by tissue injury. The cells of the innate immune system are the first to encounter 
danger signals, and they mediate the rapid local immune response. Inflammatory reactions 
are normally beneficial for the host, and inflammation is usually resolved when the threat 
has been removed. However, in chronic inflammatory diseases, the danger signals either 
are not cleared or continue to be formed. Pathogen-derived molecules and danger signals 
induce the activation of pattern recognition receptors (PRRs) in the innate immune cells. 
Several families of PRRs exist, and their interplay is needed for the induction of efficient 
immune defense reactions. 
Nucleotide-binding domain and leucine-rich repeat-containing receptors (NLRs) are 
intracellular receptors that respond to a plethora of danger- and pathogen-associated 
molecular patterns. Their activation induces the assembly and activation of cytosolic 
multiprotein complexes called inflammasomes. Inflammasomes act as a primary checkpoint 
for the activation and secretion of the strong proinflammatory cytokines interleukin (IL)-
1β and IL-18. Similar to other cellular functions, innate immune responses are operated 
via a complicated interplay between signalosomes. To become activated inflammasomes 
require the coordinated activation of Toll-like receptors (TLRs) and NLRs, which induce 
the activation and assembly of inflammasome complexes. The consequent secretion of 
inflammasome-derived cytokines is, in turn, modulated by autophagy. Inflammasome 
activation and autophagy also interact with cellular death pathways. Cellular death acts to 
limit the spread of intracellular pathogens by denying a protective niche to these pathogens, 
thereby inhibiting their replication and predisposing them for detection by the immune 
system.  
The aim of this study was to investigate the roles of ethanol and hemin in the modulation 
of innate immune cell functions, as well as the mechanisms underlying the reported 
protective effects of ethanol and hemin against chronic inflammatory diseases. Alcohol 
is the most commonly and widely used drug in the world. The consequences of alcohol 
consumption depend on both the pattern of consumption and the amounts consumed. 
Alcohol abuse predisposes to more frequent and severe infections, whereas the light to 
moderate consumption of alcoholic beverages has been associated with a reduced incidence 
of chronic inflammatory conditions, such as cardiovascular diseases and rheumatoid 
arthritis. These seemingly different responses may both derive from attenuated reactions of 
innate immunity. In the present thesis study, ethanol was shown to reduce the viability and 
proliferation of mast cells. This reduced viability resulted from the immunologically silent 
apoptotic death of mast cells. In macrophages, ethanol reduced the pyroptotic cell death 
induced by inflammasome activation and instead directed cell death toward apoptosis. 
Excessive inflammasome activation is a prominent feature of several chronic inflammatory 
diseases. The mechanisms that restrain inflammasome activation were studied in greater 
detail in cultured macrophages. Ethanol dose-dependently inhibited inflammasome 
activation and the secretion of IL-1β in human macrophages. It was further shown that the 
inhibitory effect of ethanol was mediated by a reduction in lysosomal disruption and the 
release of active cathepsin B, which thus contributed to diminished inflammasome assembly.
The majority of mammalian cells are constantly renewed. Enormous numbers of senescent 
red blood cells are phagocytosed daily by macrophages. In certain pathologies, such as 
malarial infection, massive hemolysis occurs that exceeds the capacity of the scavenging 
and degradation systems of hemoglobin. As a consequence, free heme and hemin are 
released into the circulation. Free heme and hemin are cytotoxic and proinflammatory 
compounds. However, heme and hemin are also potent inducers of the heme oxygenase-1 
(HO-1) enzyme, which possesses anti-inflammatory and cytoprotective effects. In the 
present thesis study, hemin and its synthetic derivative cobalt protoporphyrin (CoPP) 
blocked inflammasome activation and assembly. Decreased secretion of IL-1β was also 
observed in vivo in a nucleotide-binding domain and leucine-rich repeat-containing family, 
pyrin domain-containing 3 (NLRP3)-dependent peritonitis model in mice. The inhibitory 
effects of hemin and CoPP were partially dependent on the induction of HO-1 transcription 
by NF-E2-related factor-2 (Nrf2) and the enzymatic activity of HO-1. The inhibitory effects 
of  hemin and CoPP were mediated by increased degradation of inflammasome components, 
which was due to elevated autophagy. 
Overall, the results of this study demonstrate that ethanol and hemin markedly prevent 
inflammatory cellular responses in macrophages and mast cells. This inhibition may 
contribute to the cardioprotective effect of ethanol and the anti-inflammatory effects of 
hemin. An enhanced molecular understanding of the mechanisms by which ethanol and 
hemin inhibit inflammation may help reveal new therapeutic options in the treatment of 
chronic inflammatory diseases.    
12
I Introduction
The immune system has evolved to detect potential threats and to provide protection against 
microbial infections and other harmful agents. The mammalian defense system consists of 
innate and adaptive components that function via close interactions with each other. The 
innate immune system relies on both cellular and humoral mechanisms to eradicate threats. 
Hence, the key function of the immune system is to initiate the immune response by the direct 
recognition of molecular patterns that signal danger or intrusion by pathogens (Matzinger 
2002, Medzhitov & Janeway 2002). The cells of the innate immune system serve as a first 
line of defense, as exemplified by the ability of activated macrophages and mast cells to 
secrete powerful proinflammatory cytokines and mediators that act as strong attractants for 
other immune cells, thereby initiating local and systemic inflammation (Beutler 2004, da 
Silva et al. 2014). 
Several pattern recognition receptors (PRRs) account for the recognition of danger signals. 
Among them, nucleotide-binding domain and leucine-rich repeat-containing receptors 
(NLRs) are intracellular receptors that induce the assembly of large proinflammatory 
signalosomes, called inflammasomes, in response to a wide variety of pathogen-derived 
and endogenous danger signals (Latz et al. 2013). Activated inflammasomes induce the 
secretion of the strong proinflammatory mediators interleukin (IL)-1β and IL-18. Despite the 
tight control of inflammasome activation, the excessive activation of the nucleotide-binding 
domain and leucine-rich repeat-containing family, pyrin domain-containing 3 (NLRP3) 
inflammasome has been associated with the pathogenesis of severe autoinflammatory 
diseases, and of certain common chronic inflammatory diseases, such as atherosclerosis, 
gout, and type 2 diabetes (Kastner et al. 2010, Duewell et al. 2010, Rajamaki et al. 2010, 
Martinon et al. 2006, Grant & Dixit 2013). Therefore, the mechanisms of inhibition, 
resolution, and downmodulation are a crucial area of inflammasome research, yet, one that 
has received less attention.  
Proteins involved in intracellular signaling have a tendency to form networks that permit 
the temporal and spatial regulation of signals, as well as the local enrichment of signal-
mediating components to enable proximity-driven signal transduction (Wu 2013). The 
major signalosomes of the cell engage in constant interactions to combine extracellular 
and intracellular signals with the appropriate outcomes. Recent evidence has revealed the 
existence of major interplay and multifaceted modulatory functions among autophagy, 
apoptosis and inflammasome activation, yet we have just begun to unravel these connections. 
 
Alcohol, heme, and hemin are potent immunomodulatory agents. Alcohol induces a biphasic 
modulation of the immune response. The effects of alcohol depend critically on the dose 
and duration of alcohol intake. Chronic abuse of alcohol increases the incidence of severe 
infections and certain tumors (Goral et al. 2008), whereas the light to moderate consumption 
of alcohol reduces the risk of chronic inflammatory diseases such as coronary heart disease 
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(Rimm et al. 1999) and rheumatoid arthritis (RA) (Jin et al. 2014). Moreover, endogenous 
heme and hemin contribute to both the enhancement and resolution of inflammation. Free 
heme and hemin induce inflammation and cytotoxic effects. The anti-inflammatory and 
cytoprotective effects of heme and hemin have been associated with the induction of heme 
oxygenase-1 (HO-1) and with the degradation products of heme and hemin (Kumar & 
Bandyopadhyay 2005, Abraham & Kappas 2008, Gozzelino et al. 2010).    
The aim of this study was to explore the effects of ethanol and hemin on two cellular key 
players of innate immune defense, mast cells and macrophages, as well as the consequences 
of such effects on the pathogenesis of chronic inflammatory diseases. Moreover, we studied 
the signaling pathways that mediate the modulation of mast cell and macrophage functions, 
and we discovered links in the multilayered crosstalk among apoptosis, inflammasome and 
autophagy. 
Introduction
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II Review of the Literature
1. Innate immune cells
Innate immune cells are the first cells to encounter infectious agents. Initial 
bacterial recognition and the rapid initiation of the immune response in 
vertebrates rely mainly on innate immune cells, which are derived from 
hematopoietic stem cells in the bone marrow. With the exception of 
natural killer (NK) cells, which originate from the lymphoid lineage, mast 
cells, macrophages, dendritic cells, and granulocytes i.e., neutrophils, 
eosinophils, and basophils are derived from a common myeloid progenitor 
(Kitamura et al. 1993, Hoebeke et al. 2007, Galli et al. 2011). Many of the 
functions of immune cells are confined to certain cell types, but they also 
share common features. For example, neutrophil numbers are greatly 
expanded during infection, and although neutrophils are the workhorses of 
bacterial phagocytosis, macrophages and dendritic cells also phagocytose 
pathogens. In addition to phagocytic bacterial clearance, innate immune 
cells secrete a plethora of mediators that orchestrate the immune response 
via the further recruitment of cells of the innate and adaptive immune 
defense systems. Furthermore, macrophages and dendritic cells present 
antigens to adaptive immune cells, which is crucial for the initiation of 
adaptive immune responses (Beutler 2004). Mast cells and macrophages, 
which are relevant to this study, are discussed in greater detail below.  
1.1 Mast cells  
 
1.1.1 Mast cell heterogeneity and distribution  
The most distinctive morphological features of mast cells are their secretory cytoplasmic 
granules and monolobular nucleus (Kritikou et al. 2015). Mast cells were first described by 
Paul Erlich, who also named them (Beaven 2009). The term “mast cells”, or “Mastzellen”, 
is derived from the German word “mästung”, meaning “to fatten or feed something”. The 
name refers to the metachromatically stained granules of mast cells, which Erlich thought 
to represent internalized material that had been fed to mast cells by other cells (Beaven 
2009). Mast cells migrate from the bone marrow as immature precursors to differentiate 
and proliferate in mucosal and connective tissues (Kitamura et al. 1993). In tissues, mast 
cell differentiation is principally regulated by stem cell factor (SCF), the ligand of the 
c-Kit receptor, which is secreted by fibroblasts and endothelial cells (Galli et al. 1993, 
Broudy et al. 1994). In addition to SCF, local concentrations of IL-3 and T helper (TH) type 
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2-associated cytokines, such as IL-4 and IL-9, and a wide array of other factors contribute 
to mast cell maturation (Galli et al. 1993, Galli et al. 2005). The wealth of factors that guide 
mast cell differentiation leads to the formation of a heterogeneous mast cell population, 
with variations in phenotype, granule content, receptor expression, and cytokine production 
(Friend et al. 1996, Galli et al. 2005). 
Mast cells are categorized into subtypes according to their granule protease content. The 
two main mast cell subtypes are the tryptase-positive (MCT) and chymase tryptase-positive 
(MCTC) types, which contain predominantly tryptase or tryptase, chymase, cathepsin G, and 
carboxypeptidase A3 (CPA3), respectively (Irani et al. 1986, Schechter et al. 1990, Dougherty 
et al. 2010). However, there are exceptions in the protease content: some tryptase-positive 
mast cells have also been shown to contain CPA3 in their granules (Dougherty et al. 2010). 
Mast cells are relatively long-lived cells; resident mast cells may survive from months up 
to years in tissues (Kiernan 1979, Dichlberger et al. 2015). Due to the plasticity of mast 
cells, the tissue microenvironment has a profound impact on mast cell phenotypes, including 
the granule protease content of mature mast cells. The sole mast cell progenitor has the 
capacity to differentiate into any subtype (Maaninka et al. 2013). In addition, the phenotype 
is reversible and can be altered during the mast cell’s lifespan in response to changes in the 
microenvironment, such as inflammation (Friend et al. 1996). In humans, mast cells are 
located predominantly at the interface of the host and the external environment. The MCTC 
subtype is mostly found in connective tissues, such as the skin and the submucosa of the 
bowel, whereas MCT predominates in the bowel mucosa, lung subepithelium and alveoli 
(Irani et al. 1986). Their strategic location allows mast cells to react quickly to intruding 
environmental pathogens, danger signals, and toxins (Galli et al. 2011). Upon stimulation, 
the number of mast cells can be increased by the enhanced recruitment and maturation of 
progenitors and by prolonged survival (Galli & Tsai 2010). In addition, the proliferation of 
resident mast cells has been reported (Galli & Tsai 2010).   
1.1.2 Mast cell activation and mediators  
Mast cells bear numerous cell surface receptors and are activated by various stimuli. The 
best studied mast cell receptor is the high-affinity immunoglobulin (Ig) E receptor (FcεRI), 
which is activated in allergic reactions. Antigen binding to IgE induces the cross-linkage of 
IgE. The subsequent aggregation of IgE-bound FcεRI receptors induces the phosphorylation 
of the cytoplasmic regions of the receptors, thereby leading to a signaling cascade via spleen 
tyrosine kinase (Syk) or other protein tyrosine kinases (Kawakami & Galli 2002). The 
activation of these protein tyrosine kinases induces the phosphorylation of several signaling 
proteins, resulting in the release of granule contents to the extracellular space and the de 
novo synthesis of mediators (Kawakami & Galli 2002). Bacterial infections induce mast 
cell activation through PRRs. Mast cells express many Toll-like receptors (TLRs) and are 
reported to induce the secretion of cytokines in response to the activation of TLR2 and TLR4 
(Supajatura et al. 2002). Further, Supajatura et al. demonstrated that mast cell-deficient mice 
reconstituted with TLR4-/- mast cells showed significantly increased mortality compared to 
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mice reconstituted with TLR4+/+ mast cells in response to cecal ligation and puncture-
induced sepsis, highlighting the vital importance of mast cell function during bacterial 
infection. 
Mast cells are endowed with the ability to release and generate a variety of newly 
synthesized and presynthesized mediators with proinflammatory, anti-inflammatory, and 
immunosuppressive activities (da Silva et al. 2014). Upon stimulation, mast cells can release 
preformed mediators stored in their granules, including 1) the mast cell proteases chymase, 
tryptase, cathepsin B, and CP3A; 2) the biogenic amines histamine and serotonin; 3) the 
proteoglycans heparin and chondroitin sulfates; 4) lysosomal enzymes and other enzymes, 
such as β-hexosaminidase; and 5) numerous cytokines, chemokines, growth factors and 
peptides, such as monocyte chemotactic protein (MCP), regulated on activation normal 
T-cell expressed and secreted (RANTES), transforming growth factor-β (TGF-β), vascular 
endothelial growth factor (VEGF), SCF, and preformed tumor necrosis factor (TNF) α 
(da Silva et al. 2014). Activation also induces the synthesis of lipid mediators, including 
leukotrienes, prostaglandins, and platelet-activating factor, from membrane phospholipids. 
De novo-generated cytokines and chemokines include several interleukins, such as IL-1α, 
IL-1β, IL-6, IL-18, and TNFα (da Silva et al. 2014). Additionally, mast cells secrete newly 
synthesized growth factors, such as granulocyte macrophage colony-stimulating factor 
(GM-CSF), nitric oxide (NO), and complement factors (da Silva et al. 2014). 
Mast cells contribute to a variety of physiological processes, such as wound healing, 
angiogenesis and the recruitment of immune cells such as neutrophils during inflammation 
(Weller et al. 2011). Mast cells can also participate in bacterial clearance by phagocytosis and 
the subsequent degradation of bacteria in acidified vacuoles, and they can kill bacteria via 
the secretion of NO and antimicrobial peptides (Malaviya et al. 1994, Rao & Brown 2008). 
However, increased numbers of mast cells, alterations in their distribution and phenotypes, 
and adverse mast cell activation are observed in numerous inflammatory conditions. Perhaps 
the most well-known conditions to which mast cells contribute are allergic reactions and 
asthma (Bischoff 2007, Dougherty et al. 2010). Furthermore, increased mast cell numbers 
and their dysregulated activation have been reported in metabolic diseases, such as diabetes 
and atherosclerosis. In atherosclerosis, mast cells contribute to plaque development by 
various mechanisms. Among others, mast cells secrete heparin and chymase, which increase 
foam cell formation by inducing the fusion of low-density lipoprotein (LDL) particles on the 
surface of exocytosed mast cell granules, after which the lipid particle-containing granules 
are phagocytosed by macrophages (Kokkonen & Kovanen 1989, Kovanen 1993). Similarly, 
the assembly of activated mast cells in plaques has been shown to contribute to plaque 
progression and instability, e.g., by increasing angiogenesis in the plaque and by eventually 
promoting plaque rupture via a histamine-induced coronary spasm (Kaartinen et al. 1994, 
Lappalainen et al. 2004, Laine et al. 1999). Further evidence of the role of mast cells in 
metabolic diseases was provided by Liu et al. in a study demonstrating that the number 
of mast cells in the adipose tissue of obese humans was increased. In addition, mast cell 
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deficiency was shown to improve glucose metabolism and to inhibit inflammation of the 
adipose tissue in a mouse model (Liu et al. 2009). Dysfunctions of mast cells have also been 
implicated in the pathology of cancer and autoimmune diseases (Rao & Brown 2008).
1.2 Macrophages  
 
1.2.1 Macrophage heterogeneity and distribution  
Macrophages are mononuclear cells that are identified by their receptor expression and 
characteristic staining. Elie Metchnikoff is generally regarded as the father of the concept 
of phagocytosis and the discoverer of phagocytic cells (Cavaillon 2011). A heterogeneous 
population of monocytes exits the bone marrow and differentiates into macrophages 
in the tissues; thus, these circulating monocytes form a reservoir for the replenishment 
of tissue macrophages in some tissues and during inflammation or pathologies (Italiani 
& Boraschi 2014). However, the local proliferation maintains the population of tissue-
resident macrophages under normal conditions in most tissues (Haldar & Murphy 2014). 
Macrophages are long-lived cells. For example, resident murine lung macrophages can live 
up to 8 months, and lifespans ranging from several weeks to months have been reported 
for resident liver macrophages, depending on the species and experimental circumstances 
(Murphy et al. 2008, Naito et al. 1997). Macrophages are found virtually everywhere in 
the body. Some tissue-specific macrophages with characteristic phenotypes and specialized 
functions and locations have been given specific names; these include Kupffer cells in the 
liver and gastrointestinal tract, Langerhans cells in the epidermis, osteoclasts in the bone, 
microglial cells in the central nervous system, alveolar macrophages in the lung, and 
histiocytes in the connective tissue (Haldar & Murphy 2014). 
Macrophages respond avidly to signals from the surrounding microenvironment, such as 
signals generated during inflammation or infection, and in response to secreted mediators. 
These signals induce rapid and reversible changes in macrophage responses by modifying 
their gene expression (Murray & Wynn 2011a, Zhou et al. 2014). Based on their gene 
expression profiles, macrophages are classified as subpopulations: M1, M2, and regulatory 
macrophages. Thus, in the macrophage phenotypic polarization, M1 and M2 represent the 
opposite ends of a continuum, rather than confined phenotypes applicable to all macrophages 
(Mosser & Edwards 2008, Murray & Wynn 2011a, Zhou et al. 2014). Proinflammatory 
M1 polarization is induced by the TH1 cytokine interferon-γ (IFNγ), TNFα, and TLR 
activation. M1 macrophages are prototypical immune effector cells, and their actions are 
vital for host defense. Upon activation, M1-polarized macrophages secrete high levels of 
proinflammatory cytokines and exhibit increased pathogen- and tumor cell-killing capacity 
(Edwards et al. 2006, Mosser & Edwards 2008, Italiani & Boraschi 2014). The classical 
TH2 cytokines IL-4 and IL-13 induce the generation of M2-polarized macrophages, which 
suppress inflammation and promote wound healing by secreting collagen and polyamine 
precursors, among other mediators (Edwards et al. 2006, Mosser & Edwards 2008, 
Italiani & Boraschi 2014). The third macrophage subpopulation, regulatory macrophages, 
resembles M2 macrophages, and their polarization is induced by IgG immune complexes in 
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the presence of TLR agonists (Edwards et al. 2006, Mosser & Edwards 2008). Other factors 
that induce regulatory macrophage polarization include apoptotic cells, prostaglandins, and 
IL-10 (Edwards et al. 2006, Mosser & Edwards 2008). Regulatory macrophages produce 
the anti-inflammatory mediators IL-10 and TGF-β1, and they induce TH2 and regulatory T 
cell responses, which further suppress immune reactions (Edwards et al. 2006, Mosser & 
Edwards 2008, Galli et al. 2011). 
1.2.2 Macrophage Activation  
Macrophages are efficient phagocytes, which, in addition to bacterial clearance, secrete 
mediators that recruit more immunity effector cells to the site of inflammation. Furthermore, 
macrophages promote immune responses by presenting antigens to cells of adaptive immune 
defence. Macrophages are endowed with a variety of PRRs that sense bacterial ligands and 
endogenous danger signals. The activation of macrophage PRRs enhances phagocytosis, 
bacterial killing, and the secretion of strong proinflammatory mediators (PRR activation 
is explained in greater detail in Chapter 4.1) (Galli et al. 2011). Proinflammatory mediator 
release at the site of inflammation recruits circulating monocytes to the tissue and guides 
them to differentiate into proinflammatory type M1 macrophages, which further enhances 
pathogen clearance or the progression of inflammation (Murray & Wynn 2011b). In addition 
to their roles in immune defense, macrophages perform important functions that contribute 
to homeostasis in tissues and the body. Macrophages express several different scavenger 
receptors, which contribute to the removal of senescent red blood cells (explained in greater 
detail in Chapter 2.2.1) and apoptotic and necrotic cells, in addition to performing other 
roles (Mosser & Edwards 2008). 
Macrophages have a marked impact on immune reactions and systemic metabolism, and 
they contribute to a variety of different processes, including angiogenesis, cancer, and 
reproduction (Murray & Wynn 2011b, Zhou et al. 2014). The pathogenic functions of 
macrophages are associated with several chronic inflammatory diseases and metabolic 
pathologies, such as atherosclerosis (Murray & Wynn 2011b). One of the defining signs 
of atherosclerosis is the accumulation of macrophages in the intima of the arterial wall. 
Macrophages contribute critically to the progression of atherosclerosis at all stages by 
the secretion of proinflammatory cytokines and foam cell formation (Duewell et al. 2010, 
Rajamaki et al. 2010, van Tits et al. 2011, Fenyo & Gafencu 2013). Macrophage colony-
stimulating factor (M-CSF) and GM-CSF are among the most important mediators of 
macrophage differentiation in plaques; however, various other stimuli in plaques or, 
possibly, a variety of monocyte populations, from which macrophages derive, contribute to 
the formation of heterogeneous macrophage populations (Fenyo & Gafencu 2013, Chinetti-
Gbaguidi et al. 2015). One example of macrophage plasticity was demonstrated by van 
Tits et al., who reported that cultured M2 macrophages were more prone to the uptake of 
minimally oxidized LDL and foam cell formation. Subsequent to oxidized LDL uptake, 
the gene expression and cytokine secretion of M2 macrophages shifted toward the M1 
phenotype (van Tits et al. 2011). Macrophage polarization may also alter the progression 
of type 2 diabetes. Macrophage infiltration to the white adipose tissue results in local 
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inflammation (Xu et al. 2003). On the other hand, the polarization of macrophages toward 
the M2 phenotype has been suggested to protect against obesity, insulin resistance and 
glucose intolerance (Odegaard et al. 2007). In addition, macrophages are among the most 
important effector cells in arthritis (Gierut et al. 2010). In synovial tissue, the normally 
quiescent macrophages become activated, and the subsequent secretion of proinflammatory 
mediators, such as IL-1 and TNFα, further accelerates inflammation and the consequent 
joint destruction (Kennedy et al. 2011). However, in addition to macrophages, other cells in 
inflamed joints are capable of secreting proinflammatory cytokines (Kennedy et al. 2011). 
2. Ethanol and heme as immunomodulatory compounds 
Both ethanol and heme/hemin are potent immunomodulatory compounds. 
The consequences of ethanol consumption are highly dependent on the 
amounts consumed and the pattern of use. Acute and chronic alcohol 
consumption induce biphasic immunologic responses. Acute ethanol 
exposure attenuates inflammatory responses; conversely, chronic 
alcohol consumption augments inflammation. Moreover, the pro-oxidant 
and cytotoxic effects of free heme/hemin are widely acknowledged. The 
deleterious effects of heme/hemin are potently reversed by the induction 
of HO-1 (Abraham & Kappas 2008). The essential role of HO-1 in cellular 
homeostasis is emphasized by its high evolutionary conservation from 
bacteria to higher plants and animals (Wilks 2002). 
 
2.1 Ethanol  
 
Alcoholic beverages have been ingested since the Neolithic Stone Age, and alcohol has been 
the most commonly abused drug throughout history (Szabo & Mandrekar 2009). Alcohol 
consumption has been reported to induce beneficial effects in addition to several serious 
health hazards. The heavy, regular, consumption of alcohol increases the risk of injury, 
violence, suicide, poisoning, cirrhosis, cardiovascular ailments (e.g., cardiomyopathy), high 
blood pressure, hemorrhagic stroke, acute respiratory distress syndrome (ARDS), and several 
types of cancer (Thun et al. 1997, Goral et al. 2008). In addition, alcohol abuse increases 
susceptibility to bacterial and viral infections (Molina et al. 2010). Moreover, alcoholics 
experience infections that are more severe and exhibit impaired resolution (Molina et al. 
2010). However, the effects of alcohol consumption are highly dependent on the pattern and 
amount of alcohol consumption, as well as on the affected organs. Thus, moderate alcohol 
consumption, i.e., daily intake up to 30 g of ethanol, has been associated with a lower risk of 
coronary heart disease (CHD) (Rimm et al. 1999). Although moderate alcohol consumption 
is socially accepted and can be part of a healthy lifestyle, it is widely acknowledged that 
alcohol consumption should not be encouraged (Rimm et al. 1999, O’Keefe et al. 2007). 
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2.1.1 Effects of ethanol on immune cell activation  
Alcohol has direct effects on immune cell functions. The varying effects of acute and 
prolonged ethanol exposure on lipopolysaccharide (LPS)-induced signaling were 
demonstrated by Manderkar et al. In their study, acute alcohol exposure increased the levels 
of IL-1 receptor-activated kinase-M (IRAK-M) in monocytes (Mandrekar et al. 2009). 
IRAK-M is a negative regulator of the LPS-induced signaling cascade, and its activation 
leads to the reduced activation of nuclear factor κ-light chain-enhancer of activated B cells 
(NFκB) and to hyporesponsiveness of peripheral blood monocytes to LPS (Mandrekar et al. 
2009). In contrast, prolonged exposure of monocytes to ethanol reduced IRAK-M, thereby 
increasing the activation of NFκB and subsequent secretion of TNFα (Mandrekar et al. 2009). 
Acute ethanol exposure has also been reported to reduce the LPS-induced secretion of TNFα 
and IL-8 by inhibiting p38 mitogen activated kinase (p38 MAPK), another signaling protein 
downstream of TLR activation (Arbabi et al. 1999). A number of studies have reported a 
general trend toward reduced inflammatory responses, which are reflected by diminished 
TLR signaling and proinflammatory mediator release, as well as increased levels of IL-
10, in response to acute ethanol exposure (Boe et al. 2001, Pruett et al. 2004, Pruett & 
Pruett 2006). The reduced secretion of proinflammatory mediators induced by acute ethanol 
exposure suppresses neutrophil chemotaxis and thus can diminish pathogen clearance and 
immune responses (Arbabi et al. 1999, Boe et al. 2001). In addition, alcohol impairs the 
function of adaptive immunity by downregulating CD4+ T cell responses and by decreasing 
the absolute numbers of T cells and B cells (Molina et al. 2010). 
The biphasic effect of ethanol may be further explained by the effects of ethanol on acute-
phase proteins. TLR activation-induced elevation of serum amyloid A (SAA) and IL-6 leves 
were decreased shortly after the administration of both higher and lower doses of ethanol in 
mice. However, the higher concentration of ethanol alone activated the acute-phase response 
at later time points, during which ethanol was already metabolized (Pruett & Pruett 2006). The 
pattern of acute-phase protein expression may reflect the immune suppression that occurs in 
the presence of low ethanol concentrations and, consequently, the proinflammatory effects 
reported at high dosages (Pruett & Pruett 2006). Pruett et al. hypothesized that the increase 
in acute-phase proteins might be due to the ethanol-induced leakiness of the gastrointestinal 
tract, which allows LPS to enter the circulation. Indeed, highly elevated levels of LPS are 
detected in the blood of alcoholics and in animal models (Hines & Wheeler 2004, Rao et 
al. 2004). In addition, ethanol and its metabolite acetaldehyde have been shown to increase 
intestinal permeability by disrupting epithelial tight junctions (Rao et al. 2004). Furthermore, 
chronic alcoholics show elevated levels of proinflammatory cytokines in their blood, and 
increased TNFα secretion from Kupffer cells is considered a sign that predicts the beginning 
of liver injury (Hines & Wheeler 2004, Nagy 2004, Goral et al. 2008). Ethanol-induced 
liver injury is further aggravated by increased oxygen radical production by Kupffer cells 
and the enhanced expression of classical and alternative pathway complement components, 
particularly C3 (Hines & Wheeler 2004, Bykov et al. 2006, Bykov et al. 2007). The synthesis 
of C3 may indirectly be due to the increased LPS levels in the blood (Bykov et al. 2007). 
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Although complement activation normally drives the clearance of damaged cellular material 
and the subsequent resolution of inflammation, ethanol-induced increases in the expression 
of early and classical pathway complement components contribute to tissue damage (Bykov 
et al. 2006, Bykov et al. 2007). The effects of acute and chronic ethanol exposure on LPS-
induced signaling and inflammatory markers are summarized in Table 1. 
Moderate or acute alcohol High or chronic alcohol
IRAK-M activation ↑ IRAK-M activation ↓
IRAK1 ↓ IRAK1 ↑
IKK activity ↓ IKK activity ↑
NFκB activation ↓ NFκB activation ↑
ERK1/2 activation ↓ ERK1/2 activation ↑
p38 MAPK ↓ p38 MAPK ↑
Proinflammatory mediator secretion ↓ Proinflammatory mediator secretion ↑
IL-10 and TGF-β secretion ↑ IL-10 ↑
SAA ↓ SAA ↓ at early time points; SAA ↑ at late time 
points
CRP ↓ CRP ↑
Leukocyte numbers: no significant change Leukocyte numbers: no significant change      
Table 1. The biphasic effects of acute and chronic ethanol exposure on LPS-induced signaling 
pathways, inflammatory mediator secretion, and systemic markers of inflammation. Changes in the 
markers are expressed as comparisons to cells or animals not treated or fed with ethanol or to abstainers. 
CRP, C-reactive protein; ERK, extracellular signal-regulated kinase; IKK, IκB kinase; IL, interleukin; IRAK, IL-1 
receptor activated kinase; MAPK, mitogen activated kinase; NFκB, nuclear factor κ-light chain-enhancer of 
activated B cells; SAA, serum amyloid A; TGF-β, transforming growth factor-β. Data were derived from Kishore 
et al. 2001, Imhof et al. 2004, Oliveira et al. 2010, and references mentioned in the text.
Increased membrane fluidity is one plausible mechanism of the decreased TLR signaling 
induced by acute alcohol exposure. This may disturb the recruitment of TLRs to lipid rafts 
and the formation of membrane-bound protein complexes (Goral et al. 2008). However, 
it has been shown that TLR signaling is affected differently in response to the separate 
activation of TLR2 and TLR4 and to their simultaneous activation in the presence of ethanol 
(Oak et al. 2006). This finding is in contrast to the model of lipid raft disturbance that should 
apply to all TLRs without exception (Goral et al. 2008).
Ethanol has been shown to affect the numbers of circulating immune defense cells. In a 
model of binge drinking, blood samples drawn from human volunteers after alcohol 
ingestion revealed an early, transient proinflammatory state (20 min after alcohol ingestion), 
during which the numbers of circulating leucocytes, monocytes and NK cells were 
increased, as was the level of TNFα but not of IL-1β (Afshar et al. 2015). Furthermore, 
during this period blood cells responded to LPS stimulation with enhanced TNFα secretion. 
The early proinflammatory state was followed by an anti-inflammatory response (2 h and 
5 h after alcohol ingestion), during which the numbers of immune cells were reduced and 
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proinflammatory cytokine secretion was inhibited and shifted toward an anti-inflammatory 
response via the enhanced secretion of IL-10 (Afshar et al. 2015). Instead, chronic alcohol 
ingestion increases the numbers of blood monocytes; however, due to a reduction in their 
capability to phagocytose and induce intracellular microbial killing by, for example, the 
generation of reactive oxygen species (ROS), pathogen clearance is impaired (Molina et 
al. 2010). Undoubtedly, several aspects contribute to ethanol-induced suppression and 
stimulation of immune responses. The more severe infections experienced by alcoholics 
may also derive, in part, from diminished phagocytotic activity of immune cells: both acute 
ethanol exposure and (even more uniformly) chronic alcohol exposure have been shown to 
reduce phagocytosis (Goral et al. 2008). 
2.1.2 Alcohol consumption in relation to coronary heart disease  
Lifestyle and dietary habits have a strong impact on cardiovascular health. Population meta-
analysis studies have consistently demonstrated positive correlations between moderate 
alcohol consumption and reduced risk of CHD and myocardial infarction compared to 
abstainers (i.e., non-drinkers) (O’Keefe et al. 2007, Costanzo et al. 2010). In stark contrast 
to moderate alcohol consumption, heavy drinking and binge drinking strongly increase 
the risk of CHD and mortality from cardiovascular events (Costanzo et al. 2010). The 
protective effect of moderate alcohol consumption may derive from alterations in a number 
of biochemical factors, including reductions in systemic markers of inflammation, such as 
C-reactive protein (CRP) and proinflammatory mediators; decreased platelet aggregation, 
blood clotting and fibrinolysis; increased vasorelaxation; elevated levels of natriuretic peptide; 
and increased insulin sensitivity (Imhof & Koenig 2003, O’Keefe et al. 2007, Costanzo et al. 
2010). Furthermore, other substances in alcoholic beverages, such as antioxidants in wines, 
have also been suggested to contribute to the beneficial effects of alcoholic drinks. However, 
a systematic review of studies analyzing the effects of consumption of specific drinks on the 
risk of CHD revealed that all types of alcoholic drinks lowered the risk of CHD (Rimm et 
al. 1996). Therefore, alcohol was concluded to be the common denominator in the beneficial 
effects (Rimm et al. 1996). 
Alcohol-induced increases in high-density lipoprotein (HDL) cholesterol and in the main 
apolipoprotein of HDL, apolipoprotein A I, along with lower fibrinogen concentrations, 
were considered the most likely mechanisms of protection against CHD in a meta-analysis 
of population studies (Rimm et al. 1999). The ability of moderate alcohol consumption to 
increase blood HDL levels has been suggested to be dependent on genetic predisposition. A 
polymorphism that slows the oxidizing activity of the alcohol dehydrogenase enzyme was 
shown to cause increased HDL levels and reduced risk of myocardial infarctions, implying 
that ethanol itself, not its metabolites or other substances in alcoholic beverages, accounts for 
these beneficial effects (Hines et al. 2001). However, data reported by Hines et al. suggested 
that the increase in HDL was not the only contributing factor in the cardioprotective effects 
of ethanol. A meta-analysis of randomized trials examining the effects of lipid modifying 
interventions revealed that a simple increase in the amount of circulating HDL did not 
reduce the risk of CHD events or deaths (Briel et al. 2009). Thus, there are reasons to be 
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suspicious of the hypothesis that the HDL-raising effects of moderate alcohol consumption 
explain its cardioprotective effects. Population studies have weaknesses, particularly in 
terms of the analysis of alcohol consumption, the heterogeneity of the study groups, and 
the insufficient analysis of multiple factors that affect cardiovascular health. Therefore, the 
observed association between elevated HDL levels and improvements in cardiovascular 
health may not reflect a causal relationship. 
2.2 Heme
Heme is a protoporphyrin IX molecule, in which an iron atom is linked at the center of 
four pyrrole rings. Heme is a ubiquitous protein in aerobic cells, and it is required to 
serve as a prosthetic group in proteins involved in a variety of fundamental biological 
processes, including the transport and storage of gases in hemoglobin and myoglobin, 
mitochondrial respiration, signal transduction, detoxification reactions, steroid biosynthesis, 
and antioxidant defense (Ryter & Tyrrell 2000). Several variants of heme exist in nature. 
The most common form in mammals is type b heme, which is present in hemoglobin and 
myoglobin (Larsen et al. 2012). Type a is found in cytochrome c oxidase, and type c is in 
cytochrome c (Larsen et al. 2012). The iron in heme can be reversibly oxidized to different 
oxidative states (Ryter & Tyrrell 2000). The most common states in hemoproteins being 
Fe2+, which is present in heme (ferroprotoporphyrin), which has a neutral charge; and Fe3+, 
which is present in hemin (ferriprotoporphyrin), which has a positive charge that binds 
anions (Kumar & Bandyopadhyay 2005). The molecular structures of heme and hemin are 
illustrated in Figure 1.
Figure 1. Structures of heme and hemin. Heme (ferroprotoporphyrin) is on the left and hemin 
(ferriprotoporphyrin) is on the right. 
2.2.1 Heme is bound to hemoproteins  
Hepatic Kupffer cells and splenic macrophages are largely responsible for the phagocytosis 
of senescent red blood cells. They recycle approximately 2 x 1011 red blood cells daily, 
which equates to nearly 3 kg of iron and hemoglobin in a year (Mosser & Edwards 2008, 
Kovtunovych et al. 2010). Subsequently, the iron released by the degradation of heme is 
returned to the circulation for reuse (Mosser & Edwards 2008). The enormous amount of 
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heme processed in macrophages requires HO-1. Deficiency in HO-1 encoding gene Hmox1 
in mice resulted in the death of macrophages and disrupted the removal of senescent red 
blood cells from the circulation (Kovtunovych et al. 2010). Upon hemolysis, hemoglobin 
is released to the circulation, and free hemoglobin can be subsequently oxidized, resulting 
in the release of heme/hemin (Larsen et al. 2012). Because free heme/hemin is toxic and 
lipophilic, its release is avoided by the binding of hemoglobin to haptoglobin (Kumar & 
Bandyopadhyay 2005, Larsen et al. 2012). The formed hemoglobin:haptoglobin complex 
is subsequently cleared by macrophages and hepatocytes (Kumar & Bandyopadhyay 2005, 
Larsen et al. 2012). In malaria and certain other pathological conditions, such as sickle 
cell anemia and ischemia reperfusion, severe hemolysis results in the massive release of 
hemoglobin from red blood cells. During such pathological processes, haptoglobin can no 
longer bind all the hemoglobin, resulting in the release of heme/hemin (Larsen et al. 2012). 
In plasma, free heme/hemin is scavenged by an acute-phase protein hemopexin or albumin, 
α1-microglobulin, and lipoproteins, but these scavenging mechanisms can also be saturated 
upon high release of hemoglobin (Balla et al. 2005, Kumar & Bandyopadhyay 2005, Larsen 
et al. 2012) 
2.2.2 Heme-induced cytotoxicity and ROS formation  
The cytotoxic effects of free heme/hemin are mediated by its pro-oxidant properties, and 
its capability to produce ROS is generally attributed to its iron atom (Balla et al. 1991, 
Kumar & Bandyopadhyay 2005). The intercalation of hemin into cellular lipid bilayers 
increases cell permeability by disrupting the bilayer composition, which may predispose 
the cell to lysis (Schmitt et al. 1993). Damage induced by iron-derived ROS is implicated 
in several vascular disorders, including atherosclerosis, microangiopathic hemolytic anemia, 
vasculitis and reperfusion injury, due to the direct cytotoxic activities of iron-containing 
heme/hemin and the oxidation of lipoproteins (Balla et al. 1991, Balla et al. 2005). Heme 
and iron chelate highly sensitize endothelial cells to injury induced by exogenous and 
endogenous oxidants (Balla et al. 2005). In addition, LDL oxidized by hemin is cytotoxic 
to endothelial cells (Balla et al. 1991). Furthermore, in macrophages, heme induces cell 
death with features of necrosis by two independent mechanisms involving the generation of 
ROS and by inducing the production of TNFα (Fortes et al. 2012). TNFα further activates 
TNF receptor 1 (TNFR) 1, which subsequently induces cell death (Fortes et al. 2012). The 
above mentioned mechanisms may mediate the deleterious effects of massive heme release. 
Heme may also provoke ROS generation via nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases. Thus, in intestinal epithelial cells, heme was shown to induce the 
activation of NADPH oxidases, which led to production of ROS (Barcellos-de-Souza et al. 
2013). It is controversial whether heme/hemin can act as a Fenton reagent, i.e., support the 
formation of free radicals from hydrogen peroxide. However, heme is capable of catalyzing 
a process that turns rather slowly reactive organic hydroperoxides into highly reactive lipid 
peroxyl, alkyl, and alkoxyl radicals, which can induce lipid peroxidation (Ryter & Tyrrell 
2000). 
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2.2.3 Proinflammatory effects of heme  
Heme possesses proinflammatory abilities, which are, like its cytotoxic effects, considered 
to be mainly due its ability to generate ROS (Dutra et al. 2014). The capability of free heme 
to provoke an immune defense response was demonstrated by hemin injection, which led to 
the local migration and accumulation of neutrophils (Graca-Souza et al. 2002). Furthermore, 
heme was shown to induce the secretion of leukotriene B4 from macrophages, which again 
acted as a chemoattractant for neutrophils, thereby promoting their recruitment (Monteiro 
et al. 2011). Hemin was also shown to trigger an oxidative burst and actin polymerization, 
which indicate the activation of neutrophils (Graca-Souza et al. 2002). Heme/hemin can 
contribute to inflammation in the vascular wall by increasing oxidative stress, vascular 
permeability, adhesion molecule expression and leukocyte infiltration (Wagener et al. 2003, 
Kumar & Bandyopadhyay 2005). Furthermore, heme has been reported to act as a TLR4 
ligand to trigger the secretion of TNFα, a process that requires the iron in heme, because 
protoporphyrin IX, i.e., the direct precursor of heme that does not contain an iron atom, was 
shown to inhibit the effect of heme (Figueiredo et al. 2007). However, heme-induced TNFα 
secretion did not proceed through the signaling pathway used in LPS-induced activation, 
which may indicate that heme uses a different site for binding to TLR4 than LPS (Figueiredo 
et al. 2007). 
The data presented by Li et al. and Dutra et al. concerning heme as an activator of the NLRP3 
inflammasome are contradictory (Li et al. 2014b, Dutra et al. 2014). Li et al. demonstrated 
that heme and protoporphyrin IX induced the activation of the NLRP3 inflammasome 
and the secretion of mature IL-1β in the absence of serum (Li et al. 2014b). On the 
contrary, Dutra et al. showed that the activation of the inflammasome, which was induced 
by the synergistic effects of heme and pathogen-associated molecular patterns (PAMPs), 
required the presence of serum (Dutra et al. 2014). Furthermore, Dutra et al. observed that 
several other protoporphyrins devoid of an iron atom did not induce the secretion of IL-
1β. The heme-induced activation of the NLRP3 inflammasome was dependent on ROS 
generated by the mitochondria and NADPH oxidase, potassium efflux from the cell, and 
Syk phosphorylation, but the activation of the NLRP3 inflammasome was independent of 
adenosine triphosphate (ATP) release and its receptor, purinergic receptor P2X7 (Dutra et 
al. 2014). The results concerning the P2X receptor were again discrepant with the previous 
study by Li et al., in which the P2X receptors P2X7 and P2X4 were required for IL-1β 
secretion (Li et al. 2014b). In addition to these contradictory results, yet more discrepancies 
were found by studies showing that hemin in fact inhibits NLRP3 inflammasome activation. 
Kim et al. demonstrated that hemin reduced the expression of proIL-1β and inhibited the 
secretion of mature IL-1β induced by NLRP3 inflammasome activation. The ROS-dependent 
dissociation of thioredoxin-interacting protein (TXNIP) from thioredoxin (TRX) has been 
shown to induce NLRP3 inflammasome activation, and Kim et al. further demonstrated 
that hemin blocked the dissociation of TXNIP from TRX (Zhou et al. 2010, Kim & Lee 
2013). In accordance with the study by Kim et al., hemin was shown to protect epithelial 
cells from LPS-induced damage by reducing the LPS-induced expression of NLRP3 
inflammasome components and the assembly of the NLRP3 inflammasome, as well as the 
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subsequent secretion of IL-1β (Li et al. 2014a). Furthermore, hemin blocked cecal ligation 
and puncture-induced pulmonary damage, neutrophil infiltration, edema, and the secretion 
of IL-1β and IL-18 by reducing the expression of NLRP3 inflammasome components, the 
assembly of the NLRP3 inflammasome, and the production of malondialdehyde and ROS 
(Luo et al. 2014). All three latter studies suggested that the inhibitory effect was mediated by 
the induction of HO-1. The results of the above mentioned studies (Kim & Lee 2013, Dutra 
et al. 2014, Li et al. 2014a, Li et al. 2014b, Luo et al. 2014) are summarized in Table 2.
Heme-induced NLRP3 inflammasome  
activation
Hemin-induced NLRP3 inflammasome  
inhibition
Heme induces the secretion of IL-1β (Dutra et al. 2014, 
Li et al. 2014b).
Hemin blocks the secretion of IL-1β (Kim & Lee 2013, 
Li et al. 2014a, Luo et al. 2014).
Heme does not reduce the expression of pro-IL-1β 
protein (Dutra et al. 2014).
Hemin reduces the expression of proIL-1β, NLRP3, 
ASC, and caspase-1 induced by inflammatory stimuli 
(Kim & Lee 2013, Li et al. 2014a, Luo et al. 2014). 
Hemin blocks the nuclear translocation of NFκB (Li et 
al. 2014a).
The dependence of inflammasome activation on serum 
is controversial (Dutra et al. 2014, Li et al. 2014b).
Inflammasome activation is dependent on mitochondrial 
and NADPH-generated ROS (Dutra et al. 2014).
Hemin blocks the dissociation of TXNIP from TRX (Kim 
& Lee 2013).
Inflammasome activation is dependent on potassium 
efflux (Dutra et al. 2014).
Hemin inhibits NLRP3 inflammasome assembly (Kim & 
Lee 2013, Li et al. 2014a, Luo et al. 2014).
Inflammasome activation is dependent on Syk 
phosphorylation (Dutra et al. 2014).
Hemin blocks the production of malondialdehyde (Luo 
et al. 2014).
The dependence of inflammasome activation on ATP 
and the P2X receptor is controversial (Dutra et al. 2014, 
Li et al. 2014b).
Inhibitory effects are suggested to be mediated by the 
induction of HO-1 (Kim & Lee 2013, Li et al. 2014a, 
Luo et al. 2014).
Table 2. Effects of heme and hemin on NLRP3 inflammasome activation. Data are derived from references 
mentioned in the table.
2.2.4 Heme oxygenase-1  
Heme/hemin is degraded by the heme oxygenase (HO) enzyme, which catabolizes the rate-
limiting step in the oxidative degradation of heme/hemin to carbon monoxide (CO), catalytic 
iron, and biliverdin, which is rapidly further converted to bilirubin (Tenhunen et al. 1968, 
Tenhunen et al. 1969). The induction of HO is the other role of heme/hemin in inflammation. 
Small amounts of heme induce cytoprotective and anti-inflammatory effects through the 
activation of HO, whereas high concentrations act in a proinflammatory and cytotoxic 
manner (Wagener et al. 2003). HO in humans exists in two isoforms. The constitutive form, 
HO-2, is expressed mainly in the brain and testis. The ubiquitous inducible form, HO-1, 
exhibits low basal expression but is readily induced in response to various stress signals, such 
as cytokines, heavy metals, its substrate heme/hemin, and other synthetic metalloporphyrins 
(Abraham & Kappas 2008, Paine et al. 2010). HO-1 is principally regulated at the expression 
level (Abraham & Kappas 2008, Paine et al. 2010), and similar to many other antioxidant 
genes, the HMOX1 possesses several antioxidant response elements in its enhancer regions, 
which act as binding sites for transcription factors (Paine et al. 2010). The transcription 
of HO-1 is regulated by several factors, including the transcriptional repressor BTB and 
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CNC homolog 1 (Bach1), which binds the stress-responsive elements in the promoter of 
HMOX1 in the absence of activating stimuli, as well as by the transcription factors NF-
E2-related factor-2 (Nrf2), NFκB, and activating protein-1 (Gozzelino et al. 2010, Paine et 
al. 2010). Nrf2 is the most prominent HO-1 activating transcription factor in response to 
oxidative cellular stress (Alam et al. 1999). Recent evidence has demonstrated that Nrf2 is 
the principal transcription factor that mediates HO-1 activation under injurious conditions, 
as the disruption of cellular homeostasis activates both HO-1 and autophagy. An unexpected 
link between these two pathways was revealed when Nrf2 and sequestosome 1 (SQSTM1, 
also called p62), a protein that acts as a receptor for selective autophagy, were shown to 
mutually enhance the expression of each other (Jain et al. 2010, Itakura & Mizushima 2011). 
HO-1 exerts potent immunomodulatory actions that promote cell survival, as well as 
antioxidant and anti-inflammatory effects. The importance of HO-1 is exemplified by 
the severe diseases observed in the absence of HO-1 in two human patients and in mouse 
knockout models. The symptoms or findings observed in HO-1 deficiency include 
anemia, elevated levels of heme and iron deposits, signs of chronic inflammation, high 
blood lipid concentrations, and endothelial and vascular injury (Poss & Tonegawa 1997a, 
Yachie et al. 1999, Wagener et al. 2003, Kovtunovych et al. 2010). The cytoprotective and 
anti-inflammatory effects of HO-1 have been well demonstrated. HO-1-deficient mouse 
models showed exaggerated immune responses and mortality in response to inflammatory 
stimuli, such as LPS (Poss & Tonegawa 1997a, Poss & Tonegawa 1997b, Brouard et al. 
2002, Kapturczak et al. 2004, Gozzelino et al. 2010). One important mechanism that down-
modulates inflammation is the inhibition of the secretion of proinflammatory mediators. The 
induction of HO-1 expression by hemoglobin reversed LPS-induced TNFα secretion in vivo 
and increased survival from toxemia (Otterbein et al. 1997). In addition, the overexpression 
of HO-1 or its induction with hemin blocked the secretion of TNFα via the induction of 
autophagy (Waltz et al. 2011). Furthermore, the activation of TLR4 alone initiated the 
expression of HO-1, suggesting the existence of a negative feedback loop (Immenschuh et 
al. 1999, Waltz et al. 2011). In addition to TLR signaling, the activation of other signaling 
pathways, including p38 MAPK, phoshatidylinositol-3 kinase (PI3K)/Akt, and the Janus 
kinase and signal transducer and activator of transcription (Jak-STAT) pathway also induce 
the expression of HO-1 (Paine et al. 2010). The beneficial effects of HO-1 are not only 
mediated by its counteractions against the effects of free heme/hemin but have also been 
attributed to the degradation products: CO, biliverdin, and bilirubin. The observation that 
the administration of CO and bilirubin mimics the anti-inflammatory and antiapoptotic 
effects of HO-1 suggests that the protective effects of HO-1 activation are mediated by 
degradation products (Kapitulnik 2004, Gozzelino et al. 2010, Constantin et al. 2012). 
However, interestingly, Kim et al. showed that CO induced the expression of HO-1 and 
the pharmacological activation of HO-1 induced CO, both of which inhibited endoplasmic 
reticulum stress-induced apoptosis (Kim et al. 2007, Gozzelino et al. 2010). 
Many of the above mentioned effects of HO-1 confer protection against chronic inflammatory 
diseases, such as atherosclerosis and RA. The beneficial effects of HO-1 in the context of 
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chronic inflammatory diseases include reduced inflammation, reduced oxidative damage, 
degradation of proinflammatory and cytotoxic free heme/hemin, and enhanced cell survival. 
Pronounced expression of HO-1 in macrophages and in the endothelium of atherosclerotic 
lesions has been reported (Wang et al. 1998, Ishikawa et al. 2001a). Accordingly, oxidized 
LDL has been shown to induce HO-1 expression in cultured macrophages, implicating 
that oxidized LDL may promote HO-1 expression in plaques (Wang et al. 1998). 
Furthermore, the formation and progression of atherosclerotic lesions, as well as monocyte 
chemotaxis, were reduced by pharmacological induction or the overexpression of HO-1 in 
hypercholesterolemic animals, and consistent with that finding, lesion development was 
exacerbated upon pharmacological inhibition of HO-1 (Ishikawa et al. 2001a, Ishikawa et 
al. 2001b, Juan et al. 2001). Similarly, in animal models of RA, markers of inflammation 
such as joint swelling, cartilage degradation, inflammatory tissue proliferation, and the 
secretion of proinflammatory mediators were reduced upon the induction of HO-1 with 
cobalt protoporphyrin (CoPP) and cilostazol, the latter of which additionally increased the 
apoptosis of inflammatory synovial tissue cells (Benallaoua et al. 2007, Park et al. 2010). 
3. Apoptosis
Apoptosis, a type of programmed cell death, is crucial for tissue homeostasis 
and normal development. Many developmental processes and immune 
defense reactions produce cells that must be removed without provoking 
unnecessary immune reactions, such as the removal of self-reactive T cells 
during their maturation in the thymus or the disposal of neutrophils after 
inflammation has been resolved (Savill 1997, Saikumar et al. 1999). Apoptosis 
has been suggested to be involved in the resolution of inflammation; 
accordingly, immune reactions have been shown to induce apoptosis, e.g., 
via TLR2 activation (Aliprantis et al. 1999, Saikumar et al. 1999, Martin et 
al. 2012). Aberrant apoptosis has been associated with a range of diseases 
varying from developmental disorders and neurodegeneration to cancer 
and dysregulated immune defense (Fuchs & Steller 2011). 
3.1 Morphological and biochemical features of apoptosis
Unlike other cell death mechanisms, most notably necrosis/necroptosis and pyroptosis, 
apoptotic cell death is immunologically silent (Kaczmarek et al. 2013, Sangiuliano 
et al. 2014). During necrosis, proinflammatory mediators present in various cellular 
compartments of the dying cell are released, which provokes inflammatory reactions in 
neighboring cells (Sangiuliano et al. 2014). In contrast, apoptosis is characterized by the 
following morphology: (1) cells and nuclei shrink, with the ensuing condensation of the 
nucleus and chromatin; (2) cells become rounded and retract from neighboring cells; and 
(3) the plasma membrane remains intact and forms blebs that may be “pinched off” as small 
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vesicles called “apoptotic bodies” (Saraste & Pulkki 2000). The morphological alterations 
that occur during apoptotic cell death are illustrated in Figure 2. Biochemically, apoptosis is 
defined by the fragmentation of DNA by DNases into typical 180- to 200-base-pair pieces 
(Saraste & Pulkki 2000). The cleavage of cellular proteins, organelles, and nuclear lamina 
as well as the morphological changes are largely mediated by caspases (Saraste & Pulkki 
2000, Taylor et al. 2008). The reasons for the cleavage of proteins and the condensation and 
fragmentation of DNA have yet to be elucidated. However, it has been proposed that these 
events facilitate the clearance of apoptotic cells (the clearance of apoptotic cells is explained 
in greater detail in Chapter 3.3) and prevent inflammatory reactions (Taylor et al. 2008, 
Martin et al. 2012).
Figure 2. Morphology of apoptosis. Similar morphological features of apoptosis are observed across 
different cell types and species. Early in the apoptotic process the cell shrinks and the nucleus and chromatin 
condensate. The condensation of chromatin, i.e., pyknosis, is a hallmark of apoptosis. Plasma membrane 
blebbing (the formation of plasma membrane protrusions) is followed by the fragmentation of the nucleus. 
The separation of the blebs from the cell forms apoptotic bodies containing cellular organelles and nuclear 
fragments. Data are derived from Ziegler & Groscurth 2004, Elmore 2007, and references mentioned in the text. 
 
 
3.2 Apoptotic cell death
Apoptotic cell death can be triggered by intrinsic or extrinsic routes. Intrinsic and extrinsic 
apoptosis differ by the signaling events that precede the activation of executor caspases, which 
mediate the morphological and biochemical changes typical of apoptosis. The apoptosome 
is a large intracellular protein complex formed during intrinsic apoptosis. The apoptosome 
and the corresponding protein complexes involved in extrinsic apoptosis are required for 
the activation of caspase-proteases. Caspase-activating complexes serve as scaffolds that 
induce the activating cleavage of procaspases by concentrating the procaspases to enable 
proximity-induced autocatalysis or to allosterically regulate caspase activation (Rodriguez 
& Lazebnik 1999, Adams & Cory 2002). Two evolutionarily conserved protein families 
are the key mediators of apoptotic events: the B cell lymphoma (Bcl-2) family proteins, 
which regulate mitochondrial integrity; and caspases, which execute the cleavage phase 
(Thornberry & Lazebnik 1998, Youle & Strasser 2008). Caspases are cysteine aspartic acid-
specific proteases that cleave substrate proteins after an aspartic acid residue. Caspases 
are translated as inactive proenzymes that usually require proteolytic cleavage to become 
active (Taylor et al. 2008). The caspase family proteins are classified as initiator caspases 
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(caspase-2, caspase-8, caspase-9, and caspase-10) and executioner caspases (caspase-3, 
caspase-6, and caspase-7), which are activated by initiator caspases (Taylor et al. 2008, 
Duprez et al. 2009). Other caspase family proteins function in innate immune responses 
(caspase-1, caspase-4, caspase-5, and caspase-12) (Taylor et al. 2008). Procaspases are 
composed of a variable-length N-terminal prodomain, a large subunit (p20) and a small 
C-terminal unit (p10). Initiator caspases possess a long prodomain, which contains protein-
protein interaction-mediating regions, including death effector domains (DED) and caspase 
activation and recruitment domains (CARD) (Duprez et al. 2009). The DED and CARD 
domains are used to recruit caspases to activation complexes (Duprez et al. 2009). Caspase 
activation during cell death is characteristic of apoptosis, and if the function of caspases 
(caspase-8 in particular) is inhibited, the cell switches to necroptosis in response to apoptotic 
stimuli (He et al. 2009, Kaczmarek et al. 2013). 
       
3.2.1 Extrinsic apoptosis  
Extrinsic apoptosis is initiated by extracellular ligands that induce the activation of the 
TNFR family death receptors, including Fas receptor (FasR), TNFR1, and TRAIL-R. The 
pathways of extrinsic apoptosis induced by the activation of FasR, TRAIL-R and TNFR1 
are illustrated in Figure 3. Subsequent to the binding of the Fas ligand, the oligomerization 
of the FasR induces a signaling cascade that results in the formation of the death-inducing 
signaling complex (DISC) (Kischkel et al. 1995, Peter & Krammer 2003). In DISC the 
FADD adapter protein binds the cytoplasmic part of the receptor through homotypic DD-
DD (death domain) interactions, which is followed by the binding of procaspase-8 to FADD 
(Kischkel et al. 1995, Peter & Krammer 2003). The recruitment of procaspase-8 to the 
complex induces its activation (Peter & Krammer 2003). The DISC formed in response 
to FasR and TRAIL-R signaling remains at the plasma membrane (Wilson et al. 2009). 
 
The activation of TNFR1 induces the formation of two distinct signaling complexes 
through the partial dissociation of the first complex from the plasma membrane and by 
the binding of new subunits in the cytoplasm. The activation of TNFR1 instantly recruits a 
scaffold protein, TRADD, to its cytoplasmic tail via homotypic interactions between their 
DDs, which leads to the recruitment of signaling proteins, i.e., TRAF2, RIPK1, and the 
cellular inhibitors of apoptosis proteins (cIAPs) (Muppidi et al. 2004). The formed complex 
is called complex I, and its formation activates the transcription factor NFκB (Muppidi et al. 
2004). Complex II is formed later (> 2 h) upon the dissociation and internalization of RIPK1, 
TRAF2, and TRADD, as well as the recruitment of FADD and caspase-8/-10 (Muppidi et al. 
2004). The formation of complex II is modified by the balance between stress and survival 
signals, e.g., NFκB and c-Jun N-terminal kinase (Jnk) signaling. In complex IIA, RIPK1 is 
ubiquinated (Wilson et al. 2009). This complex is sensitive to the rate of protein synthesis, 
and it is regulated by the NFκB-dependent expression of c-FLIP and by the Jnk-dependent 
degradation of c-FLIP (Wang et al. 2008, Wilson et al. 2009). The activation of complex 
IIB is induced by the deubiquination and dissociation of RIPK1, and it is inhibited by cIAPs 
that ubiquinate RIPK1 (Wang et al. 2008, Wilson et al. 2009). Both complexes IIA and IIB 
provide a platform for the activation of procaspase-8. Regardless of the pathway of extrinsic 
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apoptosis, the activation of caspase-8 initiates the cleavage of effector caspases (Wang et 
al. 2008, Wilson et al. 2009). Extrinsic apoptosis may require amplification through the 
intrinsic pathway; e.g., in B cells caspase-8 cleaves Bid to induce intrinsic apoptosis (Wilson 
et al. 2009). 
 
 
 
 
 
Figure 3. Signaling pathways of extrinsic apoptosis. Some steps are omitted for clarity. The activation of 
FasR or TRAIL-R induces the assembly of the DISC complex (shown on the left). The activation of the TNFR 
induces the immediate formation of complex I, and later dissociation events induce the formation of cytosolic 
complexes IIA and IIB (shown on the right). The activation of caspase-8 leads to the activation of the effector 
caspases caspase-3, caspase-6, and caspase-7 (not all the activated caspases are shown in the figure), which 
induce the cleavage of cellular components. Bid, BH3-interacting domain death antagonist; C-3, caspase-3; C-8, 
caspase-8; cIAP, cellular inhibitors of apoptosis protein; DISC, death-inducing signaling complex; FADD, Fas-
associated death domain; FasR, Fas receptor; c-FLIP, cellular FLICE inhibitory protein; JNK, c-Jun N-terminal 
kinase; NFκB, nuclear factor κ-light chain-enhancer of activated B cells; RIPK1, receptor-associated protein 
kinase 1; Smac, second mitochondrial activator of caspases; TNF, tumor necrosis factor; TRADD, TNF receptor-
associated-protein with death domain; TRAF, TNF receptor-associated protein 2; TRAIL, TNF-related apoptosis-
inducing ligand. Data are derived from references mentioned in the text.
3.2.2 Intrinsic apoptosis  
Intrinsic apoptosis can be initiated by cellular stress induced by diverse stimuli, such as toxic 
agents and DNA damage. Intrinsic apoptosis beginns by the permeabilization of the outer 
mitochondrial membrane, and it is regulated by the members of the Bcl-2 protein family 
(Taylor et al. 2008). The activation pathways of intrinsic apoptosis are presented in Figure 
4. The Bcl-2 family contains both proapoptotic and antiapoptotic proteins. The proapoptotic 
Bcl-2-family membranes include Bax, Bak, and Bok (Bcl-2-related ovarian killer) (Youle 
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& Strasser 2008). Upon the induction of apoptosis, the proapoptotic Bcl-2 family members 
permeabilize the mitochondrial outer membrane, thereby causing the release of cytochrome 
c from the space between the outer and inner mitochondrial membranes into the cytosol 
(Youle & Strasser 2008). The process that leads to the release of cytochrome c is called 
mitochondrial outer membrane permeabilization (MOMP). Cytochrome c is released 
through pores formed by Bax and Bak (Youle & Strasser 2008, Subburaj et al. 2015). The 
mechanisms of pore formation and the physical nature of the pore have remained elusive 
for long. However, Subburaj et al. recently suggested that activated Bax is inserted on 
mitochondrial outer membrane in the monomeric state. Subsequent to its insertion, Bax 
rapidly forms dimers that further oligomerize into variable size pore structures (Subburaj et al. 
2015). In the cytosol, cytochrome c associates with APAF1 and induces its oligomerization; 
then, the oligomerized APAF1 forms a complex with caspase-9, resulting in the formation of 
a large complex, called the apoptosome. (Rodriguez & Lazebnik 1999, Zou et al. 1999). The 
apoptosome is thought to be the actual active form of caspase-9. Active caspase-9 initiates 
a cascade that cleaves the downstream executioner caspases (Rodriguez & Lazebnik 1999). 
The functions of the pro-death proteins are opposed by the antiapoptotic Bcl-2 proteins, such 
as Bcl-2, Bcl-xL (Bcl-2-like protein), Bcl-w (Bcl-2-like-2), Bcl-2L10, Bcl-2A1, and Mcl-1 
(myeloid cell leukemia sequence-1) (Youle & Strasser 2008). Additionally, the proapoptotic 
proteins include a group of BH3-only proteins, such as Bim (Bcl-2-like-11), Bid, Bad 
(Bcl-2 antagonist of cell death), Puma (Bcl-2-binding component-3), Noxa (phorbol-12-
myristate-13-acetate-induced protein 1), Bik (Bcl-2-interacting killer), Hrk (harakiri), and 
Mule (Mcl-1 ubiquitin ligase E3) (Shamas-Din et al. 2011). These proteins are proposed to 
either inhibit the antiapoptotic proteins or to enhance the oligomerization and insertion of 
the proapoptotic proteins into the mitochondrial membrane by interacting with or directly 
binding to them (Willis et al. 2007, Shamas-Din et al. 2011). 
Figure 4. Signaling pathways of intrinsic apoptosis. Some steps are omitted for clarity. Intrinsic apoptosis is 
induced by cellular stress, which initiates MOMP. Bax and Bak form pores through which cytochrome c and IAP-
regulatory proteins, such as Smac/DIABLO, are released from the intermembrane space of mitochondria. BH3-
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only proteins inhibit antiapoptotic proteins by binding them. BH3-only proteins also interact with proapoptotic 
proteins, thereby enhancing their functions. Cytochrome c induces the oligomerization of APAF1, which results 
in the formation of the apoptosome. Smac/DIABLO allows the activation of caspases by binding IAPs. The 
activation of caspase-9 induces the activation of the effector caspases caspase-3, caspase-6, and caspase-7 
(not all activated caspases are shown in the figure), which mediate the destruction of cellular components. 
APAF1, apoptotic protease-activating factor-1; Bak, Bcl-2- antagonist/killer-1; Bax, Bcl-2-associated X 
protein; Bcl-2, B cell lymphoma; IAPs, inhibitor of apoptosis proteins; MOMP, mitochondrial outer membrane 
permeabilization; Smac/DIABLO, second mitochondrial activator of caspases/direct IAP-binding protein with low 
pI. Data are derived from references mentioned in the text.
3.2.3 Inhibitors of apoptosis  
The death of a cell is an irreversible process; therefore, protein families that prevent 
apoptosis exist. Among the inhibitors of apoptosis proteins (IAPs), the mammalian 
IAP, X-linked inhibitor of apoptosis (XIAP), is one of the most potent and most widely 
studied caspase inhibitors (Salvesen & Duckett 2002). IAPs bind directly to activated 
caspases through their baculovirus-inhibitory repeat domain (BIR) (Silke & Vucic 
2014). IAPs seem to be regulated by at least three different levels: transcriptionally/post-
transcriptionally, via degradation in proteasomes, and by regulatory proteins (Salvesen 
& Duckett 2002). When cells are committed to die, IAPs are inactivated by interactions 
with regulatory proteins, such as Smac/DIABLO, which are localized to the mitochondrial 
inter-membrane space, and are released simultaneously with cytochrome c (Verhagen et al. 
2000). Smac/DIABLO and another IAP regulatory protein, high-temperature requirement 
A2 (HtrA2, also known as Omi) bind IAPs directly through their IAP-binding motifs 
(Suzuki et al. 2001, Salvesen & Duckett 2002). Two negative regulators of IAPs that lack 
IAP-binding motifs have been recognized. They are also thought to interact with IAPs, 
although the mechanism of binding must differ from that exerted by other IAP-regulatory 
proteins (Salvesen & Duckett 2002).
3.3 Clearance of apoptotic cells
Apoptotic cell death does not provoke inflammation because during apoptosis no 
proinflammatory mediators are released. Instead, apoptotic cells are rapidly and efficiently 
removed by phagocytosis (Ravichandran & Lorenz 2007, Ravichandran 2011). The quick 
removal of apoptotic cells is ensured by secreted chemotactic signals that recruit phagocytes 
to the target. Among these signals is the lipid lysophosphatidylcholine, which is cleaved 
from membranous phosphatidylcholine by the caspase-3 activated calcium-independent 
phospholipase A2 (Lauber et al. 2003). Lauber et al. could not demonstrate that sphingosine-
1-phosphate (S1P) functions as a chemotactic agent; however, Gude et al. showed that S1P 
is a potent chemotactic molecule for monocytic line cells and for primary monocytes and 
macrophages (Gude et al. 2008). Additionally, ATP/UTP, when found in the extracellular 
space, signals cell death. Therefore, it also acts as a danger signal for neighboring cells 
(Elliott et al. 2009).The subcutaneous injection of nucleotides into mice induced chemotaxis 
of monocytes and macrophages, and the deletion of the nucleotide recognition receptor was 
shown to inhibit the clearance of apoptotic cells (Elliott et al. 2009). In addition, a soluble 
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fragment of fractalkine protein is a well-characterized phagocyte attractant, and the absence 
of its receptor was shown to impair macrophage recruitment to apoptotic B cells at germinal 
centers of lymphoid follicles in vivo (Truman et al. 2008). Apoptotic cells also secrete 
signals that lure phagocytes to engulf them. Phosphatidyl serine (PS) is a phospholipid that 
is normally not exposed to phagocytes because in living cells, PS is located only on the inner 
leaflet of the plasma membrane (Fadok et al. 1992). However, Fadok et al. demonstrated 
that apoptotic cells flip PS on the cell surface, which can function as an “eat me” signal. To 
avoid unwanted neutrophil migration and inflammatory reactions, cells are also capable of 
secreting lactoferrin, which is a well-recognized anti-inflammatory glycoprotein (Bournazou 
et al. 2009). 
4. Signalosomes of innate immunity
Innate immunity signaling is not merely an action of independent receptors. 
Instead proteins recruited and activated by receptor activation have a 
tendency to form protease cascades and signaling networks that permit 
the temporal and spatial regulation of the signal, as well as to induce local 
enrichment of signal-mediating components to enable proximity-driven 
signal transduction (Wu 2013). In the signaling networks, positive and 
negative feedback loops may amplify or reduce the signal, respectively, 
ensuring faster signal transduction and the efficient reduction in noise. 
Because of the obvious benefits to the host, innate immunity signaling 
cascades are highly conserved in evolution (Gay & Gangloff 2007, Wu 
2013). Many receptors of innate immunity form regulatory networks in which 
the activation of one receptor is a prerequisite for the activation of another 
receptor. For example, the stimulation of TLRs increases the expression 
of some NLRs (Becker & O’Neill 2007). Furthermore, the oligomerization 
of inflammasome proteins into an inflammasome complex allows the rapid 
proximity-induced activation of caspases and the amplification of the signal 
(Lu et al. 2014). The formation of higher-order oligomeric structures further 
explains why receptor complexes can be observed as visible punctate 
morphologies in cells (Wu 2013). 
4.1 Pattern recognition receptors
The recognition of danger is a fundamental step in the initiation of immune responses and the 
protection of the host. Distinguishing between harmless and dangerous is by no means simple 
and contains the risk of errors. The first hypothesis regarding immune system recognition 
mechanisms suggested that the immune system discriminates between self (entities defined 
during early development) and nonself (e.g., pathogenic entities). However, when it became 
apparent that the immune system does not reject all nonself (e.g., the pregnant woman does 
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not reject the fetus) and that adaptive immune responses could not be activated without 
adjuvants, Janeway proposed that innate immune cells were responsible for recognizing a 
large array of molecular patterns that distinguish noninfectious self from infectious nonself 
(Janeway 2013). In addition to pathogen-derived exogenous danger signals, an increasing 
number of endogenous signals capable of eliciting immune reactions were acknowledged, 
which led to the development of the danger model (Matzinger 2002). The danger model 
suggests that the immune system alerts to danger signals during infection, inflammation or 
tissue injury; thus, virtually any endogenous molecule is regarded as a danger signal when it 
is encountered in an unusual location (Matzinger 2002). Molecules sensed as danger signals 
are now classified according to their origin: PAMPs, which originate from pathogens, or 
danger-associated molecular patterns (DAMPs), which originate, for example, from altered 
or misplaced selfmolecules (Medzhitov & Janeway 2000, Beutler 2004, Seong & Matzinger 
2004). 
Exogenous and endogenous danger signals are sensed by a limited number of conserved 
germ line-encoded receptors, PRRs, which recognize conserved pathogenic molecules and 
endogenous signals derived from dying or stressed cells (Matzinger 2002). PRRs target 
molecules that are broadly shared by pathogens and are not readily altered by mutations 
due to their indispensability for the organism (Janeway 2013, Medzhitov & Janeway 1997). 
PRRs are primarily expressed by cells capable of presenting antigens, such as macrophages, 
dendritic cells and B cells (Medzhitov & Janeway 1997). PRRs can be classified into at least 
five families: (1) TLRs, (2) NLRs, (3) Absent in Melanoma 2 (AIM2)-like receptors (ALRs), 
(4) Retinoic acid inducible gene I-like receptors, and (5) C-type lectin receptors (Akira et 
al. 2006, Takeuchi & Akira 2010, Kumar et al. 2013). TLRs are classical receptors of innate 
immunity that perform most microbial detection in mammals (Beutler 2004). The bacterial 
and viral ligands sensed by TLRs are diverse, including proteins, nucleic acids, lipids and 
lipopeptides (Beutler 2004, Akira et al. 2006, Gay & Gangloff 2007, Beutler 2009). Some 
TLRs recognize different PAMPs of the same pathogen; in addition, there are redundancies 
in ligand recognition between different PRRs (Kawai & Akira 2011).
4.1.1 Toll-like receptors  
All TLR paralogs are type I transmembrane receptors that belong to the IL-1/TLR receptor 
superfamily, along with IL-1 and IL-18 receptors (Dunne & O’Neill 2003, Akira et al. 2006). 
Different TLRs are located on intracellular membranes or on the cell surface. TLR3 and 7-9 
recognize intracellular organisms and are located on the membranes of intracellular vesicles, 
whereas TLR1, 2, and 4-6 are located on the cell surface, where they sense ligands from the 
extracellular space (Kawai & Akira 2011). The leucine-rich repeat (LRR) of TLRs senses 
ligands, and upon ligand recognition, TLRs form either hetero- or homomeric complexes 
with each other (Kawai & Akira 2011). Their activation culminates in the innate immune cell 
responses, which are induced by the activation of NFκB and the subsequent transcription 
of proinflammatory cytokines (Doyle & O’Neill 2006). Probably the best-studied molecule 
recognized by PRRs is the bacterial endotoxin LPS. LPS was first characterized by Pfeiffer 
in 1892, and later positional cloning studies revealed that LPS is recognized by TLR4 
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(Poltorak et al. 1998, Beutler 2004). LPS is an outer membrane component of the cell wall 
of Gram-negative bacteria, and in large quantities it induces septic shock and lethality due 
to the systemic release of proinflammatory cytokines, such as TNFα, IL-1 and IL-6 (Beutler 
2004). The signal transduction that occurs after the activation of the endotoxin receptor 
TLR4 proceeds via two different routes: the myeloid differentiation factor 88 (MyD88)-
dependent pathway, which leads to the early-phase activation of NFκB and MAPK, or the 
TIR-domain-containing adaptor-inducing interferon-β (TRIF)-dependent pathway, which 
leads to the late-phase activation of NFκB and MAPK, both of which are required for the 
induction of proinflammatory cytokine transcription (Kawai & Akira 2011). 
Different PRRs cooperate in the activation of the NLRP3 inflammasome; the activation 
of TLR or cytokine receptors is a prerequisite for the activation of the NLRP3 receptor. 
Intracellular PRRs capable of inflammasome formation, the NLRs and ALRs, will be 
discussed in greater detail below.  
4.2 Inflammasomes
The inflammasome acts as a checkpoint that regulates the secretion of strong proinflammatory 
cytokines, which elicit cellular protection and bacterial clearance (Latz et al. 2013). 
Inflammasomes are intracellular multiprotein complexes formed upon the activation of their 
receptor proteins (Latz et al. 2013). The inflammasome complex acts as a platform for the 
activation of (pro)inflammatory caspase-1 (Lu et al. 2014). The activated caspase-1 further 
mediates the proteolytic maturation of the proforms of the inflammatory cytokines IL-1β 
and IL-18 (Dinarello 1998). The activation of the inflammasome may result in cell death 
via the activation of apoptotic or pyroptotic pathways, depending on the strength of the 
inflammatory stimulus (Fernandes-Alnemri et al. 2007, Sagulenko et al. 2013). Cell death 
may help to attenuate the invasion of pathogens by denying their protective niche in the cell. 
To date, many different inflammasome-forming receptors have been recognized, and they 
are divided into two superfamilies according to their sensor protein: NLRs, which recognize 
a plethora of pathogen- or stress- and danger-associated signals (Davis et al. 2011), and 
ALRs, which specifically recognize double-stranded DNA (Rathinam et al. 2012).   
4.2.1 Interleukin-1β (IL-1β)  
IL-1β is a strong proinflammatory cytokine that affects virtually all cell types. The most 
prominent symptom caused by excessive IL-1β secretion is fever (Dinarello 1998, Dinarello 
2009). IL-1β induces inflammatory and immune responses by enhancing neutrophil 
chemotaxis and the generation of proinflammatory cytokines (Apte & Voronov 2008). IL-
1β also promotes cell differentiation, angiogenesis and hemopoiesis (Apte & Voronov 2008, 
Dinarello 2009). IL-1β is a member of the IL-1 protein family, which is further divided 
into three subfamilies: the IL-1, IL-18, and IL-36 subfamilies (Garlanda et al. 2013). The 
IL-1 subfamily encompasses IL-1β, IL-1α, IL-33 and the IL-1 receptor antagonist (IL-1RA) 
(Garlanda et al. 2013). All the members of the IL-1 subfamily are encoded by different 
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genes and have different patterns of expression and secretion (Rock et al. 2010). However, 
they all bind to the receptors that belong to IL-1 receptor family: IL-1β, IL-1α, and IL1RA 
bind to IL-1 receptor 1, and IL-33 binds to the IL-1-related protein ST2L (Schmitz et al. 
2005, Palomo et al. 2015). Consequently IL-1β, IL-1α and IL-33 activate the cell, whereas 
IL-1RA acts as a competitive antagonist that physically inhibits the binding of IL-1β and 
IL-1α (Rock et al. 2010, Garlanda et al. 2013). In contrast to IL-1β, IL-1α and IL-33 are 
synthesized in a form that is ready to activate their respective receptors, and their cleaved 
forms also activate the receptors (Cohen et al. 2010, Kim et al. 2013, Palomo et al. 2015). 
IL-1α and IL-33 are released from damaged or dying cells and signal that cellular damage 
has occurred (Garlanda et al. 2013, Palomo et al. 2015). The released forms of IL-1α and 
IL-33, as well as secreted mature IL-1β are proinflammatory. Thus, in sterile inflammation, 
IL-1α has been suggested to initiate neutrophil recruitment, and the secretion of IL-1β has 
been implicated in the later recruitment of macrophages, which propagates inflammation 
(Rider et al. 2011).
IL-1β is secreted mainly by mononuclear cells, whereas nonphagocytic cells generally secrete 
only small amounts of IL-1β (Apte & Voronov 2008). The secretion of IL-1β is subjected to 
tight regulation at the levels of transcription, translation, maturation and secretion (Dinarello 
2009). The transcription of IL-1β is induced by a wide variety of microbial products through 
the activation of the TLRs; it is also induced by nonmicrobial products, such as cytokines, 
including IL-1β itself, which activate cytokine receptors (Bauernfeind et al. 2009, Marucha 
et al. 1990, Gross et al. 2011). Unlike proIL-1α, the proform of IL-1β is not active (Dinarello 
1996). IL-1β is activated by the cleavage of its N-terminal propiece between amino acids 
Asp116 and Ala117; this cleavage is catalyzed by the cysteine protease caspase-1 (previously 
known as IL-1β converting enzyme, ICE) (Thornberry et al. 1992, Higgins et al. 1994). In 
the extracellular space, the released proIL-1β can also be cleaved into its mature form by 
other proteases, such as serine proteinase 3 (Fantuzzi et al. 1997, Joosten et al. 2009).
The IL-1β protein lacks a signal sequence, which would direct it to be secreted via the 
conventional endoplasmic reticulum and Golgi secretory route (Auron et al. 1984). Different 
mechanisms have been suggested for the secretion of IL-1β. Based on the targeting of IL-1β 
in the endosomal/lysosomal compartment, which allows the colocalization of proIL-1β with 
procaspase-1, Andrei et al. suggested that the targeting of IL-1β to this compartment may 
lead to its degradation in the lysosome. However, instead of the lysosomal degradation of 
IL-1β, the ATP-induced activation of the P2X7 receptor and potassium efflux was found to 
lead to inflammasome activation and the processing of proIL-1β. Subsequently, mature IL-
1β was shown to be secreted by lysosome exocytosis in a process dependent on an increase 
in the intracellular calcium concentration, the activation of phospholipase C, and calcium-
independent and -dependent phospholipase A2 (Andrei et al. 1999, Andrei et al. 2004). The 
activation of the P2X7 receptor has also been suggested to induce the formation of plasma 
membrane-derived vesicles. In this model, the plasma membrane forms blebs in response 
to P2X7 receptor activation, and biologically active IL-1β is secreted by this microvesicle 
shedding in a process that is dependent of the extracellular calcium concentration (MacKenzie 
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et al. 2001). Another P2X7-dependent secretion model suggests that IL-1β is secreted in 
exosomes contained in multivesicular bodies, along with active caspase-1, cathepsin B, and 
lysosomal proteins (Qu et al. 2007b). However, unlike microvesicle shedding, this model is 
independent of the extracellular calcium concentration (Qu et al. 2007b). Furthermore, IL-
1β has been suggested to be released to the extracellular space from autophagosomes (the 
autophagy-based unconventional secretion of IL-1β is explained in greater detail in Chapter 
6.1) (Dupont et al. 2011). The release of IL-1β by some activators has also been associated 
with cell death. Inflammasome activation induces either lytic pyroptotic cell death, which 
releases the cell contents, or apoptosis (Sagulenko et al. 2013). The direct secretion of IL-
1β across the plasma membrane has been proposed to precede cell death by an unknown 
mechanism (Verhoef et al. 2005). However, the secretion of IL-1β does not require cell 
death per se, as shown by the inhibition of lytic cell death with glycine, which reduced but 
did not block the secretion of IL-1β (Verhoef et al. 2005).   
4.2.2 Structure of nucleotide-binding domain leucine-rich repeat-containing receptors 
To date, as many as 22 genes that encode NLR proteins have been reported in humans (Man & 
Kanneganti 2015). NLR proteins share a typical domain organization characterized by three 
main structural domains: a C-terminal ligand-binding domain consisting of several LRRs; 
followed by a conserved central nucleotide-binding and oligomerization domain (NACHT, 
also referred to as NOD), which is common to all NLRs; and an N-terminal effector domain, 
which binds downstream signaling molecules (Istomin & Godzik 2009) (An example of an 
NLR protein, NLRP3, is shown in Figure 6 on page 41). Additionally, several NLRs contain 
a NACHT-associated domain (NAD). NLR proteins differ by their signal-transducing 
N-terminal effector domains. Based on their effector domains and phylogenetic evidence, 
inflammasome-forming NLR proteins can be classified into the following subgroups: 
NLRA, which contains an acidic transactivation domain; NLRB, which contains a BIR 
domain; NLRC, which contains a CARD domain; NLRP, which contains a death fold pyrin 
(PYD) domain; and NLRX, which contains an N-terminal domain unrelated to any other 
NLR (Martinon & Tschopp 2005, Proell et al. 2008, Ting et al. 2008). In addition to ligand 
sensing, LRR has been proposed to inhibit the oligomerization of the inflammasome by 
interacting with NACHT domains in the absence of an activating stimulus (Martinon & 
Tschopp 2005). 
Upon activation certain NLR proteins, such as NLRP1, NLRP3, NLRP6, NLRP7, NLRP12, 
NLRC4 (NLR family CARD domain-containing protein 4), and NLRC4/NAIP (NLR 
family, apoptosis inhibitory protein) form cytosolic scaffolds termed inflammasomes, 
which enable the activation of the proform of caspase-1 (Martinon et al. 2009, Kofoed 
& Vance 2011, Khare et al. 2012, Rathinam et al. 2012, Latz et al. 2013). NLRPs that 
lack the CARD domain require an adaptor protein to bridge the NLR sensor proteins 
and caspase-1.The adaptor protein used in NLRP3 inflammasomes is a bipartite protein 
called apoptosis-associated speck-like protein containing a caspase-recruitment domain 
(ASC), which is composed of an N-terminal pyrin domain (PYD) and a C-terminal CARD 
domain (Mariathasan et al. 2006, Mariathasan & Monack 2007). In addition to NLRs, other 
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intracellular sensors form inflammasomes. The receptor proteins of Absent in melanoma 
2 (AIM2) and interferon-inducing protein 16 (IFI16) inflammasomes belong to the pyrin 
domain and hematopoietic expression, interferon-inducible nature, and nuclear localization 
domain-containing (PYHIN) receptor family (Hornung et al. 2009, Kerur et al. 2011). 
The AIM2 inflammasome consists of one or two DNA-binding HIN-200 domains at the 
C-terminus and an N-terminal PYD (Davis et al. 2011, Rathinam et al. 2012). Similar to 
NLRPs, AIM2 lacks a CARD domain; therefore, the assembly and activation of the AIM2 
inflammasome requires ASC (Rathinam et al. 2012). The function of the prototypical ASC-
harboring inflammasomes NLRP3 and AIM2 will be described in greater detail below.  
4.2.3 Activation of the NLRP3 inflammasome  
Inflammasomes recognize a range of environment- and host-derived DAMPs and microbial 
components through direct binding and/or through indirect mechanisms. Most inflammasome-
forming receptors recognize a limited number of conserved microbial ligands. However, the 
activation of the NLRP3 inflammasome is triggered by several heterogeneous DAMPs. The 
activation of the NLRP3 inflammasome is bipartite: the first signal, also called priming, 
initiates the expression of the NLRP3 and proIL-1β proteins, and the second signal induces 
the assembly and activation of the NLRP3 inflammasome. 
In unstimulated macrophages and monocytes the expression levels of the inflammasome 
sensor protein NLRP3 and of proIL-1β are generally low; therefore, a priming signal is 
required to induce their expression (Bauernfeind et al. 2009, Marucha et al. 1990). The 
priming signal is usually a proinflammatory compound from a microbial or endogenous 
source, such as LPS, but the acute-phase protein SAA or cytokines also activate TLRs or 
cytokine receptors to induce the activation of NFκB (Marucha et al. 1990, Gay & Gangloff 
2007, Bauernfeind et al. 2009, O’Connor et al. 2003, Niemi et al. 2011). The inflammasome 
components NLRP3 and ASC are further subjected to post-translational regulation. To be able 
to induce the assembly and activation of the inflammasome complex, the NLRP3 receptor 
protein must be deubiquitinylated, which can be mediated by the endogenic deubiquitinase 
BRCC3 (Juliana et al. 2012, Py et al. 2013, Lopez-Castejon et al. 2013). The expression 
of BRCC3 may be stimulated by the MAPK pathway, indicating that TLR activation 
might deubiquinate NLRP3 and thereby favor the activation of the NLRP3 inflammasome 
(Py et al. 2013). Furthermore, the NO-mediated S-nitrosylation of NLRP3 prevents the 
assembly of the NLRP3 inflammasome (Hernandez-Cuellar et al. 2012). In addition, the 
activity of caspase-1 can be regulated by its oxidation, which has been shown to result in the 
glutathionylation of caspase-1, which inhibits its activity (Meissner et al. 2008). 
Several kinases contribute to the inflammasome assembly and processing of IL-1β (Shio 
et al. 2009, Chuang et al. 2011, Hara et al. 2013, Martin et al. 2014). The oligomerization 
of the adaptor protein ASC is required for the formation of the active NLRP3 and AIM2 
inflammasome complexes (inflammasome complex formation is explained in greater detail 
below). ASC is subjected to post-translational regulation by kinases, such as Syk, Jnk, and 
IKKα kinase (Hara et al. 2013, Martin et al. 2014). The phosphorylation of ASC by Syk and 
Jnk is required for the oligomerization of ASC and the activation of caspase-1 (Hara et al. 
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2013). However, Syk and Jnk seem to induce the localization of ASC to perinuclear area rather 
than inducing the oligomerization of ASC (Hara et al. 2013). In resting cells, ASC is found in 
the cytoplasm, mitochondria and nucleus (Bryan et al. 2009, Zhou et al. 2011, Misawa et al. 
2013), and the redistribution of ASC to the perinuclear space is required for inflammasome 
complex formation and activation (Bryan et al. 2009). Martin et al. demonstrated that the 
nuclear localization of ASC is regulated by the kinase IKKα. Thus, in the absence of an 
activating stimulus, IKKα retains ASC in the nucleus (Martin et al. 2014). The negative 
regulation of inflammasome complex formation and activation by IKKα is illustrated in 
Figure 5. Inflammasome priming inhibits IKKα, which is followed by the relocalization of 
IKKα and ASC to the perinuclear area (Martin et al. 2014). The second signal that activates 
the NLRP3 inflammasome induces the recruitment of phosphatase PP2A, which allows the 
dissociation of IKKα from ASC, resulting in the assembly of the inflammasome (Martin et 
al. 2014). In addition to the conventional model of inflammasome activation induced by two 
separate priming and activation signals, it was recently demonstrated that a rapid NLRP3 
inflammasome activation pathway is induced by the synergistic sequential activation of 
TLRs and NLRP3, which induces acute NLRP3 inflammasome activation via the kinase 
activity of IRAK-1 downstream of TLR activation (Lin et al. 2014).
Figure 5. Negative regulation of inflammasome complex formation by IKKα. IKKα regulates the formation 
of ASC-dependent inflammasome complexes by controlling the subcellular location of ASC. In the absence of a 
priming signal, IKKα retains ASC in the nucleus. LPS induces the translocation of IKKi to the nucleus and allows 
the signaling events leading to the translocation of the ASC-IKKα complex to the perinuclear area. An NLRP3 
inflammasome-activating signal (e.g., ATP) inhibits IKKα kinase activity by recruiting PP2A, which participates 
in the dissociation of ASC from IKKα. The liberated ASC is able to participate in NLRP3 inflammasome 
complex formation in the perinuclear area. ASC, apoptosis-associated speck-like protein containing a caspase-
recruitment domain; ATP, adenosine triphosphate; IKK, IκB kinase; IRAK, IL-1 receptor-activated kinase; LPS, 
lipopolysaccharide; PP2A, protein phosphatase 2. Data are derived from Martin et al. 2014. 
In the absence of an activating stimulus, the NLRP3 receptor has been suggested to be in an 
autorepressed state, and a sufficient stimulus is needed to overcome the autorepression to 
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further induce the oligomerization of NLRP3 (Martinon & Tschopp 2005). The activation of 
the NLRP3 receptor induces the recruitment of inflammasome components and the assembly 
of the multiprotein complex. The assembly of the inflammasome is mediated by homotypic 
interactions between the receptor complex and two members of the death domain superfamily, 
PYD and CARD (Ferrao & Wu 2012). Upon inflammasome assembly, the PYD domain of 
NLRP3 interacts with the PYD of ASC, which induces the polymerization of ASC. ASC 
forms hollow filaments, thereby creating a platform for the nucleation of caspase-1 filaments, 
and flexibly linked CARD domains allow the polymerization of caspase-1, leading to the 
formation of filaments that continue the structure of ASC filaments (Lu et al. 2014). The 
oligomerization of caspase-1 induces its proximity-induced dimerization, which results 
in its autoproteolytic processing and the activation of the p10 and p20 subunits (Lu et al. 
2014). According to a recent study by Lu et al., relatively few sensor molecules of the AIM2 
and NLRP3 inflammasomes are needed for the assembly of the inflammasome complex. 
An active inflammasome complex is a large structure (approximately 2 µm), and upon 
inflammasome assembly the oligomerization of ASC is readily visualized as structures called 
ASC specks (Lu et al. 2014, Bauernfeind et al. 2009, Hornung et al. 2009). In another model 
proposed by Man et al., Salmonella infection induced the formation of an inflammasome 
complex in which caspase-1 and caspase-8 are located in the center and are surrounded by 
ASC and both NLRP3 and NLRC4 (Man et al. 2014). However, it has also been questioned 
whether ASC speck formation is always related to inflammasome activation and whether 
inflammasome activation can also be induced without speck formation (Elliott & Sutterwala 
2015). The structures of the NLRP3 inflammasome in the unoligomerized and oligomerized 
states, the latter representing the active inflammasome complex, are illustrated in Figure 6.
Figure 6. Structure of the NLRP3 
inflammasome. The domains of the NLRP3 
inflammasome are depicted on the left, 
and the active multiprotein inflammasome 
complex, according to the model of Lu et al., 
is shown on the right (Lu et al. 2014). The 
LRRs of the NLRP3 inflammasome sense 
the activating stimulus, and the central 
NACHT domain mediates the oligomerization 
of the complex. This oligomerization 
induces the proximity-induced cleavage of 
caspase-1, which results in the formation of 
heterotetrameric complexes consisting of two 
p10 and two p20 subunits. The complex of p10 
and p20 is the activated form of caspase-1. 
ASC, apoptosis-associated speck-like protein 
containing a caspase-recruitment domain; 
CARD, caspase recruitment domain; LRR, 
leucine-rich repeat; NACHT, nucleotide-
binding and oligomerization domain; 
PYD, pyrin domain. Data are derived from 
references mentioned in the text.
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Many of the DAMPs that activate the NLRP3 inflammasome are misplaced cellular 
components, which are exposed to receptors that normally do not encounter them or are 
generated in response to inflammation, infection, cellular damage, metabolic dysregulation 
or environmental stress. A great variety of different exogenous and endogenous activators 
have been described, including bacterial nucleic acids (Sha et al. 2014) and bacterial toxins, 
such as nigericin (Mariathasan et al. 2006); DNA and RNA viruses (Lupfer & Kanneganti 
2013); fungi and protozoa, e.g., the fungal pathogen Candida albicans and the hemozoin 
formed during malarial infection (Franchi et al. 2012, Shio et al. 2009); ATP (Mariathasan 
et al. 2006); and particles such as silica and asbestos (Dostert et al. 2008), cholesterol 
crystals, and uric acid crystals (Duewell et al. 2010, Rajamaki et al. 2010, Martinon et 
al. 2006). Although the precise mechanism of NLRP3 inflammasome activation has yet 
to be elucidated, it is generally accepted that instead of the direct ligation of an agonist, 
disturbances in cellular homeostasis mediate the activation of the NLRP3 inflammasome. 
The most common mechanisms implicated in the transduction of the activating signal to 
the NLRP3 inflammasome are potassium efflux, the disruption of lysosomal integrity, and 
the production of ROS (Davis et al. 2011, Man & Kanneganti 2015). It seems that more 
than one activating signal is often induced simultaneously. The three main mechanisms 
suggested to mediate the activation of the NLRP3 inflammasome are summarized below 
and are illustrated in Figure 7. Subphysiological amounts of intracellular potassium 
induced by NLRP3 activators, such as ATP and nigericin, have been shown to activate 
the NLRP3 inflammasome (Mariathasan et al. 2006, Petrilli et al. 2007). Reciprocally, 
high extracellular potassium concentrations, which prevent the lowering of intracellular 
potassium by inhibiting potassium efflux, inhibit the activating effect of various NLRP3 
activators (Petrilli et al. 2007). Extracellular ATP induces potassium efflux by the activation 
of the P2X7 receptor, which opens pannexin-1 hemichannels that form pores on the cell 
membrane, thereby leading to potassium efflux (Pelegrin & Surprenant 2006). However, 
the role of pannexin in potassium efflux seems controversial: the receptor P2X7 is a cation 
channel itself, and a deficiency in pannexin-1 was shown to not impair the activation of the 
NLRP3 inflammasome (Qu et al. 2011). 
Lysosomal destabilization has been implicated as the activating mechanism, especially in 
response to crystals (Hornung et al. 2008, Duewell et al. 2010, Rajamaki et al. 2010). The 
phagocytosis of crystals and particles induces lysosomal swelling, which results in the leakage 
of lysosomal contents, along with lysosomal proteases, to the cytoplasm (Hornung et al. 
2008). Additionally, the noncrystalline substance nigericin induces the release of cathepsin 
B from seemingly intact lysosomes (Hentze et al. 2003). Cathepsin B has been suggested to 
induce the activation of the NLRP3 inflammasome because the pharmacological inhibition 
or deficiency in cathepsins B and/or L blocks the activation of the NLRP3 inflammasome by 
nigericin and various particulate matters (Hentze et al. 2003, Hornung et al. 2008, Duewell 
et al. 2010, Rajamaki et al. 2010). In addition, purified lysosomal cathepsin B has been 
shown to cleave caspase-1 (Vancompernolle et al. 1998). The release of cathepsin B has 
also been suggested to be required for necrosis-like cell death during NLRP3 inflammasome 
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activation induced by nigericin, S. flexneri or disease-associated mutated NLRP3 protein 
(Hentze et al. 2003, Willingham et al. 2007). However, the mechanisms that mediate NLRP3 
activation in response to cathepsin B are not yet fully understood. 
Cellular redox imbalance has been strongly implicated in the activation of the NLRP3 
inflammasome. Antioxidants, such as diphenylene iodium (DPI) and N-acetyl cysteine 
(NAC), and the deletion of the NADPH subunit p22phox inhibit NLRP3 activation in 
response to several activators, which first led to an assumption that NLRP3 was activated 
in response to ROS generated by NADPH oxidases (Dostert et al. 2008, Rubartelli et 
al. 2011). However, this theory was called into question by analyses of monocytes from 
patients with chronic granulomatous disease, who have defective NADPH-oxidase activity 
and consequently are unable to produce ROS via the NADPH system. It was shown that 
the activation of the NLRP3 inflammasome and the secretion of IL-1β in the monocytes of 
these patients were similar to, or even higher than, cells with normal NADPH activity (van 
de Veerdonk et al. 2010, Meissner et al. 2010). Therefore, rather than NADPH oxidases, 
oxygen radicals derived from dysfunctional or senescent mitochondria and oxidized 
mitochondrial DNA are now considered the source of ROS that induces the activation of the 
NLRP3 inflammasome (Zhou et al. 2011, Shimada et al. 2012). One mechanism of ROS-
induced inflammasome activation is the oxidation of TRX, which enables the dissociation 
of TXNIP from TRX and its subsequent binding to NLRP3, which induces the activation of 
the NLRP3 inflammasome (Zhou et al. 2010).
 
Review of the Literature 
44
 
 
 
 
Figure 7. Proposed models of NLRP3 inflammasome activation. Priming is presented on the left, and 
the most frequently suggested intermediate signaling pathways leading to the activation of the NLRP3 
inflammasome are presented on the right. The priming of the NLRP3 inflammasome is induced by LPS or 
cytokines that activate TLRs or cytokine receptors, respectively. Priming induces the expression of NLRP3 and 
proIL-1β proteins. (1) Extracellular ATP activates the P2X7 receptor, which is an ATP-gated ion channel. The 
stimulation of P2X7 is proposed to open the hemichannel pannexin-1 on the membrane. The activation of P2X7 
induces potassium efflux, which results in a decrease in the intracellular potassium concentration. The reduced 
potassium concentration induces the activation of the NLRP3 inflammasome. (2) Phagocytosed crystals 
and particles induce lysosomal swelling and disruption, which results in the leakage of lysosomal proteases, 
including cathepsin B. Active cathepsin B induces the activation of the NLRP3 inflammasome. (3) One NLRP3 
inflammasome activator can induce several activating events. Nigericin induces the release of cathepsin B 
from nonruptured lysosomes (nonruptured lysosomes are not shown for clarity), ROS formation, and potassium 
efflux. (4) Several DAMPs and PAMPs induce mitochondrial dysfunction either directly or via potassium efflux 
or lysosomal destabilization. Mitochondrial dysfunction increases the production of mitochondrial ROS and 
the release of oxidized mtDNA. Both mitochondrial ROS and mtDNA induce the activation of the NLRP3 
inflammasome. The autocleavage and activation of caspase-1 is induced in the NLRP3 inflammasome complex. 
Active caspase-1 cleaves proIL-1β to its mature form, which is secreted from the cell. ASC, apoptosis-associated 
speck-like protein containing a caspase-recruitment domain; ATP, adenosine triphosphate; DAMP, danger-
associated molecular patterns; IL-1β, interleukin 1β; LPS, lipopolysaccharide; mtDNA, mitochondrial DNA; 
NLRP3, nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain containing 3; P2X7, 
P2X purinergic receptor 7; PAMP, pathogen-associated molecular patterns; ROS, reactive oxygen species; TLR, 
Toll-like receptor; TNF, tumor necrosis factor. Data are derived from references mentioned in the text; figure 
adapted from (Nurmi et al. 2013).
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4.2.4 Activation of the AIM2 inflammasome  
AIM2 inflammasome activation is induced by double-stranded DNA from bacterial, viral 
or synthetic sources, irrespective of the DNA sequence or GC content (Hornung et al. 2009, 
Rathinam et al. 2010, Jin et al. 2012, Rathinam et al. 2012). However, the length of the 
sequence may restrict the activation; double-stranded DNA of less than 80 base pairs ceases 
to activate the AIM2 inflammasome (Rathinam et al. 2012). In general, the assembly and 
activation of the AIM2 inflammasome do not require priming (Bauernfeind et al. 2011). 
However, an early priming event induced by IFNβ and IFNγ has also been described for 
AIM2 (Burckstummer et al. 2009, DeYoung et al. 1997, Schattgen & Fitzgerald 2011). 
Furthermore, IFN-mediated priming was shown to be required for inflammasome activation 
in response to Francisella infection (Henry et al. 2007). Upon activation, AIM2 forms a 
star-shaped ternary complex with ASC in the center of the star (Lu et al. 2014). Cytosolic 
double-stranded DNA is a direct ligand for the sensor protein HIN-200 of the AIM2 
inflammasome (Jin et al. 2012). Positively charged HIN-200 binds the sugar-phosphate 
backbone of both strands of double-stranded DNA, which displaces the PYD domain of the 
AIM2 inflammasome, thereby allowing PYD to bind ASC (Jin et al. 2012). Jin et al. have 
also suggested that in the absence of an activating stimulus the PYD and HIN domains of 
the AIM2 inflammasome are complexed in a manner that inhibits its accidental activation. 
An intriguing question is, although all bacteria and DNA viruses contain DNA, why is the 
AIM2 inflammasome activated only by certain pathogens. At least a partial answer to this 
question was offered by the recent discovery of virulence factors expressed by some bacteria. 
Francisella tularensis ssp. novicida was demonstrated to encode the short palindromic repeat 
Clustered, regularly interspaced, short palindromic repeats-CRISPR-associated (CRISPER-
Cas) system, which is assumed to protect the integrity of the bacterial envelope, thereby 
reducing the release of DNA from bacteria (Sampson et al. 2014). The reduced release of 
bacterial DNA downgrades the activation of the AIM2 inflammasome and subsequent cell 
death, which would otherwise reduce the survival of F. novicida (Sampson et al. 2014).
4.2.5 Inhibition of the NLRP3 inflammasome  
Considering the severity of autoinflammatory diseases, such as Muckle-Wells syndrome, that 
are caused by the inappropriate activation of the NLRP3 inflammasome (Rigante 2012) and 
the consequences of prevalent chronic inflammatory diseases, such as atherosclerosis, gout, 
and type 2 diabetes, it is obvious that stringent control of NLRP3 inflammasome activation 
is needed (Strowig et al. 2012). Therefore, inhibition, resolution and down-modulation 
mechanisms are crucial, although a less well known area of inflammasome research. In this 
chapter, the focus is on the mechanisms that reduce NLRP3 inflammasome activation that 
are relevant to this study. Viral and bacterial inhibitors are not included because they are not 
relevant to this thesis study. The negative regulators of the NLRP3 inflammasome that are 
described below are summarized in Table 3.  
A number of endogenic protein interactors with the inflammasome proteins ASC and 
caspase-1 have been described, and most of them share considerable sequence similarity 
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with the PYD domain of ASC or the CARD domain of caspase-1 (Stehlik & Dorfleutner 
2007). ASC and caspase-1 inhibitors evolved through gene duplications in the course of 
evolution, and the timing of these duplication events corresponds to the different presence 
of these genes among species (Kersse et al. 2007, Stehlik & Dorfleutner 2007, da Cunha et 
al. 2008). Pyrin-only proteins (POPs), including pyrin, POP1, and POP2 (the last two are 
present only in the human genome), interact with the PYD domain of ASC, thereby blocking 
the recruitment of ASC to the inflammasome complex (Stehlik & Dorfleutner 2007). 
CARD-containing proteins (CARD-only proteins, COPs), such as Iceberg, INCA, COP1, 
caspase-12, and the short variant of Nod2 (all of which are found in the human genome, 
whereas only caspase-12 is present in the murine genome), are hypothesized to function in a 
manner similar to POPs. COPs interfere with the recruitment and/or processing of caspase-1 
by interacting with its CARD domain (Stehlik & Dorfleutner 2007). Similarly, leucine-rich 
repeat Fli-I-interacting protein 2 (LRRFIP2) has been shown to inhibit caspase-1 activation 
by binding to NLRP3 (Jin et al. 2013). Jin et al. demonstrated that LRRFIP2 binds the 
NLRP3 protein through its N-terminus and simultaneously interacts with the caspase-1 
pseudosubstrate Flightless-I. The recruitment of Flightless-I inhibited caspase-1 activation. 
In accordance with that finding, the silencing of Flightless-I reversed the inhibitory effect of 
LRRFIP2 (Jin et al. 2013). 
Promyelocytic leukemia protein (PML) acts as a scaffold protein in structures called PML 
nuclear bodies (Dowling et al. 2014). PML nuclear bodies are markers of cellular stress 
that can recruit diverse regulatory proteins that mediate their functions in several cellular 
processes (including senescence, apoptosis, tumor suppression, metabolic control, and anti-
viral defense) (Sahin et al. 2014). However, PML is capable of interacting with ASC, and 
as a consequence of ASC-PML interaction ASC is retained in the nucleus, thereby leading 
to reduced inflammasome activation (Dowling et al. 2014). Additionally, a hematopoietic-
restricted protein, G protein signaling modulator-3 (GPSM3), has been shown to interact with 
NLRP3. The association of GPSM3 with the C-terminus of NLRP3 inhibited the secretion of 
IL-1β, possibly by reducing interactions between LRR and activating ligands (Giguere et al. 
2014). The described interaction between GPSM3 and NLRP3 was increased by heat shock 
protein HSPA8 (Giguere et al. 2014). Indeed, the interaction of NLRP3 with a complex 
of HSP90 and ubiquitin ligase-associated protein, suppressor of G2 allele of skp1 (SGT1), 
has been shown to prevent spontaneous activation of NLRP3 while maintaining NLRP3 in 
a signaling-competent state for the activatory stimulus, which induces the dissociation of 
SGT1 and possibly also HSP90 from NLRP3 (Mayor et al. 2007). Furthermore, heat shock 
did prevent caspase-1 activation in response to the activation of NLRP1 with anthrax lethal 
toxin and the activation of NLRP3 with nigericin (Levin et al. 2008). In addition, caspase-1 
activity was also inhibited by whole-cell lysate from heat shocked cells (Levin et al. 2008). 
The cells of the adaptive immune system can also dampen the activation of innate immune 
responses by cell-cell contacts and cytokines. The inhibitory actions of adaptive immunity 
may help to resolve the activation of innate immunity after the adaptive immune responses 
have been activated (Chen & Sun 2013). The anti-inflammatory effects of type I IFNs may 
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be mediated, at least in part, by their inhibitory effects on inflammasome activation. Type I 
IFNs were shown to suppress the activity of the NLRP1 and NLRP3 inflammasomes as well 
as the expression of proIL-1β via signal transducers and activators of transcription (STAT)1- 
and STAT3-dependent signaling, respectively (Guarda et al. 2011). Guarda et al. found 
that the main mechanism of the reduced expression of proIL-1β was the secretion of IL-10, 
which was induced by the synergistic effects of LPS and type I IFNs (Guarda et al. 2011). In 
accordance with reduced inflammasome activation and the secretion of IL-1β in vitro, the 
induction of type I IFN production reduced monocyte recruitment and the secretion of IL-1β 
in vivo in response to intraperitoneal alum injection or challenge with C. albicans (Guarda 
et al. 2011). The induction of IL-10 is specific to type I IFNs, and Guarda et al. reported that 
IFNγ lacks the inhibitory effect of type I IFNs under the same experimental circumstances. 
In contrast, Mayer-Barber et al. reported that IFNγ dampened the expression of IL-1β, 
although the suppression of cytokine signaling was observed in monocyte-macrophages 
but not in dendritic cells (Mayer-Barber et al. 2011). Cell-cell contact-mediated blockage 
of caspase-1 activation and the subsequent secretion of IL-1β in mouse macrophages 
and dendritic cells by effector and memory CD4+T cells has been reported to require the 
expression of T cell TNF superfamily ligands (Guarda et al. 2009). Furthermore, cell-cell 
contact between monocytes and IFNβ-primed active human memory T cells was shown 
to reduce P2X7-mediated inflammasome activation in monocytes by downgrading the 
expression of the P2X7 receptor (Beynon et al. 2012). The reduced expression of the P2X7 
receptor was partially dependent on the secretion of soluble Fas ligand (Beynon et al. 2012). 
The results reported by Beynon et al. suggested a potential feedback loop triggered by IFNβ, 
which could augment the cessation of immune responses after infection.  
Missense mutations in Tripartite-motif protein (TRIM) family proteins have been linked to 
autoinflammatory diseases. Pyrin, also called TRIM20, is mutated in familial Mediterranean 
fever, and the overexpression of another member of the TRIM family, TRIM30, has been 
shown to inhibit NLRP3 inflammasome activation in response to ATP (Hu et al. 2010). In 
accordance with this, a deficiency in TRIM30 increased the secretion of IL-1β in response 
to several well-known NLRP3 inflammasome activators. The inhibitory effect of TRIM30 
was mediated by reduced ROS production (Hu et al. 2010). NO exhibits pleiotropic effects 
on immune responses. The anti-inflammatory effects of NO have been suggested to partially 
derive from its suppressive effect on inflammasome activation (Mao et al. 2013). NO was 
shown to reduce the IL-1β secretion induced by the activation of the NLRP3 inflammasome. 
To a lesser extent NO also reduced AIM2- and NLRC4-induced IL-1β secretion. In keeping 
with that finding, a deficiency in endogenous inducible NO synthase enhanced the secretion 
of IL-1β in vivo (Mao et al. 2013).  The deletion of inducible NO synthase was shown 
to increase mitochondrial ROS production and mitochondrial damage, implying that NO-
mediated inflammasome inhibition results from reduced ROS production and subsequently 
diminished inflammasome activation (Mao et al. 2013). Additionally, certain drugs have 
been shown to reduce inflammasome activation. Sulfonylurea-containing compounds, 
including glyburide, cytokine release-inhibitory drugs, and the small-molecule drug 
MCC950, have been shown to inhibit the secretion of IL-1β (Lamkanfi et al. 2009, Coll & 
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O’Neill 2011, Coll et al. 2015). All the above mentioned drugs have been shown to inhibit 
the activation of caspase-1 by reducing the assembly of the ASC-dependent inflammasomes 
(Coll & O’Neill 2011, Coll et al. 2015). A variety of endogenous microRNAs (miRNAs), 
small RNA pieces (typically approximately 23 nucleotides) that do not encode proteins, 
are implicated in the posttranscriptional control of protein mRNA (Bartel 2009). Various 
single-nucleotide polymorphisms associated with the pathogenesis of several common 
disorders have the potential to interfere with the function of miRNAs that may modulate 
inflammasome pathway components (Glinsky 2008). However, only one miRNA, miR-
223, has been shown to inhibit NLRP3 inflammasome activity so far. miR-223 targets 
NLRP3 transcripts, and it was found to reduce NLRP3 transcript levels (Bauernfeind et al. 
2012). Therefore, Bauernfeind et al. concluded that miR-223 sets a threshold for NLRP3 
inflammasome activation by reducing the availability of short-lived NLRP3 transcripts.
Autophagy and certain autophagic and apoptotic signaling proteins have been shown to 
interact with and inhibit inflammasome activation via multiple mechanisms, which are 
discussed in greater detail in Chapters 6.1 and 6.3 Additionally, the inhibitory effects of 
HO-1 on the activation of the NLRP3 inflammasome are discussed in Chapter 2.2.3. 
Regulator Mechanism Reference
Deubiquitinases Ubiquination of NLRP3 inhibits the assembly 
of the inflammasome
(Juliana et al. 2012, Lopez-Castejon 
et al. 2013, Py et al. 2013)
S-nitrosylation S-nitrosylation of NLRP3 inhibits the 
assembly of the inflammasome
(Hernandez-Cuellar et al. 2012)
Superoxidase dismutase 1 Oxidation of caspase-1 inhibits caspase-1 
activity
(Meissner et al. 2008)
Syk and Jnk Phosphorylation of ASC allows its 
localization to the perinuclear area
(Hara et al. 2013)
IKKα Retains ASC in the nucleus preventing 
spontaneous inflammasome activation
(Martin et al. 2014)
Pyrin-only proteins (POPs) Interactions with ASC prevent inflammasome 
assembly
(Stehlik & Dorfleutner 2007)
CARD-only proteins (COPs) Interactions with caspase-1 prevent the  
processing of caspase-1
(Stehlik & Dorfleutner 2007)
LRRFIP2 Interactions with NLRP3 recruit Flightless-I, 
which prevents caspase-1 processing
(Jin et al. 2013)
PML Interactions with ASC retain ASC in the 
nucleus
(Dowling et al. 2014)
GPSM3 Interactions with LRR inhibit the secretion of 
IL-1β
(Giguere et al. 2014)
HSP90-SGT complex Interactions with NLRP3 prevent 
spontaneous inflammasome activation
(Mayor et al. 2007)
Heat shock Induces a cellular factor/modification that 
inhibits caspase-1 activity
(Levin et al. 2008)
Type I interferons Inhibits NLRP3 activation and the expression 
of proIL-1β
(Guarda et al. 2011)
Type II interferon IFNγ Reduces IL-1β expression (Mayer-Barber et al. 2011)
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Effector and memory CD+ T 
cells
Cell-cell contact inhibits caspase-1 activation (Guarda et al. 2009)
INFβ-primed memory T cells Reduces the expression of P2X7 (Beynon et al. 2012)
TRIM30 Decreases ROS production (Hu et al. 2010)
NO Decreases ROS production (Mao et al. 2013)
Sulfonylurea-containing 
compounds
Prevents inflammasome assembly (Lamkanfi et al. 2009, Coll & O’Neill 
2011, Coll et al. 2015)
miR-223 Reduces the level of NLRP3 transcripts (Bauernfeind et al. 2012)
Autophagy Degrades inflammasome components, and 
reduces mitochondrial ROS production and 
the release of mitochondrial DNA
(Harris et al. 2011, Zhou et al. 2011, 
Shi et al. 2012, Shimada et al. 2012)
HO-1 Reduces inflammasome assembly and ROS 
production
(Kim & Lee 2013, Li et al. 2014a, Luo 
et al. 2014) 
Table 3. Summary of mechanisms that inhibit the NLRP3 inflammasome. Data are derived from the 
references listed in the table.
4.3 NLRP3 inflammasome in pathophysiological conditions
As a part of the innate immune system, the role of inflammasome activation is to maintain 
homeostasis, yet deregulated function of the inflammasome is detrimental to the host. The 
diseases affected by excessive or aberrant inflammasome function and IL-1β secretion range 
from autoimmune diseases and rare autoinflammatory diseases to much more common 
multifactorial conditions, such as atherosclerosis, gout, type 2 diabetes, and Crohn´s disease. 
Most autoinflammatory diseases and several autoimmune diseases are caused by known 
mutations in pyrin, NLRP1, NLRP3, NLRC4 or AIM2 inflammasomes. Autoinflammatory 
and autoimmune diseases are generally thought as a spectrum of diseases in which 
autoinflammatory diseases form one end and autoimmune diseases the other (Lamkanfi et 
al. 2011). Numerous autoinflammatory diseases with varying etiologies and symptoms have 
been described; nevertheless, the common denominator of these diseases is the dysregulated 
generation of IL-1β in the absence of apparent infection or antigen-specific cellular and 
humoral responses (Rigante 2012, Saavedra et al. 2015). In autoimmune diseases, on the 
other hand, the adaptive immune system recognizes self molecules and attacks them with 
antibodies and antigen-specific T cells (Lamkanfi et al. 2011). Thus, understanding the 
molecular mechanisms of these diseases and inflammasome functions will offer means 
to develop more efficient therapies. NLRP3 inflammasome-related autoimmune and 
autoinflammatory diseases as well as the NLRP3-derived inflammatory components of 
atherosclerosis and gout that are relevant for the study are discussed below.
4.3.1 NLRP3-associated autoinflammatory and autoimmune diseases  
Mutations in the NLRP3 gene that encodes the NLRP3 protein, i.e., cryopyrin are associated 
with autoinflammatory diseases. Cryopyrin-associated periodic syndromes (CAPS) 
encompass familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome 
(MWS), and chronic infantile neurologic cutaneous articular syndrome (CINCA), also 
Review of the Literature 
50
called neonatal onset multi-system inflammatory disorder (NOMID) (Rigante 2012). All 
three syndromes are associated with autosomal dominant gain-of-function mutations in the 
NLRP3 gene, which lead to the continuous activation of the NLRP3 inflammasome and the 
secretion of IL-1β (Goldbach-Mansky 2011, Rigante 2012). Systemic inflammation and 
the release of IL-1β cause episodes of fever, which are typical of all CAPS (Goldbach-
Mansky 2011, Rigante 2012). In addition, systemic inflammation mediates the organ 
damage associated with MWS and CINCA (Goldbach-Mansky 2011). CAPS can be seen 
as a continuum defined by their severity, with FCAS being the mildest and CINCA being 
the most severe (Lamkanfi et al. 2011, Rigante 2012). FCAS is characterized by rashes, 
fever, and arthralgia occurring in an episodic manner, usually 1-2 hours after cold exposure 
(Hoffman et al. 2001). Some of the mutations linked to FCAS have also been associated 
with MWS, and, although more severe, MWS symptoms resemble the symptoms of FCAS 
(Maksimovic et al. 2008). MWS manifests as episodic fever with abdominal pain, myalgia, 
arthralgia, arthritis, urticaria, conjunctivitis, and later-occurring deafness, as well as possible 
AA amyloidosis (Cuisset et al. 1999, Maksimovic et al. 2008). The symptoms of CINCA 
occur early, often at birth, and are the most severe of all CAPS. The clinical phenotype 
of CINCA includes fever; rash; inflammations of the eye, inner ear, and central nervous 
system; possible amyloidosis; and cognitive and physical disabilities (Goldbach-Mansky 
2011). Three different strategies to block IL-1β in CAPS have been used in clinical trials: 
a recombinant human IL-1R antagonist (Anakinra®), which is approved for the treatment 
of RA for example in the United States (US); a recombinant IL-1R-Ig fusion protein 
(Rilonacept®), which is accepted for the treatment of CAPS for example in the US; and a 
humanized anti-IL-1β antibody (Canakinumab®), which is accepted for treatment of CAPS 
for example in the US (Goldbach-Mansky 2011). All the above mentioned medications were 
found beneficial in the treatment of CAPS in clinical trials (Goldbach-Mansky 2011).
Several autoimmune diseases, including RA, inflammatory bowel disease, celiac disease, 
type 1 diabetes, and systemic lupus erythematosus, are associated with polymorphisms in 
genes that encode NLRP3 or NLRP1 inflammasome-associated proteins (Saavedra et al. 
2015). Although autoimmune diseases are defined by the inappropriate recognition of self-
antigens by the adaptive immune system, the components of innate immune defense, PRRs, 
macrophages, and mast cells play a key role in the pathogenesis of RA (Lee et al. 2002, 
Gierut et al. 2010). RA is the most common type of inflammatory arthritis. In RA, the 
chronic inflammation of synovial tissue leads to the infiltration of CD4+ T cells, B cells, 
mast cells, and macrophages; increased concentrations of proinflammatory cytokines; 
and the aggressive growth of synovial tissue, which fills the joint, destroying the articular 
structure (Firestein 2003, Gierut et al. 2010). In RA, the expression of NLRP3 is enhanced 
in the synovium (Rosengren et al. 2005). Certain polymorphisms of NLRP3 inflammasome 
components have been shown to correlate with increased susceptibility to RA (Mathews 
et al. 2014, Yang et al. 2014). Intriguingly, in genetically modified mice (A20/TNFAIP3 
deleted in myeloid cells) that spontaneously develop arthritis, the deletion of IL-1R, NLRP3 
and caspase-1, but not of TNFR1, attenuated the joint inflammation (Vande Walle et al. 
2014). TNFα inhibitors have been shown to be more efficient than the IL-1R antagonist 
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Anakinra® in the treatment of RA (Mertens & Singh 2009). Unfortunately, neither treatment 
helps all patients. In the case of Anakinra®, this may be because Anakinra® is a competitive 
IL-1R antagonist, rather than a direct inhibitor of IL-1β (Firestein 2003, Mertens & Singh 
2009).
4.3.2 Multifactorial diseases  
The above mentioned autoinflammatory diseases are induced by mutations that affect the 
functions of the NLRP3 inflammasome. However, the dysregulated activation of the NLRP3 
inflammasome is implicated in the pathogenesis of several chronic diseases, including 
atherosclerosis, gout, type 2 diabetes, and Alzheimer´s disease (Ozaki et al. 2015). In many 
cases, the altered metabolism related to the pathogenesis of these diseases induces the 
accumulation of DAMPs, which activate the inflammasome (Martinon et al. 2006, Duewell 
et al. 2010, Rajamaki et al. 2010, Grant & Dixit 2013). In atherosclerosis, the deposition 
of circulating LDL particles into the arterial wall, together with the recruitment and 
proliferation of immune cells leads to chronic inflammation, and the progressive growth of 
plaques, thus contributing to the narrowing of the vessel lumen (Cochain & Zernecke 2015). 
Inflammation is considered the principal driving force in the pathogenesis of atherosclerosis. 
In the arterial wall, LDL particles are oxidized and consequently taken up by macrophages 
(Moore & Tabas 2011, Weber & Noels 2011). Oxidized LDL particles have been shown to 
prime and activate the NLRP3 inflammasome via cathepsin B and ROS generation (Jiang 
et al. 2012). In support of that finding, Sheedy et al. demonstrated that scavenger receptor 
cluster of differentiation (CD) 36 mediated the uptake of oxidized LDL particles and primed 
the NLRP3 inflammasome in cooperation with TLR4 and TLR6. In macrophages, oxidized 
LDL particles were further crystallized to cholesterol crystals in lysosomes, which led 
to lysosomal destabilization and the subsequent activation of the NLRP3 inflammasome 
(Sheedy et al. 2013). In accordance with that finding, the deletion of CD36 was shown to 
inhibit the accumulation of cholesterol in plaques, and to suppress IL-1β secretion in vivo 
(Sheedy et al. 2013). 
Additionally, extracellularly added cholesterol crystals have been shown to induce lysosomal 
destabilization and subsequent NLRP3 inflammasome activation in both mouse and human 
macrophages in culture (Duewell et al. 2010, Rajamaki et al. 2010). The influence of the 
NLRP3 inflammasome on atherogenesis was demonstrated in vivo in an atherosclerosis-
prone mouse model in which the deletion of the NLRP3 inflammasome in bone marrow-
derived cells significantly reduced the lesion size and the inflammasome-dependent 
secretion of IL-18 (Duewell et al. 2010). The significance of IL-1β in the pathogenesis 
of atherosclerosis was further emphasized by findings demonstrating that the deletion of 
Il1b in hypercholesterolemic (ApoE-deficient) mice reduced atherosclerotic lesions in the 
aorta (Kirii et al. 2003). The deficiency in IL-1β led to diminished expression of adhesion 
molecules (Kirii et al. 2003). Another metabolite shown to activate NLRP3 is monosodium 
urate (MSU) crystals, which are formed in gout as a consequence of high blood urate levels 
(So 2008). In patients with gout, deposits of MSU induce inflammatory episodes, during 
which neutrophils are recruited and inflammatory mediators are secreted locally in the joint 
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(So 2008). Indeed, MSU crystals have been shown to induce the activation of the NLRP3 
inflammasome in cultured macrophages and in an in vivo mouse model of MSU-induced 
peritonitis (Martinon et al. 2006). Martinon et al. also demonstrated that, in mice deficient 
in IL-1R or the inflammasome components ASC and caspase-1, neutrophil recruitment 
was significantly reduced. In accordance with the results of Martinon et al., IL-1R and 
its downstream signaling molecule MyD88 were required for the secretion of IL-1β and 
other proinflammatory cytokines in another model of MSU peritonitis, although in this 
model, only nonhematopoietic cells responded to deletion of IL-1R or MyD88 with reduced 
neutrophil recruitment (Chen et al. 2006). However, although MSU deposits remain in the 
joints constantly, gout attacks occur only occasionally. Recent results reported by Joosten 
et al. may offer a partial explanation for this discrepancy; they demonstrated that MSU per 
se, without prior priming, did not elicit the secretion of IL-1β. However, the combination 
of MSU and free fatty acids induced the potent secretion of IL-1β in vitro, and intraarticular 
joint injections of MSU and free fatty acids induced arthritis in vivo (Joosten et al. 2010). 
Curiously, the in vivo joint inflammation was independent of NLRP3 but dependent on ASC 
and caspase-1 (Joosten et al. 2010). The role of IL-1β as a key mediator of gout was further 
emphasized by the results of clinical trials of Canakinumab®, Rilonacept®, and Anakinra®, 
all of which have been shown to efficiently reduce gout flare-ups (Schlesinger et al. 2011, 
Schumacher et al. 2012, Ottaviani et al. 2013).
5. Autophagy
To preserve their functionality, living cells must constantly remove aberrant 
and excess proteins, cell organelles, and protein aggregates. Senescent 
cytoplasmic constituents are recycled by two major degradation systems: 
lysosomes and proteasomes. Lysosomes degrade both extracellular and 
intracellular material. Extracellular material is delivered to lysosomes by the 
endocytic pathway, whereas cytosolic material is transported to lysosomes 
via autophagy. Autophagy (Greek for “self-eating”) is an evolutionarily 
conserved process of eukaryotic cells that maintains homeostasis 
by controlling the quality and number of cell organelles (Levine et al. 
2011, Noda & Inagaki 2015). Previously, autophagy was thought to be 
nonselective, but increasing evidence suggests that in addition to the 
nonselective autophagy induced by stress, basal autophagy selectively 
targets damaged and obsolete organelles as well as protein aggregates for 
degradation in lysosomes (Lamb et al. 2013, Sica et al. 2015). A low basal 
level of autophagosomal activity is constantly present in cells. However, 
autophagy is rapidly induced by environmental stress, such as nutrient or 
growth factor deprivation and hypoxia (Behrends et al. 2010, Lamb et al. 
2013). During starvation, nonessential cellular components are recycled in 
autophagosomes to amino acids, lipids and carbohydrates to sustain cell 
viability and homeostasis (He & Klionsky 2009). 
Review of the Literature 
53
5.1 Mechanisms of autophagy
In mammalian cells, three different forms of autophagy can be distinguished: macroautophagy, 
microautophagy, and chaperone-mediated autophagy (illustrated in Figure 8) (Mizushima 
et al. 2011). Despite differences in cargo sequestration, all autophagic pathways transport 
their cargo to lysosomes for degradation (Wirawan et al. 2012, Damme et al. 2015). The 
mechanisms and functions of macroautophagy are discussed below.
 
Figure 8. Principal types of autophagy. All autophagic routes target the cargo to the lysosome (the lysosome 
is shown in the figure). 1) Macroautophagy sequesters cytoplasm and cell organelles to specialized double-
membraned vesicles called autophagosomes, which transport the cargo to lysosomes. Both nonselective 
and selective macroautophagy exist. During selective macroautophagy, cell organelles, such as mitochondria, 
are targeted to autophagosomes by proteins acting as autophagy receptors. 2) During microautophagy, 
the lysosomal membrane invaginates and a portion of the cytoplasm is engulfed. 3) Chaperone-mediated 
autophagy directly targets proteins that possess a KFERQ sequence on their surface to the lysosome. Proteins 
are bound by Hsc70 and its co-chaperones. The cargo proteins are translocated across the lysosomal 
membrane by a translocation complex formed by the multimerization of the lysosomal membrane protein 
LAMP2A. The autophagosomal cargo is degraded in lysosomes. Autophagy has great degradative capacity and 
leads to the degradation of entire organelles, large protein aggregates, and lipids. The degradation products, 
such as amino acids, nucleic acids, and fatty acids, are transported from the lysosome to the cytosol and used 
for anabolic processes, such as the synthesis of macromolecules or for energy production. AA, amino acid; FFA, 
free fatty acid; Hsc70, heat shock 70 kDa protein 8; LAMP2A, A isoform of lysosomal-associated membrane 
protein 2. Data are derived from references in the text.
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5.1.1 Autophagic process  
Macroautophagy (referred to hereafter as autophagy) is the best-characterized form of 
autophagy, and it is thought to represent the major type of autophagy (Mizushima et al. 
2011). During autophagy, a portion of the cytoplasm and cellular components, ranging 
from soluble molecules to entire organelles, is encapsulated in a double-membraned vesicle 
called the autophagosome (Lamb et al. 2013). A mature autophagosome can subsequently 
fuse with an endosome, and ultimately with a lysosome, in which the cargo and the inner 
membrane of the autophagosome are degraded by lysosomal hydrolases (Yang & Klionsky 
2010, Hamacher-Brady 2012). In mammalian cells, autophagosomes can form in multiple 
locations. The source of the lipids used to form autophagosomal membranes is unclear; 
the endoplasmic reticulum, endosomes, Golgi complex, mitochondria, plasma membrane 
and nuclear membrane have all been suggested to contribute to the autophagosome 
formation (Chen & Klionsky 2011, Mizushima et al. 2011). Whether some or all of the 
above mentioned sources participate in membrane delivery likely depends on the site and 
conditions of autophagosome formation, as well as on the targeted cargo (Chen & Klionsky 
2011, Mizushima et al. 2011). 
5.1.2 Autophagosome formation  
The formation of the autophagosome begins with the nucleation of an isolation membrane, 
also called the phagophore, a double-lipid bilayer that eventually encloses the cytosolic 
cargo. The cargo-loaded mature autophagosomes subsequently fuse with lysosomes, 
thereby forming structures called autolysosomes. The autophagic process, beginning with 
the formation of the autophagosome and ending in the degradation of the autolysosomal 
contents, is outlined in Figure 9. Each stage of the autophagic process is regulated by an 
ordered interaction of conserved autophagy-related proteins (Atg), and a failure of signaling 
or the disturbance of these consecutive steps at any point can interrupt the flow (for clarity, 
autophagy proteins are hereafter referred to using the human ortholog nomenclature) 
(Parzych & Klionsky 2014). The core signaling complexes required for autophagosome 
formation are divided into four key complexes based on their functional properties. First, 
the farthest upstream step that controls the induction of autophagosome formation is the 
recruitment of the ULK1 complex to the isolation membrane assembly site (Itakura & 
Mizushima 2010, Yang & Klionsky 2010, Parzych & Klionsky 2014). Second, the nucleation 
of the isolation membrane is mediated by the active PI3K complex (Itakura & Mizushima 
2010, Yang & Klionsky 2010, Parzych & Klionsky 2014). Third, WIPI proteins and two 
transmembrane proteins, ATG9 and VMP1, are recruited to the forming isolation membrane 
(Itakura & Mizushima 2010, Yang & Klionsky 2010, Parzych & Klionsky 2014). Fourth, 
two ubiquitin-like protein conjugation systems, the ATG12 and LC3 systems, are recruited 
to the isolation membrane to control the elongation and closure of the autophagosome 
(Itakura & Mizushima 2010, Yang & Klionsky 2010, Parzych & Klionsky 2014). 
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Figure 9. Autophagic process. Some steps are omitted for clarity. The sequential arrival of the protein 
complexes to the autophagosome assembly site results in the formation of the isolation membrane. ULK1, 
ATG13, ATG101, and FIP200 are mainly cytosolic proteins, which form a complex irrespective of nutrient status. 
In the nourished state, the ULK1 complex is inhibited by MTORC1. Starvation induces the dissociation of 
MTORC1, which activates the ULK1 complex. The next complex recruited to the forming isolation membrane 
is the PI3K complex, which consists of PIK3C3, PIK3R4, ATG14L (also called Barkor), Beclin1, and the 
Beclin1-interacting protein AMBRA1. Through the actions of PIK3C3, this complex produces the lipid PI3P. 
In mammalian cells, ATG9, WIPI1, WIPI2, and DFCP1, along with VMP1 (not shown in the figure) are also 
required for the formation of the isolation membrane. The elongation and complete closure of the isolation 
membrane are controlled by two ubiquitin-like conjugation systems. The first complex is the ATG12-ATG5 
conjugate, which interacts with the dimeric ATG16L1 to form the ATG16L1 complex. The ATG16L1 complex 
associates with the isolation membrane to promote its expansion, and Atg16L1 later dissociates from the 
completed autophagosome. For the second elongation complex, the precursor of LC3 protein is first cleaved 
by ATG4 to LC3-I; LC3-I is then conjugated to the lipid PE. The conjugation of PE may be aided by the ATG16L1 
complex. The conjugated form of LC3, called LC3-II, is a structural component of both the inner and outer 
membranes of the autophagosome. During the elongation stage the isolation membrane grows in size, and the 
ubiquitinated cargo is sequestered by cargo receptor proteins, such as SQSTM1, to the forming autophagosome 
(SQSTM1 is depicted as a green ball). The cargo loaded isolation membrane seals itself to form the completed 
autophagosome. For the final stage of maturation, the autophagosome is transported along the microtubules 
toward a lysosome to form the final degradative compartment. The fusion of the autophagosome with the 
lysosome is aided by autophagy proteins and SNARE machinery proteins. This fusion allows lysosomal acid 
hydrolases to degrade the sequestered material and the inner limiting membrane of the autophagosome. The 
resulting macromolecules are transported back to the cytosol, and the LC3-II proteins at the outer limiting 
membrane are recycled by ATG4 back to LC3-I and PE. AMBRA1, Activating molecule in Beclin-1-related 
autophagy-1; ATG16L1; autophagy-related 16-like 1; DFCP1, double FYVE-containing protein 1; FIP200, focal 
adhesion kinase family-interacting protein of 200 kDa; LC3, microtubule-associated protein 1 light-chain 3; 
MTORC1, mammalian target of rapamycin complex; PE, phosphatidylethanolamine; PI3K, phoshatidylinositol-3 
kinase PI3P, phosphatidylinositol 3-phosphate; SNARE, soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor; SQSTM1, sequestosome 1; ULK1, UNC-51-like kinase; VMP1, vacuole membrane protein 1; 
WIPI, WD-repeat protein interacting with phosphoinositide. Data are derived from references mentioned  
in the text.
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The majority of the autophagy-inducing signaling pathways that sense cellular stress 
converge at the mammalian target of rapamycin (mTOR). mTOR forms a complex, 
called MTORC1, that under growth-promoting conditions associates with ULK1 (or with 
ULK2, another mammalian Atg1 ortholog that may have a partially redundant role with 
ULK1), thereby phosphorylating the ULK1 and ATG13 components of the ULK1 complex 
(Hosokawa et al. 2009, Parzych & Klionsky 2014). At the ULK1 complex, MTORC1 acts 
as a negative regulator, inhibiting the formation of the autophagosome under nutrient-rich 
conditions and promoting cell growth by upregulating protein translation and ribosome 
biogenesis (Wullschleger et al. 2006). Under catabolic conditions, MTORC1 is inactivated 
and it dissociates from the ULK1 complex, which is then dephosphorylated (Parzych & 
Klionsky 2014). Subsequently ULK1 complex translocates to the site of autophagosome 
formation and initiates the formation of isolation membrane (Parzych & Klionsky 2014). 
Additionally, several other energy level- and stress-sensing kinases can promote autophagy 
and/or activate the ULK1 complex, including the major energy-sensing kinase adenosine 
monophosphate-activated protein kinase (AMPK), protein kinase C, and the MAPKs: 
extracellular signal-regulated kinase (ERK), p38, and Jnk (Sridharan et al. 2011).
The autophagic process is not only controlled at the level of initiation. Autophagosome 
nucleation and formation are also regulated by several inhibitory and activating proteins 
that attach to the core complexes or influence their assembly. The Beclin 1-interacting 
proteins, such as Bcl-2, inhibit autophagosome nucleation by regulating the availability of 
Beclin 1. The dissociation of Beclin 1 from Bcl-2 is required for the activation of the PI3K 
complex that locally produces PI3P, which is needed for the initiation of autophagosome 
formation (Burman & Ktistakis 2010, Mizushima et al. 2011, Parzych & Klionsky 2014). 
The activity of the PI3K complex is regulated by the association of several subunits, such 
as Beclin 1-associated autophagy-related key regulator (Barkor or ATG14L), Activating 
molecule in Beclin-1-related autophagy-1 (AMBRA1), UV irradiation resistance-associated 
gene (UVRAG), Endophilin B1 (also called Bif-1), and RUN domain and cysteine-rich 
domain-containing, Beclin 1-interacting (Rubicon) subunits, which either promote or inhibit 
autophagosome formation (Yang & Klionsky 2010, Parzych & Klionsky 2014). UVRAG 
has also been shown to regulate autophagosome maturation into autolysosomes (Liang et al. 
2008, Kim et al. 2015).  
Autophagy is a bulk process that enables cell survival under harsh conditions. In addition, 
autophagy can specifically select cargo by the actions of proteins that may be called autophagy 
receptors. The selective autophagic degradation of organelles, such as mitochondria 
and peroxisomes, and the targeting of ubiquitinated protein aggregates or bacteria to the 
autophagosomes are examples of this phenomenon (Kundu et al. 2008, Zhang & Ney 2009, 
Mortensen et al. 2010, Huybrechts et al. 2009, Kim et al. 2008). Mammalian autophagy 
receptors, such as SQSTM1 (also called p62), the neighbor of BRCA1 gene 1 (NBR1), and 
Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Bnip3L), act as adaptors 
that connect the cargo, which is often marked by ubiquitination, to LC3-II (Bjorkoy et al. 
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2005, Mizushima et al. 2011). The selective sequestration of ubiquinated proteins or protein 
aggregates and large organelles can be mediated by SQSTM1 (Bjorkoy et al. 2005). The 
direct binding of SQSTM1 both to the hydrophobic amino acids of ubiquitin and to LC3 is 
needed to target the ubiquinated substrate to autophagosomes (Pankiv et al. 2007, Kim et 
al. 2008). 
5.2 Autophagy in physiology and pathophysiology
Autophagy plays key roles in multiple specific cellular processes. Basal constitutive 
autophagy is required to prevent the accumulation of polyubiquitinated protein aggregates. 
This process is critical for the maintenance of cellular homeostasis, particularly in postmitotic 
cells such as neurons and muscle cells. Therefore, it is not surprising that malfunctions in 
autophagy predispose cells to pathophysiological conditions. The dysregulation of autophagy 
has been described in neurodegenerative diseases and cancer, as well as in disturbances of 
embryogenesis and developmental processes (Wu et al. 2013).
 
5.2.1 Autophagy maintains homeostasis  
The degradation of protein aggregates and senescent mitochondria is vital for preserving 
essential cellular functions and preventing the accumulation of ROS (Cuervo et al. 2005). 
Most misfolded proteins are ubiquitinated and eliminated via the proteasomes. However, 
autophagy is required for the removal of large protein aggregates, i.e., inclusion bodies, 
which form during cellular stresses such as oxidative stress, infection and toxication 
(Zatloukal et al. 2002, Canadien et al. 2005, Kaniuk et al. 2007). The polyubiquitin-binding 
protein SQSTM1, a component of ubiquitinated cellular inclusion bodies, is needed for 
the targeting of ubiquinated aggregates to autophagosomes (Bjorkoy et al. 2005, Pankiv 
et al. 2007). The loss of basal autophagy results in the massive accumulation of SQSTM1 
and protein aggregates, which disrupts cellular homeostasis (Komatsu et al. 2005, Hara 
et al. 2006, Pankiv et al. 2007, Saitoh et al. 2008). Additionally, exposure to oxidative 
stress increases the intracellular level of SQSTM1 (Ishii et al. 1997). Recently, reciprocal 
interactions were demonstrated between SQSTM1 and the transcription factor Nrf2, which 
is an important transcriptional regulator for several cytoprotective genes and antioxidant 
enzymes (Jain et al. 2010). Both SQSTM1 and Nrf2 are needed to preserve cellular 
functions during stress. In response to oxidative stress, Nrf2 induced the expression of 
SQSTM1, which induced the constitutive activation of Nrf2, thereby forming a signaling 
cascade that positively regulated the expression of both proteins (Jain et al. 2010). Abnormal 
accumulation of inclusion bodies and SQSTM1 is associated with many neurodegenerative 
and other diseases, such as Parkinson´s disease, Alzheimer´s disease and Huntington´s 
disease, inclusion body myopathies, an experimental model of type 2 diabetes in rats, and 
alcoholic and non-alcoholic liver disorders (Kuusisto et al. 2001, Kuusisto et al. 2002, 
Rub et al. 2014, Komatsu et al. 2005, Kaniuk et al. 2007, Zatloukal et al. 2002). In these 
disorders, the capacity of cellular rescue systems, such as increased chaperone expression 
and proteasomal degradation, may be overwhelmed by the chronic stress caused by the 
degenerative disease or alcohol (Zatloukal et al. 2002). 
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5.2.2 Role of autophagy in inflammation  
Autophagy is versatile process capable of controlling and modulating both the innate and 
adaptive immunity responses. Autophagy may have first evolved as a mechanism for the 
clearance of intracellular microbes; therefore, it aims to ensure the survival of cells and 
to restrict the spread of pathogens (Deretic 2011). The induction of autophagy facilitates 
the recognition and elimination of intruding pathogens by increasing the efficiency of the 
immune response. Indeed, autophagy has been reported to enhance antigen presentation 
and to contribute to the T cell selection process in the thymus (Schmid & Munz 2005). 
Autophagy contributes directly to the degradation and abrogation of a variety of pathogens, 
such as viruses or bacteria, including Shigella, Mycobacteria, and Salmonella, that reside in 
the cytoplasm or phagosomes (Gutierrez et al. 2004, Deretic 2009). In addition, autophagy 
is involved in the elimination of normally extracellular pathogens that invade the host cell 
interior, such as Streptococcus pyogenes (Nakagawa et al. 2004). As a counterattack in the 
course of evolution, pathogens have developed multiple mechanisms to escape autophagic 
clearance, which initially led to the misconception that autophagy promotes the survival of 
pathogens (Schmid & Munz 2007, Deretic 2009). Autophagy also plays a role in the central 
function of innate immunity, i.e., the recognition of pathogens. Autophagy is induced by 
the activation of the PRRs, including the TLRs and NLRs. Furthermore, autophagy can 
modulate innate immune signaling, including NLR activation. The engagement of the 
TLRs in response to stimuli such as LPS, single stranded RNA, and zymosan enhances 
autophagosome formation (Xu et al. 2007, Delgado et al. 2008). TLR4-induced autophagy 
proceeds via receptor-interacting protein 1 (RIP1), p38 MAPK, and TRIF, which mediate 
the slower response downstream of TLR4 activation (Xu et al. 2007). Instead, MyD88 was 
reported to not contribute to the TLR4-induced activation of autophagy (Xu et al. 2007). On 
the contrary, the activation of autophagy in response to the activation of TLR7 depended 
on MyD88 (Delgado et al. 2008). However, NFκB, which is also stimulated during TLR 
activation and is needed for the induction of transcription of many proinflammatory 
cytokines, was shown to act as a negative regulator of autophagy under certain circumstances 
(Djavaheri-Mergny et al. 2006).
6. Crosstalk between signalosomes
Multiple shared components with dual activities, i.e., components of one 
process that also directly regulate another process, are known to function 
in signaling pathways for autophagy, inflammasomes and apoptosis. 
Interactions among autophagy, inflammasomes and apoptosis are likely 
because all of the above mentioned pathways respond to cellular stress. 
Thus, the investigation of the reciprocal interactions between signalosomes 
is of outmost importance for our understanding of intracellular signaling 
cascades and the possible outcomes of inhibiting or enhancing any one 
of these pathways. In many syndromes and diseases, it is more than likely 
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that the function of more than one pathway is involved. In addition, several 
currently existing drugs or those in the development phase inhibit or aim to 
modulate autophagy, inflammasomes or apoptosis. For instance, several 
cancer treatments induce apoptosis by the activation of caspases (Thorburn 
2008). Crosstalk between apoptosis and autophagy or inflammasomes may 
fundamentally alter the outcomes of these treatments (Thorburn 2008). In the 
next section, crosstalk between autophagy and inflammasomes, between 
autophagy and apoptosis and between inflammasomes and apoptosis is 
discussed. The main links between these pathways are presented in Figure 
10 on page 64.
6.1 Crosstalk between autophagy and NLRs
Complicated interactions between autophagy and the functions of the NLRP3 and AIM2 
inflammasomes have been reported in several studies, whereas the activation of the NLRC4 
inflammasome has been shown to directly inhibit autophagosome formation via the 
association of NLRC4 with Beclin 1 (Dupont et al. 2011, Harris et al. 2011, Jounai et al. 
2011, Nakahira et al. 2011, Zhou et al. 2011, Shi et al. 2012). The loss of autophagy protein 
ATG16L1 has been shown to enhance the secretion of IL-1β and IL-18 in response to LPS 
(Saitoh et al. 2008). Thus, autophagy is mostly described as a negative regulator of NLRP3 
and AIM2 inflammasome activation (Harris et al. 2011, Nakahira et al. 2011, Zhou et al. 
2011, Shi et al. 2012). However, the secretion of IL-1β has also been reported to depend on 
the activation of autophagy (Dupont et al. 2011). Autophagy can inhibit the activation of the 
NLRP3 inflammasome by reducing the availability of NLRP3 inflammasome agonists, such 
as intracellular ROS. A basal autophagic process called mitophagy (Mortensen et al. 2010), 
targets damaged mitochondria for autophagic degradation, thereby reducing the generation 
of mitochondrial ROS and the leakage of mtDNA, which are potent activators of the NLRP3 
inflammasome (Zhou et al. 2011, Nakahira et al. 2011, Shimada et al. 2012). 
Both the TLR-induced priming of the NLRP3 inflammasome and activation of the NLRP3 
and AIM2 inflammasomes induce autophagy, and further enhancement of autophagy has 
been shown to target the components of the activated NLRP3 and AIM2 inflammasomes 
to autophagosomes for subsequent degradation (Harris et al. 2011, Shi et al. 2012). 
Upon activation of the inflammasome, the oligomerized ASC within the inflammasome 
complex is ubiquitinated, which leads to the recruitment of ASC and possibly the entire 
inflammasome complex to autophagosome by SQSTM1 (Shi et al. 2012). Subsequent to 
their targeting to autophagosomes the inflammasome components are degraded (Shi et al. 
2012). Harris et al. reported the sequestration of only the proform and mature form of IL-1β, 
but not of caspase-1, into autophagosomes (Harris et al. 2011). Three independent groups 
have reported that IL-1β co-localizes with autophagosomes, although one of the studies 
reported a very different outcome for the stimulation of autophagy in combination with 
inflammasome activation. Harris et al. and Shi et al. reported that stimulating autophagy via 
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rapamycin or starvation inhibits inflammasome activation, thereby reducing the secretion 
of mature IL-1β. In contrast, results by Dupont et al. demonstrated that the secretion of 
mature IL-1β was enhanced in response to starvation-induced autophagy (Dupont et al. 
2011). These contradictory results regarding the secretion of IL-1β upon the activation of 
autophagy were unified in a model proposed by Deretic et al. According to this model, the 
induction of autophagy is required for the secretion of IL-1β early in the process. However, 
the degradation of inflammasome components in autophagosomes becomes dominant at 
later stages, and the secretion of IL-1β is consequently reduced (Deretic et al. 2012). 
Thus, the results of Dupont et al. also present a plausible mechanism for the unconventional 
secretion of leaderless proteins. In addition to IL-1β, high-mobility group box 1 (HMGB1), 
a major DAMP released from cells during necrosis, was reported to be secreted via 
this autophagy-based route. Dupont et al. suggested that the autophagosome creates a 
compartment that brings cathepsin B and the activated inflammasome complex close together, 
instead of being a mere carrier. The compartmentalization of the activated inflammasome 
complex together with cathepsin B would allow cathepsin B to cleave proIL-1β and/
or possibly enhance inflammasome activation (Dupont et al. 2011, Hornung et al. 2008). 
Because cytokines are vital mediators of innate and adaptive immune responses, it is no 
surprise that cytokines are also reported to modulate autophagy. TNFα and the classical TH1 
cytokine IFNγ have been reported to enhance autophagy, whereas the TH2 cytokines IL-4 
and IL-13 were shown to inhibit the autophagic control of mycobacteria (Harris & Keane 
2010, Gutierrez et al. 2004, Harris et al. 2007). Additionally, IL-1β promotes autophagy, 
which suggests that IL-1β limits its own processing by controlling inflammasome activity 
(Harris 2013). 
6.2 Crosstalk between autophagy and apoptosis  
The association between autophagy and cell death pathways has been known for years. 
Autophagic structures are commonly observed in dying cells (Kroemer & Levine 2008, 
Shen & Codogno 2011). Autophagy is activated in stressed cells as a survival mechanism; 
consequently, autophagic structures are often present in dying cells. Therefore, it was originally 
suggested that autophagy functions as an independent programmed cell death mechanism. 
However, other than the Human Immunodeficiency Virus (HIV) envelope glycoprotein-
induced cell death of CD4+ T cells that requires the induction of autophagy, but for which 
the induction of apoptosis is dispensable, there is little evidence that autophagy causes cell 
death independently of apoptosis or other pathways of programmed cell death in mammals 
(Espert et al. 2006, Shen & Codogno 2011). Although the concept of “autophagic cell death” 
may exist only for experimentally manipulated cells (Pattingre et al. 2005, Thorburn 2008), 
it has been shown that autophagy and apoptosis share convergence points at which signals 
derived from one pathway modulate the other. However, autophagy and apoptosis can also 
function in concert. For example, in apoptotic cells autophagy maintains sufficient energy 
levels for the generation of signals that promote phagocytosis, thereby assuring the clearance 
Review of the Literature 
61
of apoptotic cells (Qu et al. 2007a). Resolving the tangled interactions between autophagy 
and apoptosis is complicated because both are induced by similar stimuli and both modify 
each other’s functions. The majority of the interactions known to date seem to favor the 
function of one process over the other. 
Under normal growth conditions, Beclin 1, a critical protein in the autophagy initiation 
complex, is bound to antiapoptotic Bcl-2 family members, such as Bcl-2, which is a 
prototypical antiapoptotic protein. In fact, Beclin 1 has been shown to be a BH3-only 
protein, and similar to other BH3-only proteins, Beclin 1 is capable of physically interacting 
with the BH3 receptor domains of Bcl-2 and with the BH3 receptor domains of other 
antiapoptotic proteins, such as Bcl-xL and Mcl-1 (Feng et al. 2007, Maiuri et al. 2007). The 
interaction between Bcl-2 and Beclin 1 inhibits the activation of autophagy. Therefore, the 
phosphorylation-induced dissociation of Bcl-2 from Beclin 1 is required for the induction of 
autophagy. This phosphorylation could be mediated by either JNK1, which phosphorylates 
Bcl-2, or by death-associated protein kinase (DAPk) 1, which mediates the phosphorylation 
of Beclin 1 (Wei et al. 2008, Zalckvar et al. 2009a, Zalckvar et al. 2009b). In addition 
to phosphorylation, Bcl-2 can be displaced from Beclin 1 by HMGB1, which also acts 
to hamper apoptosis (Tang et al. 2010). The translocation of HMGB1 from the nucleus 
to the cytoplasm does not require the type of severe insult that would lead to necrosis; 
instead, ROS and other autophagy-inducing stimuli are sufficient (Tang et al. 2010). In 
addition, the binding of the proapoptotic BH3 proteins to Bcl-2 releases Beclin 1 (Maiuri et 
al. 2007). However, despite the increased level of dissociated Beclin 1, the overexpression 
of the proapoptotic Bax decreased autophagy by inducing the caspase-mediated cleavage of 
Beclin 1 (Luo & Rubinsztein 2010). 
Although Bcl-2 inhibits autophagy by interacting with Beclin 1, the effect of this interaction 
is not necessarily reciprocal. Several authors have shown that the antiapoptotic effect of Bcl-
2 is not affected by its interaction with Beclin 1, which might be due to the weaker physical 
interactions between Beclin 1 and Bcl-2 or possible counteracting regulatory sequences in 
Beclin 1 (Feng et al. 2007, Ciechomska et al. 2009, Wirawan et al. 2010). On the contrary, 
Cho et al. reported that modifications of Beclin 1 expression affected apoptosis. The deletion 
of Beclin 1 using siRNA was shown to lower the threshold for the induction of apoptosis, 
and consistent with that finding, the overexpression of Beclin 1 reduced apoptosis induced 
by a recombinant TRAIL (Cho et al. 2009). In addition, most of the Atg proteins can be 
cleaved by caspases and calpains 1 and 2, and the cleaved forms of Beclin 1 and ATG5, 
another autophagy protein, have thus far been shown to increase apoptosis (Yousefi et al. 
2006, Norman et al. 2010, Wirawan et al. 2010). The cleaved forms of ATG5 and Beclin 
1 were shown to localize to mitochondria and to induce the release of cytochrome c by 
binding to Bcl-xL (Yousefi et al. 2006, Luo & Rubinsztein 2007, Wirawan et al. 2010). 
ATG5-induced cell death has also been shown to proceed through interactions with FADD. 
In a study by Pyo et al., IFNγ induced autophagic vacuole formation in cells, and the cells 
subsequently underwent caspase-dependent death via the interaction of ATG5 with FADD 
(Pyo et al. 2005). However, the activation of apoptosis by the cleaved form of ATG5 was 
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considered to be independent of autophagy (Yousefi et al. 2006, Luo & Rubinsztein 2007). 
Adding complexity to the relationship between autophagy and FADD-dependent cell death 
results indicate that the inhibition of caspase-8, the apical caspase of extrinsic apoptosis, 
causes exaggerated autophagy, which results in cell death (Yu et al. 2004, Bell et al. 2008). 
Therefore, FADD and caspase-8 were suggested to protect T cells from necroptotic cell 
death caused by excessive autophagy (Bell et al. 2008). Thus, apoptosis has been suggested 
to also restrict the autophagic response by the caspase-mediated cleavage of autophagic 
proteins, which often results in the inhibition of autophagy (Cho et al. 2009, Norman et 
al. 2010, Wirawan et al. 2010). Because mitochondria are key players in the initiation 
of intrinsic apoptosis and autophagy is a major pathway for mitochondrial turnover, it is 
conceivable that autophagy raises the threshold for the induction of apoptosis by degrading 
compromised mitochondria, which could release cytochrome c (Thorburn 2008). However, 
the mechanisms and consequences of such a functional connection remain to be elucidated. 
 
6.3 Crosstalk between inflammasome activation and apoptosis  
 
The ability of caspase-8 to cleave the proforms of IL-1β and IL-18 and to induce apoptotic 
cell death suggests a role for caspase-8 as a switch between the inflammatory response 
and cell death. Accumulating evidence has revealed connections between caspase-8 and 
both canonical and noncanonical inflammasomes. Noncanonical inflammasomes induce the 
caspase-8-dependent processing of IL-1β in response to the activation of certain receptors, 
dectin-1 and FasR, as well as endoplasmic reticulum stress. The endoplasmic reticulum 
stress-induced secretion of IL-1β was dependent on the priming of the cells via the activation 
of TLR4, which induced both the transcription of IL-1β and TRIF-dependent signaling, 
which is needed for caspase-8 activation and subsequent cytokine secretion (Shenderov 
et al. 2014). The cross linkage of the FasR or the formation of a FADD-RIPK1 complex 
mediated the activation of caspase-8, which was followed by the maturation and secretion of 
inflammasome-dependent cytokines and cell death or, as occurs in response to the Yersinia 
protein YopJ, by the subsequent activation of caspase-1 and cell death (Bossaller et al. 
2012, Philip et al. 2014). Furthermore, the activation of dectin-1 by extracellular fungal and 
mycobacterial antigens induced the assembly of a CARD9-Bcl-10-MALT1 complex (MALT, 
mucosa-associated lymphoid tissue lymphoma translocation protein), which was required 
for the transcription of proIL-1β. The further association and activation of the noncanonical 
MALT1-caspase-8-ASC complex to the above mentioned CARD9-Bcl-10-MALT1 complex 
mediated the caspase-8-dependent maturation of IL-1β (Gringhuis et al. 2012). In addition, 
Grinhuis et al. demonstrated that, unlike the extracellular fungal antigens, the internalized 
fungal antigens of some Candida albicans strains were able to induce canonical NLRP3-
dependent IL-1β processing. These results were supported by other studies reporting an 
absolute requirement for the NLRP3 inflammasome in the secretion of mature IL-1β induced 
by the fungal cell wall component β-glucan and strains of C. albicans (Ganesan et al. 2014, 
Kankkunen et al. 2010). Internalized fungal antigens simultaneously activated caspase-1 
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and caspase-8, both of which contributed to the secretion of IL-1β in response to β-glucans 
and heat-killed, but not live, C. albicans (Ganesan et al. 2014). However, the induction of 
cell death did not require NLRP3 or ASC (Ganesan et al. 2014). 
The activation of caspase-8 has been strongly associated with canonical inflammasome 
activation. Recent findings have demonstrated that caspase-8 is capable of enhancing the 
transcription of proIL-1β and NLRP3, as well as the secretion of mature IL-1β via FADD 
(Gurung et al. 2014). Furthermore, the activation of the AIM2 and NLRP3 inflammasomes, 
particularly the association of NLRP3 with ASC, induced the processing of caspase-8 
independently of caspase-1 (Sagulenko et al. 2013, Gurung et al. 2014). Additionally, co-
operation between caspase-8 and caspase-1 has been suggested. Activated caspase-8 was 
shown to enhance the posttranslational maturation of IL-1β via the caspase-8-induced 
activation of caspase-1, which would explain the observed reduction in the secretion of 
IL-1β and IL-18 in the absence of caspase-8 (Gurung et al. 2014). Similarly, Salmonella 
(enterica serovar Typhimurium) infection, which induces the activation of the NLRC4 
inflammasome, required caspase-8 for the transcription of proIL-1β (Man et al. 2013). The 
activation of the NLRC4 inflammasome was shown to recruit both caspase-1 and caspase-8 
to the ASC structure of the NLRC4 inflammasome (Man et al. 2013). 
Several authors have shown that caspase-8 associates with ASC through the pyrin domain 
of ASC (Masumoto et al. 2003, Pierini et al. 2012, Sagulenko et al. 2013). The existence 
of crosstalk between caspase-8 and inflammasomes was further verified by results 
demonstrating an interaction between caspase-8 and ASC of the AIM2 inflammasome. 
In the absence of caspase-1, AIM2 inflammasome activation was shown to result in the 
processing of caspase-8 and subsequent apoptotic cell death (Pierini et al. 2012, Sagulenko 
et al. 2013). Sagulenko et al. proposed that the continuum between caspase-8-driven 
apoptosis and caspase-1-induced pyroptosis depends on the strength of the activating signal: 
weaker inflammasome stimulation induces apoptosis, whereas the initiation of pyroptosis 
predominates in the presence of a strong stimulus (Sagulenko et al. 2013). On the contrary, 
an inhibitory role for caspase-8 in the activation of the NLRP3 inflammasome has also 
been reported. Thus, in a study by Kang et al., caspase-8 deficiency promoted the secretion 
of mature IL-1β and IL-18 and increased mortality in response to LPS alone in vivo and 
in vitro in dendritic cells (Kang et al. 2013). The discrepant results in response to NLRP3 
inflammasome activation may, however, be due to the use of a dendritic cell-targeted 
conditional deletion in the study of Kang et al. instead of the Rip3 casp8 double knockout 
used in the study by Gurung et al., as well as the use of different inflammasome-activating 
stimuli in the two studies. 
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Figure 10. Convergence points between apoptosis, inflammasome activation and autophagy. The 
main links between apoptosis, inflammasomes and autophagy discussed in Chapters 6.1, 6.2, and 6.3 are 
illustrated here. Some details are omitted for clarity. Atg5 protein and a complex of Bcl-2 and Beclin 1 act as 
switches between autophagy and cell death. The antiapoptotic Bcl-2 binds Beclin 1, and the dissociation of 
Beclin 1 can be mediated by the phosphorylation of Bcl-2 by JNK1 or the phosphorylation of Beclin 1 by DAPk1. 
Additionally, HMGB1 binds Beclin 1 upon the translocation of HMGB1 to the cytosol, thereby disrupting the 
interaction between Bcl-2 and Beclin 1. Most autophagic proteins can be cleaved by calpains and caspases, 
which often results in reduced autophagic activity. The caspase-induced cleavage of Beclin 1 inhibits autophagy 
but enhances apoptosis by releasing proapoptotic factors from mitochondria. Additionally, the calpain-
mediated cleavage of Atg5 results in the formation of a truncated form of Atg5, which associates with Bcl-xL 
on mitochondria and induces the release of cytochrome c. Autophagy modulates inflammasome activation on 
several levels. Autophagy suppresses NLRP3 inflammasome activation by removing damaged mitochondria, 
which are sources of ROS and mtDNA. Autophagy modulates inflammasome activation differentially at early and 
late time points during autophagy activation. Initially, autophagy-based unconventional secretion enables the 
secretion of IL-1β (Early); later, inflammasome components are sequestered and degraded in autophagosomes 
when the induction of autophagy is continued (Late). Diverse interconnections exist between inflammatory 
signaling and apoptosis. Caspase-8 can be activated during canonical and noncanonical inflammasome 
activation. Fungal antigens activate caspase-8, which can cleave proIL-1β and promote inflammasome-
independent cell death. FADD may function as a platform for the activation of procaspase-8 in the NLRP3 
inflammasome. Furthermore, caspase-8 and FADD act as upstream regulators of the NLRP3 inflammasome by 
promoting the expression of NLRP3 inflammasome components and the activation of the NLRP3 inflammasome. 
Caspase-8 can also enhance IL-1β processing by activating caspase-1. However, caspase-8 has also been 
demonstrated to inhibit the secretion of inflammasome-dependent cytokines (not shown in the figure). Atg, 
autophagy-related protein; Bcl-xL, Bcl-2-like protein; CASP, caspase; DAPk1, death-associated protein kinase 
1; FADD, Fas-associated death domain; HMGB1, high-mobility group box 1; JNK1, c-Jun N-terminal kinase; 
mtDNA, mitochondrial DNA; NLRP3, nucleotide-binding domain and leucine-rich repeat-containing family, pyrin 
domain-containing 3; ROS, reactive oxygen species. Data are derived from references mentioned in the text.
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III Aims of the Study
The aims of this study were to elucidate the regulation of the innate immune system and 
to identify novel means of inhibiting innate immune responses that could be applied to the 
treatment of inflammatory diseases in the future. Another aim was to explore the molecular 
mechanisms of the immune-suppressive effects of ethanol, particularly whether the effects 
of ethanol are mediated by its actions on cells of the innate immune system. A final aim 
was to study the mechanisms that regulate the activation of the NLRP3 inflammasome to 
discover novel means of inhibiting the exacerbated inflammasome activation observed in 
the pathogenesis of several chronic inflammatory diseases. 
The specific aims of the study were the following: 
1. To explore whether the immunosuppressive effects of ethanol exposure are mediated by 
the downregulation of mast cell functions.
2. To study the mechanisms that modulate the release of proinflammatory cytokines in 
human macrophages in response to acute ethanol exposure (treatment of the cells with 
ethanol for 1 h or 3 h prior to and during the activation) and, in particular, to study the 
effect of ethanol on the function of the NLRP3 inflammasome. 
3. To explore the molecular mechanisms that regulate the function of the NLRP3 
inflammasome and, in particular, to study whether the endogenous molecule hemin 
modulates the activation of the NLRP3 inflammasome in macrophages. 
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IV Materials and Methods 
 
1. Methods used in publications I-III 
 
Table 4 summarizes the main methods used in the present study; more detailed materials 
and methods are presented in the original publications. The references provided in Table 
4 refer to more detailed descriptions of protocols published elsewhere or to manufacturer-
provided protocols.
Table 4. Methods used in the present study.  
In vitro stimulation and inhibition Reference/Manufacturer
Isolation, maturation and stimulation of human primary 
macrophages II, III (Nakanishi et al. 2009)
Isolation, maturation and stimulation of mouse bone marrow-
derived mast cells of wild-type Balb/C mice I (Eklund et al. 1994)
Isolation, maturation and stimulation of mouse bone marrow-
derived, and thioglycollate-elicited peritoneal macrophages of 
wild-type C57BL and Nrf2- or HO-1- deficient mice
III (Tzima et al. 2009)
Isolation, maturation and stimulation of human cord blood-derived 
mast cells I
(Saito et al. 1995, Lappalainen 
et al. 2007)
Culture and stimulation of human cell line mast cells (HMC-1) I (Butterfield et al. 1988)
Culture and stimulation of human cell line macrophages (THP-1) II,III (Tsuchiya et al. 1980)
Lipofectamin-induced transfection of double-stranded DNA II, III Invitrogen 
In vivo stimulation and inhibition
Sterile MSU-induced peritonitis of wild-type C57BL mice III
Detection
[3H] Thymidine incorporation I
Terminal transferase mediated nick end labelling (TUNEL) assay I ApopTag
Reverse transcriptase polymerase chain reaction I
Quantitative real-time reverse transcriptase polymerase chain 
reaction II, III (Heid et al. 1996)
Western blotting II, III (Burnette 1981)
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis II, III (Laemmli et al. 1970)
BCA assay II, III Pierce
Inductively Coupled Plasma-Mass Spectrometry II, III (ISO 17294-2:2005 Water 
quality)
Cathepsin B/L activity measurement II, III (Luheshi et al. 2012)
Cytotoxicity detection II, III Roche
Thin-layer chromatography II (Lahdesmaki et al. 2009)
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Enzyme-linked Immunosorbent Assay (ELISA)  
Human cytokines IL-1β, IL-18, and TNFα II, III R&D Systems
Mouse cytokine IL-1β III R&D Systems
Caspase-3,-8, or -9 activity assay I R&D Systems
Cell death detection I Roche
Cell imaging
Fluorescence imaging of cathepsin B and lysosomes II BIOMOL
Immunofluorescent microscopy of ASC II, III
Double immunofluorescenct microscopy of ASC and SQSTM1 III
Generation of CORM-3
Synthesis of CORM-3 from CORM II III (Clark et al. 2003)
Genotyping of HO-1-deficient mice
Reverse transcriptase polymerase chain reaction III (Tzima et al. 2009)
Crystal preparation
Preparation of cholesterol crystals II (Rajamaki et al. 2010)
Preparation of monosodium urate crystals III (Scanu et al. 2010)
Statistical analysis
Student s´ t-test I, II, III
Wilcoxon matched-pairs signed rank test II
Mann-Whitney s´ U test III
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V Results and Discussion
1. Ethanol induces apoptosis and reduces inflammatory 
responses
Alcohol abuse predisposes to infectious diseases, which are more frequent 
and more severe among alcoholics. In contrast, the moderate use of alcohol 
has been associated with a reduced risk of coronary heart disease (Rimm 
et al. 1999, Molina et al. 2010). The common denominator of increased 
susceptibility to infections and reduction in cardiovascular diseases could be 
a reduction in innate immune system function. Mast cells are key players 
in innate immune responses. They are located in tissues that are in close 
contact with the external environment, such as mucosal surfaces of the 
upper alimentary tract, in which they encounter pathogens but may also be 
exposed to high alcohol concentrations (Irani et al. 1986, Galli et al. 2011). 
In addition to the mucosal surfaces of the upper alimentary tract, fairly high 
(over 8‰) ethanol concentrations have been observed in portal vein blood. 
Furthermore, among alcoholics peripheral blood ethanol concentrations of 
3‰ to 4‰ or even over 7‰ are not uncommon at the time of hospitalization 
(Slukvin & Jerrells 1995).
1.1 Ethanol reduces human and mouse mast cell viability and proliferation 
(Study I)
The effect of ethanol on mast cell viability was studied using a human mast cell line 
(HMC-1) and mouse bone marrow-derived mast cells. HMC-1 is a malignant human mast 
cell line that is phenotypically similar to human MCT type mast cells, despite the lack of 
functional high-affinity FcεRI receptors (Butterfield et al. 1988, Nilsson et al. 1994). A 
dose-dependent reduction in the viability of both HMC-1 cells and mouse bone marrow-
derived mast cells (mBMMCs) was observed after a 4 day culture in the presence of ethanol. 
There was a significant reduction in the viability of HMC-1 cells in the presence of 344 mM 
(20‰) ethanol (Study I, Figure 1A). The daily quantification of the viability of the HMC-
1 cells revealed a gradual reduction in the number of viable cells in the presence of ethanol 
concentrations from 43 mM to 860 mM (2.5‰ to 50‰, respectively) (Study I, Figure 1B). In 
the presence of the highest ethanol concentration (1720 mM; 100‰) a total loss of viability 
during the first day of culture was observed. The reduction in viability was independent of 
growth factors because in HMC-1 cells, survival is mediated by the constitutively active 
c-kit, and mBMMCs are sustained by IL-3 (Nilsson et al. 1994). Consistent with our results, 
ethanol at concentrations of 60 mM and higher has been shown to reduce the viability of 
Hep G2 cells in a model of liver damage (Cameron et al. 1998). 
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The reduction in the number of viable mast cells was connected to a reduction in 
proliferation. The exposure of HMC-1 cells to ethanol at concentrations of 86 mM to 3440 
mM (50‰ - 200‰) significantly reduced their proliferation (Study I, Figure 2). Because 
ethanol is readily metabolized to acetaldehyde, we cultured HMC-1 cells and mBMMCs 
in the presence of acetaldehyde. Acetaldehyde is a product of ethanol metabolism that 
exhibits carcinogenic and neurotoxic effects (Koivisto & Salaspuro 1998, Lee et al. 2005). 
Surprisingly, even at the very high concentrations of 500 µM and 1000 µM, which were 
similar to the concentrations used in the study by Koivisto et al., acetaldehyde had no effect 
on the viability or the proliferation of HMC-1 cells or mBMMCs (Study I, Figures 1C and 2). 
In contrast to our results, Koivisto et al. reported an increase in the proliferation of a human 
adenocarcinoma cell line cultured in the presence of acetaldehyde for 5 weeks (Koivisto & 
Salaspuro 1998). However, significantly reduced viability of an intestinal goblet cell line 
has also been reported at low (25 µM to 100 µM) concentrations of acetaldehyde (Elamin 
et al. 2014). In the latter study, the reduction in viability was attributed to increased ROS 
production (Elamin et al. 2014). The discrepant effects of acetaldehyde may be explained by 
different mechanisms of proliferation among different cell types. Taken together, the results 
indicate that ethanol, but not acetaldehyde, dose-dependently reduced mast cell viability and 
proliferation.    
1.2 Ethanol induces apoptosis in mast cells and macrophages (Studies I and II)  
 
To further elucidate the events leading to the significant loss of mast cell viability in the 
presence of ethanol, we studied the mechanisms of cell death. A significant induction of 
apoptosis was noted in HMC-1 cells in the presence of ethanol at concentrations of 43 
mM (2.5‰) and higher (Study I, Figure 3). In mBMMCs, apoptosis was initially reduced 
at low ethanol concentrations. However, the numbers of apoptotic nuclei increased at 
concentrations of 344 mM (20‰) and higher. These findings suggest that mBMMCs may 
be more susceptible to the cytotoxic effects of ethanol because the attenuation of mBMMC 
viability was more pronounced at lower ethanol concentrations compared with HMC-1 
cells (Study I, Figure 1A). To confirm the induction of apoptosis, the activity of caspase-3, 
which is the apical caspase of the apoptotic process, was measured. Again, ethanol dose-
dependently increased caspase-3 activity in HMC-1 cells (Study I, Figure 5A). This finding 
was also supported by the modest inhibition of ethanol-induced apoptosis in the presence of 
a caspase-3 inhibitor (data not shown). The highest caspase-3 activities were measured in 
the presence of ethanol at concentrations of 344 mM (20‰) and 860 mM (50‰). Caspase-3 
activity was attenuated at the highest 1720 mM (100‰) concentration, conditions under 
which the number of apoptotic nuclei was also decreased. Combined with the observations 
of dramatic reductions in viability, this result suggests that at high concentrations, the toxic 
effects of ethanol dominate and cells experience lytic cell death instead of apoptosis. The 
ability of ethanol to induce apoptosis was further studied in human mast cells (huMCs) 
derived from peripheral cord blood CD34+ cells, which are the best cellular model of human 
mast cells available. In huMCs, 860 mM (50‰) ethanol clearly increased the fragmentation 
of genomic DNA as indicated by TUNEL staining (Study I, Figure 4). Intranucleosomal 
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fragmentation of DNA and formation of characteristic ladder pattern is considered a 
definitive proof of apoptosis (Saraste & Pulkki 2000). 
To further elucidate the apoptotic mechanism, the activities of caspases-8 and -9, which are 
activated in the extrinsic and intrinsic apoptosis pathways, respectively, were measured. The 
enzymatic activities of both caspase-8 and caspase-9 were modestly induced in mast cells 
exposed to ethanol (Study I, Figure 5B). In the intrinsic apoptosis pathway, proapoptotic 
Bax promotes the induction of apoptosis and antiapoptotic Bcl-2 inhibits the actions of 
Bax (Youle & Strasser 2008). We further examined the expression of apoptotic proteins 
because relationships among these proteins have been suggested to modulate the initiation 
of apoptosis (Perez-Navarro et al. 2005). Ethanol promoted the expression of Bax mRNA 
but had no effect on the expression of Bcl-2 mRNA, which suggests the promotion of 
intrinsic apoptosis if the expression of Bax is equally increased on the protein level (Study 
I, Figure 6). However, because increase in caspase-9 activity was very modest, it could 
not be definitively concluded that ethanol promotes intrinsic apoptosis. Previous studies 
have shown that ethanol induces apoptosis in many cell types, such as thymocytes, T and 
B lymphocytes, primary hepatocytes and hepatocyte cell lines, and cerebellar granule cells 
(Slukvin & Jerrells 1995, Neuman et al. 1999, Heaton et al. 2011). In response to ethanol 
exposure, intrinsic apoptosis was induced in cerebellar granule cells, and ethanol-induced 
apoptosis could be inhibited by an antioxidant (Heaton et al. 2011). In hepatoma HepG2 cells, 
ethanol has been shown to induce both intrinsic and extrinsic apoptosis (Nakayama et al. 
2001, Castaneda & Kinne 2001). It was suggested that the dominant apoptosis mechanism is 
dependent on the ethanol concentration, i.e., low concentrations of ethanol induce extrinsic 
apoptosis and higher concentrations induce intrinsic apoptosis (Castaneda & Kinne 2001). 
Regardless, it seems that ethanol is capable of inducing both intrinsic and extrinsic apoptosis 
in hepatoma cells.
In conclusion, in the present study ethanol, but not its metabolite acetaldehyde, induced the 
dose-dependent apoptosis of mast cells. Whether intrinsic or extrinsic apoptosis (or both 
simultaneously) is activated in mast cells in response to ethanol requires further study.
Inflammasome activation by most inflammasome activators results in cell death (Fernandes-
Alnemri et al. 2007). Depending on the strength of the inflammasome activation, either 
pyroptosis or apoptosis ensues (Sagulenko et al. 2013). Caspase-8-mediated apoptosis 
accompanies weaker inflammasome stimulation, whereas strong inflammasome activation 
promotes pyroptosis via caspase-1 activation (Sagulenko et al. 2013). Interestingly, we 
observed that ethanol was able to inhibit the activation of the NLRP3 inflammasome 
and caspase-1 in macrophages. Because ethanol did not inhibit the activation of 
caspase-8, these findings suggest that apoptosis, rather than pyroptosis, is induced in 
macrophages when inflammasome activation is blocked by ethanol (Study II, Figure 6C,D). 
 
Results and Discussion 
71
2. Ethanol and hemin inhibit the secretion of proinflammatory 
cytokines (Studies I, II, III, and unpublished data)
IL-1β and TNFα are strong proinflammatory mediators that play key roles 
in the propagation of immune responses. Because of the potentially 
harmful and damaging effects of IL-1β, its secretion is subjected to strict 
regulation at multiple levels (Dinarello 2009). The secretion of mature IL-1β 
requires two consecutive steps. The first activating signal, called priming, is 
accomplished via the activation of TLRs or cytokine receptors, which initiate 
the transcription of IL-1β and NLRP3 (Marucha et al. 1990, O’Connor et al. 
2003, Bauernfeind et al. 2009, Gross et al. 2011). A second activating signal 
is required to induce the assembly and the activation of the inflammasome. 
As a result of inflammasome activation, mature IL-1β and IL-18 are secreted.
2.1 Ethanol inhibits the secretion of IL-1β and IL-18 in macrophages 
Ethanol was shown to inhibit the secretion of inflammasome-dependent cytokines IL-1β 
and IL-18 in primary human macrophages and in a THP-1 monocyte macrophage cell line 
(Study II, Figures 1A-F and 2C-E). Incubating the cells in the presence of ethanol induced 
a significant dose-dependent reduction in IL-1β secretion in response to all studied well-
known NLRP3 inflammasome activators, i.e., cholesterol crystals, extracellular ATP, SAA, 
and nigericin, which is a potassium-proton antiporter (Perregaux & Gabel 1994). The 
inhibitory effect was likely caused by the modulation of inflammasome signaling pathways 
because ethanol did not induce cell death in nonactivated or activated macrophages, as 
measured by the release of lactate dehydrogenase (LDH) and trypan blue exclusion (Study 
II, Figure S3A-C). Furthermore, the inhibitory effect of ethanol was rapid; the simultaneous 
addition of ethanol with the NLRP3 inflammasome activator also significantly inhibited 
the secretion of IL-1β (Study II, Figure S2A). In addition, the removal of ethanol after an 
initial treatment for 3 h reduced, but could not fully reverse, the inhibitory effect (Study II, 
Figure S2B), which implies that either the ethanol-induced changes in signaling were (at 
least partially) reversed more slowly or that some cytotoxicity was induced, although the 
cytotoxicity measurements strongly argue against the latter option. 
In macrophages, ethanol is readily metabolized to acetaldehyde, primarily by the ethanol-
metabolizing cytochrome P450 but also to a lesser extent by alcohol dehydrogenase (Hutson 
& Wickramasinghe 1999). However, in the present study the inhibitory effect was shown 
to be specific to ethanol because exposing THP-1 cells to acetaldehyde at concentrations 
as high as 1 mM did not inhibit IL-1β secretion (Study II, Figure S4A). In accordance with 
that result, the inhibition of alcohol dehydrogenase using 4-methylpyrazole did not reverse 
the inhibitory effect of ethanol in human primary macrophages (Study II, Figure S4B). In 
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conclusion, these results demonstrate that ethanol, but not acetaldehyde, was responsible for 
the diminished secretion of IL-1β and IL-18 in response to inflammasome activation.
2.2 Hemin inhibits the secretion of IL-1β and IL-18 in macrophages 
Hemin and cobalt protoporphyrin (CoPP), which is a synthetic derivative of heme, were 
also shown to inhibit the secretion of IL-1β in primary human macrophages, mouse 
macrophages and THP-1 cells in response to several NLRP3 inflammasome activators, 
i.e., ATP, SAA, nigericin, and MSU crystals (Study III, Figures 1A-F and 2A,B). Similarly, 
the inflammasome-dependent secretion of IL-18 was also reduced in THP-1 cells in the 
presence of CoPP or hemin (Study III, Figure 3C). The reduced secretion of IL-1β and 
IL-18 could not be attributed to increased cell death because neither CoPP nor hemin 
exhibited significant cytotoxicity (Study III, Suppl. Figure 1G,H). There was some variation 
in sensitivity between the different cell types in their response to CoPP and hemin. THP-
1 cells were more sensitive than human primary macrophages: THP-1 cells responded 
to 1-5 µM concentrations of CoPP and to 2-5 µM concentrations of hemin, whereas 20-
50 µM concentrations of CoPP and 30-50 µM concentrations of hemin were required 
for inhibitory effects in human primary macrophages. However, in mouse bone marrow-
derived macrophages (mBMMCs), 0.05-0.5 µM concentrations of CoPP were sufficient for 
an inhibitory effect, whereas a hemin concentration of 50 µM was required. It is noteworthy 
that hemin and CoPP could inhibit NLRP3 inflammasome activation by several different 
activators although the mechanisms that mediate the activation are most likely different. 
However, neither hemin nor CoPP reduced the inflammasome activation induced by 
cholesterol crystals (Study III unpublished data, data not shown). The lack of inhibition 
in response to cholesterol crystal activation implies that the mechanism mediating the 
cholesterol crystal-induced activation differs from the activating mechanisms of ATP, SAA, 
nigericin and MSU crystals. 
2.3 Ethanol and hemin inhibit the activation of the AIM2 inflammasome but 
not the secretion of TNFα in macrophages
To determine whether the inhibitory effects of ethanol, hemin and CoPP were specific 
to the NLRP3 inflammasome, their effects on the activation of another ASC-dependent 
inflammasome, i.e., the AIM2 inflammasome, were studied. The activation of the AIM2 
inflammasome can be induced with double-stranded DNA derived from synthetic, viral or 
bacterial sources (Hornung et al. 2009, Rathinam et al. 2012). In the present study, AIM2 
inflammasome activation was induced by the transfection of synthetic double-stranded 
DNA. The exposure of THP-1 cells to ethanol induced a dose-dependent inhibition of 
IL-1β secretion in response to stimulation with double-stranded DNA while having no 
significant effect on AIM2 expression (Study II, Figure 6A,B). The incubation of THP-
1 cells in the presence of CoPP completely blocked the AIM2-induced secretion of IL-1β. 
However, CoPP also significantly inhibited the expression of AIM2 (Study III, Figure 2E,F). 
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Generally, priming is not considered necessary for the activation of the AIM2 inflammasome 
(Bauernfeind et al. 2011). Nonetheless it is conceivable that the reduced expression of AIM2 
contributed to the inhibitory effect of CoPP. In conclusion, these results demonstrate that, 
in addition to NLRP3 inflammasome activation, the activation of the AIM2 inflammasome 
and the subsequent secretion of IL-1β were also inhibited by ethanol and CoPP. Therefore, 
it is conceivable that their inhibitory effects may be more general and apply to all ASC-
dependent inflammasomes. However, the possible inhibition of other inflammasomes and 
the mechanism of AIM2 inflammasome inhibition remain to be elucidated.
Both IL-1β and IL-18 are synthesized as proforms, which require caspase-1-mediated 
cleavage for their maturation and secretion (Dinarello 1998). To demonstrate that ethanol, 
hemin and CoPP specifically inhibited the inflammasome rather than merely inhibiting 
cytokine secretion in general, their effects on the TLR-induced secretion of TNFα were 
studied. TLR activation was induced either by its most widely used ligand, LPS, or by 
SAA, which activates both TLR2 and TLR4 (Niemi et al. 2011). Ethanol did not inhibit 
the secretion of TNFα in response to SAA activation (Study II unpublished data, data not 
shown). Furthermore, neither CoPP nor hemin had significant effects on the secretion of 
TNFα (Study III unpublished data, data not shown). These results confirmed that ethanol, 
CoPP and hemin did not induce general defects in macrophage responsiveness or the 
secretion of proinflammatory cytokines. 
2.4 Ethanol inhibits the secretion of TNFα in activated mast cells 
Ethanol consumption modulates the immune defense system and the ability of immune cells 
to activate and secrete proinflammatory cytokines by various mechanisms (see Chapter 2.1.1 
in Review of the literature). Previously, Toivari et al. demonstrated that the degranulation 
and secretion of TNFα and IL-8 were blocked in response to ethanol exposure in mast cells 
(Toivari et al. 2000). A steep dose-dependent inhibition of TNFα secretion was observed in 
HMC-1 cells first challenged with ethanol and then activated with a combination of phorbol 
12-myristate 13-acetate (PMA) and calcium ionophore A23187 (Figure 11). In the first study, 
we showed that ethanol induced apoptosis in mast cells. Therefore, it was conceivable that 
the reduced secretion of TNFα was at least partially dependent on the initiation of apoptosis. 
However, IgE-activation has been shown to render mast cells less responsive to apoptosis 
(Xiang et al. 2006). In the present experiment, considerable cell death was observed in 
activated mast cells with ethanol at concentrations of 344 mM (20‰) or higher. However, 
the secretion of TNFα was reduced already in the presence of 43 mM and 86 mM (2.5‰ 
and 5‰) ethanol. In RA, mast cells in the inflamed tissue are mostly activated. Theoretically, 
ethanol could reduce the inflammatory effects of mast cells in the synovium both by 
inducing apoptosis and by inhibiting the secretion of proinflammatory cytokines, which 
would explain the observed protective effect of moderate alcohol consumption against the 
development of RA (Jin et al. 2014).      
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3. Ethanol and hemin do not disrupt NLRP3 inflammasome 
priming (Studies II and III)
Priming is an absolute requirement for the activation of the NLRP3 
inflammasome because IL1B and NLRP3 are not constitutively expressed. 
The expression of IL1B and NLRP3 is commonly induced by the activation 
of TLRs or cytokine receptors, which signal at least partly via the activation 
of NFκB (Marucha et al. 1990, O’Connor et al. 2003, Bauernfeind et al. 2009, 
Franchi et al. 2009, Gross et al. 2011). In addition to priming, a separate 
second signal is needed for the activation of the inflammasome. However, 
some inflammasome activators are capable of inducing both priming and 
inflammasome-activating signals, in which case a separate priming step is 
not needed. Bacteria are able to induce both priming and the activation of the 
inflammasome because bacterial components activate TLRs and bacterial 
toxins activate the NLRP3 inflammasome (Harder et al. 2009). In addition, 
SAA activates TLR2 and TLR4, and it can also provide the second activating 
signal (Niemi et al. 2011).
Several studies have shown that ethanol inhibits TLR signaling (see Chapter 2.1.1 in 
Review of the literature). However, differences in these studies’ experimental settings 
and duration of ethanol exposure complicate the interpretation of the results. In addition 
to the inhibitory effects of ethanol, it has been demonstrated that ethanol stimulates TLR-
induced signaling and expression of the IL-1β. The addition of ethanol simultaneously 
with the combined activation of the TLR2 and TLR4 receptors increased the activation of 
NFκB, the phosphorylation of Jnk, and the nuclear binding of activator protein 1 (Oak et 
al. 2006). In addition, short-term ethanol intake has been shown to increase the expression 
Figure 11. Ethanol dose-dependently 
inhibits the secretion of TNFα in activated 
mast cells. HMC-1 cells were incubated 
in the presence of ethanol at the indicated 
concentrations (‰) for 1 h and were then 
activated using PMA and the calcium ionophore 
A23187 for 20 h in the presence of ethanol. The 
secretion of TNFα was determined by ELISA 
and is expressed as fold changes compared 
to control cells. EtOH, ethanol; TNFα, tumor 
necrosis factor α. The data represent the 
means ±SEM of 2 independent experiments.   
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of Il1b and other cytokines in vivo via TLR4 signaling (Pascual et al. 2011). In the current 
study, human primary macrophages were first activated with LPS and then challenged with 
ethanol. Under these experimental conditions, ethanol did not reduce the expression of IL1B, 
and the expression of NLRP3 was slightly augmented (Study II, Figure 2A,B). THP-1 cells 
constitutively express another IL-1 cytokine, IL-18, as a proform that must be cleaved by 
activated caspase-1 in the inflammasome (Lin et al. 2000). The ability of ethanol to inhibit 
the secretion of IL-18 in addition to the secretion of IL-1β indicates that the inhibitory effect 
of ethanol did not depend on priming and cytokine expression; instead, ethanol specifically 
inhibited the second inflammasome-activating signal (Study II, Figure 1E,F). 
Similar to ethanol, CoPP and hemin did not reduce the expression of IL1B or NLRP3 
(Study III, Figure 3A,B). Instead, they significantly increased the expression of IL1B. This 
finding is in accordance with the results of Dutra et al., who demonstrated that heme did 
not reduce the expression of the proIL-1β protein in mouse macrophages (Dutra et al. 2014). 
In contrast to our results and the results of Dutra et al., hemin was shown to reduce the 
expression of inflammasome components in vitro in epithelial cells in response to LPS, and 
in vivo both in hepatic tissue in response to D-Galactosamine and LPS and in lung tissue in 
response to cecal ligation and puncture (Li et al. 2014a, Kim & Lee 2013, Luo et al. 2014). 
In our studies, CoPP and hemin also inhibited the nigericin-induced secretion of IL-18 in 
THP-1 cells, implying that their inhibitory effects were independent of priming (Study III, 
Figure 3C). The discrepant effects of hemin on the priming step may have resulted from 
diverse experimental conditions. Taken together, our results suggest that the inhibition of 
IL-1β secretion by ethanol, hemin, and CoPP was not caused by the reduced expression of 
inflammasome components. 
 
4. Effects of ethanol and hemin on signaling events that induce 
inflammasome activation (Studies II and III)
The NLRP3 inflammasome is activated by a wide variety of chemically and 
structurally diverse activators. Therefore, it has been suggested that all of 
these activators could not be direct ligands for the NLRP3 receptor (Latz et 
al. 2013). Many mechanisms have been suggested to trigger the activation 
of the NLRP3 inflammasome. The mechanisms most frequently associated 
with the activation of the inflammasome are 1) potassium efflux (Mariathasan 
et al. 2006, Petrilli et al. 2007), 2) mitochondrial ROS production (Zhou et al. 
2011), and 3) lysosomal destabilization (Hornung et al. 2008). 
4.1 Effects of ethanol and hemin on potassium efflux  
The induction of potassium efflux is among the most frequently proposed mechanisms of 
NLRP3 inflammasome activation. Of the activators used in the present study, ATP, nigericin, 
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and cholesterol crystals have been demonstrated to induce potassium efflux (Mariathasan 
et al. 2006, Petrilli et al. 2007, Rajamaki et al. 2010). To explore the effects of ethanol 
and CoPP on potassium efflux, we directly measured the potassium concentrations of cell 
lysates using Inductively Coupled Plasma –Mass Spectrometry (ICP-MS). Neither ethanol 
nor CoPP alone induced changes in the intracellular potassium concentration in THP-1 cells, 
nor did they inhibit the potassium efflux induced by nigericin (Study II, Figure 4B, Study III, 
Figure 3D). Nigericin-induced potassium efflux has not been shown to induce the activation 
of P2X7, which is thought to contribute to the potassium efflux induced by ATP and the 
subsequent inflammasome activation (Pelegrin & Surprenant 2006). Because ethanol, 
hemin, and CoPP inhibited both the ATP- and nigericin-induced secretion of IL-1β in human 
and mouse macrophages, it is conceivable that their inhibitory effect was not mediated by 
the inhibition of P2X7. These data suggest that ethanol and CoPP target inflammasome-
activating signaling pathways downstream of the P2X7 receptor and potassium efflux.
4.2 Effects of ethanol on ROS
The production of ROS is another general mechanism that is hypothesized to mediate the 
activation of the NLRP3 inflammasome. Ethanol exposure increases the production of 
ROS primarily via its metabolism to acetaldehyde. All the pathways of ethanol metabolism 
produce oxygen radicals, such as the hydroxyethyl radicals generated via cytochrome P450 
(Hutson & Wickramasinghe 1999, Das & Vasudevan 2007, Szuster-Ciesielska et al. 2009). 
Moreover, the mitochondrial dysfunction and damage caused by the ROS formed during 
ethanol metabolism has been associated with ethanol-induced cytotoxicity and apoptosis 
(Das & Vasudevan 2007). Interestingly, although increased mitochondrial ROS induce the 
activation of the NLRP3 inflammasome, the overproduction of ROS has been shown to 
oxidize and gluthathionylate caspase-1, which in turn inhibits caspase-1 activity (Meissner 
et al. 2008). To assess the role of ROS in the ethanol-induced inhibition of inflammasomes, 
we inhibited ROS production using NAC, a general ROS scavenger. NAC has been shown to 
not only inhibit NLRP3 inflammasome activation but also reduce LPS-induced priming, i.e., 
the expression of IL-1β (Bauernfeind et al. 2011). Consistent with our expectations, NAC 
potently inhibited ATP-induced inflammasome activation (Study II, Figure S6). However, 
NAC did not inhibit IL-1β secretion in THP-1 cells activated with SAA (Study II, Figure 
4A), which led us to assume that NAC was able to scavenge ROS but could not inhibit 
SAA-induced inflammasome activation. The inhibitory effect of ethanol was not reversed 
or modulated in the presence of NAC in either ATP or SAA activated cells, which led to the 
conclusion that the possible induction of ROS by ethanol did not contribute to the inhibitory 
effect of ethanol in THP-1 cells. In the present study, the effects of hemin or CoPP on ROS 
production were not studied. In the future, it would be interesting to determine whether 
hemin and CoPP reduce ROS via the antioxidant effects of HO-1. It is also conceivable that 
hemin and CoPP induce the generation of mitochondrial ROS: Dutra et al. recently reported 
that heme increased mitochondrial ROS production (Dutra et al. 2014). Future studies should 
address whether the increased ROS production would in fact inhibit caspase-1 activity by 
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oxidizing and gluthathionylating caspase-1, thereby contributing to the inhibitory effect of 
hemin (Meissner et al. 2008).
4.3 Effects of ethanol and hemin on lysosomal disruption and the release of 
cathepsin B
The phagocytosis of particulate material, such as silica and cholesterol crystals, is required 
for the activation of the NLRP3 inflammasome (Hornung et al. 2008, Duewell et al. 2010, 
Rajamaki et al. 2010). The ingestion of particles elicits lysosomal swelling and disruption, 
which results in the leakage of cathepsin B to the cytoplasm and the subsequent activation 
of the inflammasome (Hornung et al. 2008, Duewell et al. 2010, Rajamaki et al. 2010). 
To assess the effects of ethanol on lysosomal integrity, cells were stained with acridine 
orange, which becomes concentrated in acidic compartments. The treatment of THP-1 cells 
with cholesterol crystals reduced the number of lysosomes and induced the formation of 
large, swollen lysosomes compared to the control cells (Study II, Figure 3A, and Figure 12). 
However, the loss and swelling of lysosomes was inhibited by incubating the cells in the 
presence of 171 mM (10‰) ethanol (Study II, Figure 3A, and Figure 12). Consistent with 
these results indicating that ethanol reduced lysosomal swelling, ethanol also diminished 
lysosomal rupture, as reflected by the decreased leakage of cathepsin B from lysosomes 
(Study II, Figure 3A, and Figure 12). The reduction in lysosomal disruption was not due to 
the diminished phagocytosis of cholesterol crystals, as indicated by cholesterol esterification, 
which was not altered by ethanol (Study II, Figure S5). 
Figure 12. Ethanol inhibits lysosomal disruption and the release of cathepsin B. THP-1 cells were 
incubated in the presence of 171 mM ethanol (10‰) for 1 h prior to and during the cholesterol crystal-induced 
activation of the NLRP3 inflammasome. Live cells were stained with acridine orange (AO), and a change in color 
from green to red/orange was used to indicate the acidic pH of lysosomes. The fluorescently labeled cathepsin 
B substrate z-Arg-Arg-cresyl violet (catB; red) was used to monitor the cholesterol crystal-induced lysosomal 
swelling and the disruption and leakage of lysosomal contents. CHC, cholesterol crystals; EtOH, ethanol.
In addition to cholesterol crystals, a noncrystalline inflammasome activator, nigericin, has 
been shown to activate the NLRP3 inflammasome via the release of cathepsin B from 
AO
catB
c
Control CHC EtOH+CHC
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seemingly intact lysosomes (Hentze et al. 2003). We further studied the nigericin-induced 
release of cathepsin B to the cell culture medium by measuring the cleavage of Z-Phe-Arg-
AMC, which is a substrate for both cathepsin B and cathepsin L, which closely resembles 
cathepsin B. Most studies reporting cathepsin B as a mediator of NLRP3 inflammasome 
activation have used a cathepsin B inhibitor that inhibits both cathepsin B and cathepsin L 
(Montaser et al. 2002). Therefore, the possibility that cathepsin L contributes to the activation 
of the NLRP3 inflammasome cannot be excluded. The cleavage of the cathepsin B/L substrate 
was found to be significantly reduced in cells incubated in the presence of 43 mM or 86 
mM ethanol (2.5‰ and 5‰, respectively) (Study II, Figure 3B). Furthermore, CoPP, the 
other potent inflammasome inhibitor studied, was also shown to reduce the cleavage of the 
cathepsin B/L substrate very efficiently (Study III, Figure 3E,F). In conclusion, the results 
indicate that ethanol reduced the inflammasome activation induced by cholesterol crystals 
and nigericin at least partially by inhibiting the release of cathepsin B from lysosomes and 
that the inhibitory effect of CoPP may also be partially mediated by the diminished release 
of cathepsin B/L. 
Cathepsin B has been shown to mediate NLRP3 inflammasome activation. However, the 
exact location of inflammasome activation or the possible cathepsin B-mediated cleavage 
and activation of caspase-1 (Vancompernolle et al. 1998) is not known. According to 
the current hypothesis, cathepsin B is released to the cytoplasm, where it activates the 
NLRP3 inflammasome (Vancompernolle et al. 1998, Henze & Wolfram 1988, Hornung 
et al. 2008). However, it was recently shown that autophagy contributes to the secretion 
of IL-1β (Dupont et al. 2011). Therefore, it has been suggested that inflammasomes are 
sequestered to autophagosomes, which offer a compartment for inflammasome activation 
(Dupont et al. 2011). The subsequent fusion of autophagosomes with lysosomes brings 
lysosomal proteases, such as cathepsin B in close contact with the NLRP3 inflammasome, 
which would allow cathepsin B to activate the inflammasome and/or cleave caspase-1 
(Dupont et al. 2011, Andrei et al. 2004). The theory that inflammasomes are captured in 
autophagosomes and IL-1β is secreted from the autophagosomal compartment is further 
supported by data demonstrating the simultaneous release of inflammasome components 
and cathepsins upon inflammasome activation (Dupont et al. 2011, Andrei et al. 2004). 
In addition, the lysosomal release of cathepsins from mouse macrophages has also 
been reported to occur solely in response to the ATP-induced activation of P2X7, in the 
absence of inflammasome priming or the processing of IL-1β, (Lopez-Castejon et al. 
2010). This finding does not exclude the suggested role of autophagy in the secretion of 
cathepsins and inflammasome components, but it may reflect the ability of ATP to induce 
autophagy. Thus, the diminished secretion of active cathepsin B/L in the presence of 
ethanol and CoPP may not be primarily due to a reduction in inflammasome-activating 
signaling. Alternatively, the reduced release of active cathepsin B/L potentially implies a 
decrease in the secretion of IL-1β and inflammasome components from autophagosomes. 
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5. Ethanol and hemin inhibit inflammasome assembly and 
activation (Studies II and III) 
Activating stimuli induce subsequent intermediate signaling that triggers 
the assembly of the NLRP3 inflammasome. ASC is an obligatory adaptor 
of the NLRP3 inflammasome, which is needed for the formation of the 
functional NLRP3 inflammasome complex. ASC mediates the assembly 
of the inflammasome via homotypic interactions. ASC itself is recruited to 
NLRP3 via PYD-PYD interactions, and CARD-CARD interactions mediate 
the recruitment of caspase-1 to ASC (Mariathasan et al. 2006, Mariathasan 
& Monack 2007). Upon activation, inflammasome components are localized 
to the perinuclear area, where the inflammasome complex is assembled 
(Zhou et al. 2011). In the perinuclear area, the formed inflammasome 
complex colocalizes with the endoplasmic reticulum and mitochondria 
(Zhou et al. 2011). The oligomerization of inflammasome components is 
a self-propagating process that typically results in the formation of one 
multiprotein complex per cell (Lu et al. 2014). The formed inflammasome 
complexes are large and can be easily visualized as specks by staining the 
inflammasome proteins (Masumoto et al. 1999, Bauernfeind et al. 2009). 
5.1 Ethanol inhibits the assembly of the NLRP3 inflammasome 
We took advantage of the ability of ASC to form visible specks to determine whether 
ethanol-induced inhibition was dependent on reduced inflammasome assembly. In THP-
1 cells, nigericin elicited robust ASC speck formation, which was visualized by staining 
ASC with a monoclonal antibody. The incubation of the THP-1 cells in the presence of 171 
mM (10‰) ethanol substantially reduced the speck formation, and the diffuse cytosolic 
staining of ASC, comparable to control cells, remained in the presence of ethanol and 
nigericin (Study II, Figure 5C,D). Previously, it was demonstrated that, in unstimulated 
macrophages, ASC predominantly resides in the cytoplasm, mitochondria and nucleus, 
whereas NLRP3 localizes to the endoplasmic reticulum (Zhou et al. 2011, Misawa et al. 
2013). Upon inflammasome activation, ASC and the attached mitochondria are transported 
along microtubules to the perinuclear area, where NLRP3 is present on the endoplasmic 
reticulum (Zhou et al. 2011, Misawa et al. 2013). Inflammasome activation is associated 
with the robust secretion of IL-1β. However, other inflammasome components, such as ASC, 
are also secreted simultaneously with IL-1β (Martinon et al. 2002, Baroja-Mazo et al. 2014). 
In fact, there have been reports of the release of whole NLRP3 inflammasome complexes, 
which can induce caspase-1 activation in the extracellular space and in neighboring 
macrophages upon its phagocytosis (Baroja-Mazo et al. 2014, Franklin et al. 2014). Indeed, 
the activation of the NLRP3 inflammasome with nigericin induced the secretion of ASC, 
which was blocked by exposing the cells to 171 mM (10‰) ethanol prior to the induction of 
inflammasome activation (Study II, Figure 5A,B). Furthermore, the activation of the NLRP3 
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and AIM2 inflammasomes has been demonstrated to induce the recruitment of caspase-8 to 
ASC via the PYD domain of ASC (Sagulenko et al. 2013), and this noncanonical caspase-
8-mediated cleavage of IL-1β was also induced by the activation of the dectin-1 (Gringhuis 
et al. 2012). In the present study, ethanol was shown to specifically inhibit the activation of 
caspase-1 because no reduction in SAA-induced caspase-8 activation was observed in the 
presence of ethanol (Study II, Figure 6C,D). The results indicate that ethanol was capable 
of disrupting the CARD-mediated recruitment and activation of caspase-1 but not the PYD-
mediated recruitment and activation of caspase-8. Overall, these results indicate that ethanol 
significantly reduced the nigericin-induced assembly of the NLRP3 inflammasome in THP-
1 cells.
5.2 Hemin inhibits the assembly of the NLRP3 inflammasome 
The finding that hemin and CoPP readily inhibited the secretion of IL-1β prompted us to 
study their effects on the assembly of the inflammasome. A nearly complete inhibition of 
ASC speck formation in response to CoPP or hemin treatment was observed in THP-1 cells 
activated with nigericin (Study III, Figure 5A,B). Surprisingly, diffuse cytoplasmic ASC 
staining was no longer detected in cells treated with CoPP or hemin prior to inflammasome 
activation. The results of immunofluorescence staining were confirmed by Western blots, 
which demonstrated reductions in ASC in cell lysates in the presence of CoPP or hemin, in 
both nonactivated and nigericin-activated cells (Study III, Figure 5C,D). To elucidate the 
mechanism mediating the dramatic reduction in intracellular ASC in response to hemin or 
CoPP treatment of the cells, we first assessed whether hemin or CoPP induced the secretion 
of ASC. However, neither hemin nor CoPP alone induced the secretion of ASC, and treating 
THP-1 cells with hemin or CoPP prior to their activation with nigericin actually diminished 
the secretion of ASC compared to the cells activated with nigericin (Study III, Figure 5E,F). 
Furthermore, ASC mRNA was shown to be expressed at a low basal level in THP-1 cells, 
and ASC expression was not induced in response to inflammasome activation. Importantly, 
CoPP did not reduce the expression of ASC (Study III, Suppl. Figure 3C). In conclusion, we 
infer that hemin and CoPP reduced the level of intracellular ASC, which led to diminished 
assembly of the NLRP3 inflammasome. 
5.3 Ethanol and hemin inhibit the activation of the NLRP3 inflammasome 
In the present study, we have shown that ethanol, hemin and CoPP reduce the secretion of 
mature IL-1β in response to many substances that activate the NLRP3 inflammasome via 
distinct mechanisms. The activation of caspase-1 is a hallmark of inflammasome activation 
and is required for the processing of proIL-1β into its mature, secreted form (Dinarello 1998, 
Davis et al. 2011). The incubation of THP-1 cells in the presence of 171 mM (10‰) ethanol 
reduced the SAA- and nigericin-induced cleavage of procaspase-1 to active caspase-1 
(Study II, Figure 2F,G). Similarly the incubation of THP-1 cells in the presence of hemin 
and CoPP was shown to reduce the caspase-1 activation induced by nigericin or SAA (Study 
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III, Figure 2C,D). The observed inhibition of caspase-1 activation in the presence of ethanol, 
hemin and CoPP was in accordance with the results demonstrating the diminished secretion 
of IL-1β in response to several well-defined NLRP3 inflammasome activators. 
Furthermore, in a model of NLRP3-dependent peritonitis, the injection of CoPP into the 
peritoneal cavity of wild-type mice prior to the administration of MSU crystals significantly 
reduced the secretion of IL-1β into the peritoneal cavity (Study III, Figure 2G). In addition, 
a slight, statistically insignificant reduction in leukocyte recruitment was observed in mice 
that received CoPP prior to the induction of peritonitis (Study III, Figure 2H). The reason for 
the modest inhibition of leukocyte recruitment could be related to the possible secretion of 
other proinflammatory mediators that are not inhibited by CoPP and may thus contribute to 
leukocyte recruitment. In conclusion, CoPP was shown to significantly inhibit the secretion 
of IL-1β in response to NLRP3 inflammasome activation in vivo.
Only a few studies have addressed the effects of ethanol on inflammasome activation. 
It seems that the responses of different cell types vary. Ethanol was shown to induce 
neuroinflammation and to inhibit neurogenesis in cultured slices of hippocampal-entorhinal 
cortex by inducing the activation of the NLRP1 and NLRP3 inflammasomes (Zou & Crews 
2012). Zou et al. demonstrated that brain slices cultured in the presence of ethanol (100 
mM) for 4 days exhibited increased staining of IL-1β, NLRP1 and NLRP3. Furthermore, 
the proinflammatory effects of ethanol could be reversed by an IL-1β receptor antagonist 
and neutralization of IL-1β (Zou & Crews 2012). In accordance with that finding, an in vivo 
study assessing the effects of a 5-week 5% ethanol diet reported increased expression of 
the inflammasome components NLRP1, NLRP3, and ASC, as well as enhanced caspase-1 
activity and IL-1β secretion, confirming the inflammasome activation in the mouse 
cerebellum (Lippai et al. 2013). Furthermore, a recent study in a rat hepatocyte cell line 
reported that 24-48 h ethanol (250 mM) exposure induced the production of ROS and 
expression of NLRP3, ASC, and caspase-1 proteins, along with the secretion of mature IL-
1β and other proinflammatory cytokines, and apoptosis (Xiao et al. 2015). Moreover, these 
proinflammatory responses to ethanol were reversed by a multitarget iron chelator (Xiao et 
al. 2015). In the above-mentioned studies, ethanol was reported to increase inflammasome 
activation, which is in contrast to the results of the present study. These contradictory results 
may be due to the significantly longer exposures to ethanol used in the studies reporting 
inflammasome activation. 
Heme and hemin have been reported to both induce and inhibit NLRP3 inflammasome 
activation. In a recent study, Dutra et al. showed that heme, but not the other protoporphyrins, 
including CoPP, induced NLRP3 inflammasome activation in cells cultured in the presence 
of serum. However, in the absence of serum, heme had only a very modest activating 
effect (Dutra et al. 2014). Heme-induced inflammasome activation was mediated by 
the activation of Syk and was dependent on potassium efflux and the NADPH oxidase-
dependent generation of ROS and mitochondrial ROS (Dutra et al. 2014). Heme-induced 
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inflammasome activation could be inhibited by NAC, the NADPH oxidase inhibitor apocynin, 
the deletion of the NADPH oxidase subunit gp91phox, and the pharmacological inhibition 
of mitochondrial ROS (Dutra et al. 2014). Furthermore, the harmfull effects of heme were 
demonstrated by the administration of heme to wild-type mice, which was not lethal, but 
induced organ damage (Larsen et al. 2010). However, heme exacerbated the production of 
free radicals in combination with TNFα but not alone (Larsen et al. 2010). In accordance 
with the results of Dutra et al., it was concluded that the increased ROS generation and 
cytotoxicity induced by heme were confined to the iron atom of heme (Dutra et al. 2014, 
Larsen et al. 2010). Because both elevated levels of free heme and TNFα can enhance 
inflammation, their combined cytotoxic actions potentially contribute to the pathogenesis of 
inflammatory diseases (Gozzelino et al. 2010). 
Nevertheless, the proinflammatory effects of heme can be inhibited by the induction of 
HO-1 expression. HO-1 has well-acknowledged cytoprotective, anti-oxidant, and anti-
inflammatory effects. HO-1-deficient mice have been shown to exhibit increased mortality 
in response to cecal ligation and puncture (Larsen et al. 2010). Furthermore, hemin has been 
reported to dampen the NLRP3 inflammasome activation induced by LPS in epithelial cells, 
by D-Galactosamine and LPS in vivo in hepatic tissue, and by cecal ligation and puncture 
in vivo in lung tissue (Li et al. 2014a, Kim & Lee 2013, Luo et al. 2014). However, the 
three above-mentioned studies, which reported anti-inflammatory effects of hemin, also 
revealed reductions in the expression of inflammasome components, which may have also 
contributed to the observed inhibition. Nonetheless, Kim et al. and Luo et al. demonstrated 
that hemin reduced ROS generation, which contributed to the diminished assembly of the 
NLRP3 inflammasome reported by all three studies (Kim & Lee 2013, Luo et al. 2014, Li 
et al. 2014a). Diminished inflammasome activation was suggested to derive from the ability 
of hemin to induce HO-1. The most important difference between the study of Dutra et al. 
compared to the studies of Li et al., Kim et al., Luo et al. (Dutra et al. 2014, Li et al. 2014a, 
Kim & Lee 2013, Luo et al. 2014), and the present study is that in the latter three studies and 
in the present study, the effects of hemin were examined under proinflammatory conditions. 
In addition, the presence of serum may be critical for the proinflammatory actions of heme. 
However, the mechanisms by which serum modulates cellular responses to heme have yet 
to be elucidated. 
6. Mechanisms of the hemin-induced inhibition of 
inflammasomes (Study III and unpublished data)
Heme/hemin is a potentially cytotoxic and proinflammatory compound due to 
its pro-oxidant properties (Balla et al. 1991, Kumar & Bandyopadhyay 2005). 
However, heme is also a prominent inducer of HO-1 (Abraham & Kappas 
2008). The anti-inflammatory effects of HO-1 are generally attributed not only 
to heme catabolism, which reduces the level of free heme, but also to the 
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degradation products of heme: CO, biliverdin, and bilirubin (Constantin et 
al. 2012, Kapitulnik 2004, Gozzelino et al. 2010). Autophagy is a vesicular 
degradation system, and similar to HO-1, autophagy is activated in response 
to cellular stress in order to maintain homeostasis (Waltz et al. 2011, Parzych 
& Klionsky 2014). The multifaceted and converging signaling networks that 
mediate autophagy and inflammasome functions are not well understood 
(Deretic et al. 2012). 
6.1 Inhibition of the NLRP3 inflammasome by hemin is partially dependent 
on HO-1 enzymatic activity
HO-1 is readily induced by hemin and CoPP (Abraham & Kappas 2008). To examine 
whether HO-1 mediates the inhibitory effects of hemin and CoPP, we studied the induction 
of HO-1 protein expression. In THP-1 cells, both CoPP and hemin significantly induced 
the expression of HO-1 at the 4 h time point (Study III, Figure 4A, Suppl. Figure 2A), 
and HO-1 protein expression was further increased at later time points. The possible 
involvement of HO-1 in the inhibitory effects of hemin and CoPP was further studied by 
inhibiting the enzymatic activity of HO-1 using its competitive inhibitor, tin mesoporphyrin 
(SnMP) (Abraham & Kappas 2008). SnMP partially reversed the inhibitory effect of CoPP 
on the nigericin-induced secretion of IL-1β in THP-1 cells (Study III, Figure 4B). However, 
SnMP could not increase IL-1β secretion when combined with nigericin to test whether 
the nigericin-induced IL-1β secretion would be limited by the possible induction of HO-1 
expression during inflammasome activation. Thus, the lack of additional IL-1β secretion 
may imply that the nigericin-induced secretion of IL-1β was already maximal or that no 
HO-1 expression was induced during inflammasome activation. 
CO and bilirubin, the degradation products of heme/hemin, have been shown to be 
cytoprotective. The effects of HO-1 and the degradation products of heme are similar, and 
they have been suggested to form positive feedback loops by which they increase each 
other’s expression (Gozzelino et al. 2010). However, Brouard et al. demonstrated that 
the cytoprotective effect induced by HO-1 overexpression required its enzymatic activity 
because the antiapoptotic effect of HO-1 was abrogated by scavenging CO with hemoglobin 
(Brouard et al. 2000). In the present study, the water-soluble CO-generating molecule 
CORM-3 dose-dependently inhibited the secretion of IL-1β in human primary macrophages 
induced by ATP activation (Study III, Figure 4C). In accordance with our results, exposing 
macrophages to CO inhibited the LPS-induced secretion of IL-1β, TNFα, and macrophage 
inflammatory protein-1β, and it promoted the secretion of IL-10 (Otterbein et al. 2000). 
Furthermore, the inhalation of CO reduced the LPS-induced production of TNFα and 
increased the levels of IL-10 in vivo (Otterbein et al. 2000). 
Another heme degradation product, biliverdin, which is rapidly further converted to bilirubin 
by biliverdin reductase activity, also possesses anti-inflammatory properties. Biliverdin 
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and bilirubin have been demonstrated to ameliorate LPS-induced lung inflammation 
and to reduce mortality in mice (Sarady-Andrews et al. 2005). In addition to reducing 
inflammatory responses, biliverdin promoted anti-inflammatory responses by increasing the 
expression of IL-10 (Sarady-Andrews et al. 2005). Similar results were obtained in a model 
of cecal ligation and puncture, in which biliverdin reduced neutrophil recruitment and the 
mRNA expression of the proinflammatory mediators IL-6 and monocyte chemoattractant 
protein-1, but promoted the expression of IL-10 (Overhaus et al. 2006). We added bilirubin 
to THP-1 cell cultures and subsequently activated the NLRP3 inflammasome with ATP. 
However, under our experimental conditions, only a very modest inhibition of IL-1β was 
observed (Study III, Suppl. Figure 2B). These contradictory results imply that the effects of 
bilirubin may be specific to certain models or cell types. Taken together, these results of the 
present study imply that the hemin- and CoPP-induced inhibition of NLRP3 inflammasome 
activation may be mediated by HO-1.
6.2 Inhibition of the NLRP3 inflammasome by hemin is partially attributed to 
Nrf2 and HO-1
The cellular level of HO-1 is regulated principally via the transcription of HMOX1, which 
can be induced by several signaling routes. Thus, several transcription factors, including 
Nrf2, NFκB, and AP-1 and the transcriptional repressor Bach1, regulate the expression 
of HMOX1 (Paine et al. 2010). Oxidative stress activates the transcription factor Nrf2 
(Paine et al. 2010). However, considering the pro-oxidant nature of the hemin and ROS 
generated during inflammation, it is conceivable that the primary route of HO-1 expression 
in response to heme and NLRP3 inflammasome activation proceeds via the induction of 
Nrf2 (Gozzelino et al. 2010, Paine et al. 2010). Thus, we studied the involvement of Nrf2 in 
the inhibitory effects of hemin and CoPP in macrophages derived from Nrf2 knockout mice 
(Nrf2-/-) (Study III, unpublished data). In Nrf2-/- mouse bone marrow-derived macrophages 
(mBMDM), the expression of HO-1 was significantly reduced compared to wild-type 
macrophages (Figure 13A,B). 
 
 
Figure 13. Deletion of Nrf2 reduces the expression of Hmox1. BMDMs derived from Nrf2 knockout (KO) 
and wild-type (WT) mice were incubated in the presence of CoPP or hemin at the indicated concentrations for 
Results and Discussion 
85
(A) 1 h or (B) 3 h, after which they were activated with (A) SAA (2 µg/ml, 18 h) or  (B) ATP (5 mM, 30 min). (A, B) 
The expression of Hmox1 was determined using quantitative real-time RT-PCR and is expressed in arbitrary 
units (AU). LPS-induced priming (3 h) of the cells (0.01 µg/ml) was as indicated. Statistical significancies were 
determined by comparing corresponding samples of wild-type and Nrf2-deficient macrophages. ATP, adenosine 
triphosphate; CoPP, cobalt protoporphyrin; LPS, lipopolysaccharide, SAA; serum amyloid A. The data represent 
the means ±SEM of 4 individual experiments.
Supporting the hypothesis that the inhibitory effects of hemin and CoPP are mediated by the 
induction of HO-1, CoPP and hemin were unable to inhibit the secretion of IL-1β in Nrf2-/- 
mBMDMs induced by 18 h SAA activation (Figure 14A). This finding contrasted with the 
results from their wild-type littermates, in which CoPP and hemin inhibited the secretion 
of IL-β. Furthermore, the treatment of Nrf2-/- mBMDMs with CoPP or hemin significantly 
increased the secretion of IL-1β in response to SAA compared to Nrf2-/- mBMDMs incubated 
in the presence of SAA alone. Because heme has been shown to promote ROS production 
in mBMDMs (Dutra et al. 2014), it is conceivable that during the 18 h incubation, hemin 
(and possibly CoPP) induced ROS production, which could not be inhibited in the Nrf2-/- 
mBMDMs. The increase in ROS production could therefore explain the increased secretion 
of IL-1β in the CoPP- and hemin-treated Nrf2-/- mBMDMs. The inhibitory effects of CoPP 
and hemin were also partially reversed during shorter ATP-induced inflammasome activation 
in Nrf2-/- mBMDMs (Figure 14B). However, in the ATP-activated Nrf2-/- mBMDMs, CoPP 
retained the ability to inhibit the ATP-induced secretion of IL-1β at the higher concentration 
of 0.5 µM, but not at the lower concentration of 0.05 µM. It is unclear why the inhibitory 
effect was not reversed at the 0.5 µM concentration. However, because the expression of 
Hmox1 was slightly elevated at the higher 0.5 µM concentration compared to the lower 
0.05 µM concentration, it is possible that the expression of Hmox1 was sufficient for the 
inhibitory effect. Another possibility is that CoPP-induced inhibition is not fully mediated 
by Nrf2. Furthermore, reduced secretion of IL-1β was also observed in response to NLRP3 
stimulation in Nrf2-/- BMDMs compared to wild-type mBMDMs (data not shown), which 
is in accordance with previous reports by Freigang et al. and Zhao et al. (Freigang et al. 
2011, Zhao et al. 2014). In conclusion, because the deletion of Nrf2 was able to reverse the 
inhibitory effects of CoPP and hemin to a certain extent, it is plausible that the inhibitory 
effects of CoPP and hemin were mediated by the induction of Nrf2.
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Figure 14. Hemin- and CoPP-induced inhibition of inflammasome depends on transcription factor Nrf2. 
BMDMs derived from Nrf2 knockout (KO) and wild-type (WT) mice were incubated in the presence of the indicated 
concentrations of CoPP or hemin for (A) 1 h or for (B) 3 h and were subsequently activated with (A) SAA (2 µg/ml, 
18 h) or (B) ATP (5 mM, 30 min). (A, B) The secretion of IL-1β was determined using ELISA and is expressed as fold 
changes compared to control cells. LPS-induced priming (0.01 µg/ml, 3 h) of the cells was performed as indicated. 
ATP, adenosine triphosphate; CoPP, cobalt protoporphyrin; IL, interleukin; LPS, lipopolysaccharide; SAA, serum 
amyloid A. The data represent the means ±SEM of 4 independent experiments.
HO-1 protects against hypoxia-induced inflammation (Minamino et al. 2001). Reductions 
in the expression of proinflammatory mediators and reduced neutrophil recruitment have 
been observed in HO-1-overexpressing mice in vivo (Minamino et al. 2001). To further 
clarify the participation of HO-1 in the inhibitory effects of hemin and CoPP, we isolated 
thioglycollate-elicited peritoneal macrophages (TEPMs) from mice with a conditional 
deletion of Hmox1 (LysMCre+/- HMOXfl/fl) and stimulated the TEPMs with nigericin. 
TEPMs were selected for this study because they were used in the original study in which 
the HMOX1fl/fl mouse strain, which was also used in the present study, was generated (Tzima 
et al. 2009). The HO-1 deficient TEPMs (LysMCre+/- HMOXfl/fl) exhibited an 80% overall 
reduction of Hmox1 expression compared with the control TEPMs (LysMCre-/- HMOXfl/
fl) in nonactivated and nigericin-activated cells (Study III, Figure 4D). The activation of 
the HO-1-deficient TEPMs with nigericin significantly promoted the secretion of IL-1β 
compared to TEPMs derived from the control mice (Study III, Figure 4E). However, CoPP 
and hemin exhibited equal levels of inhibition of the secretion of IL-1β by TEPMs derived 
from both HO-1-deficient and control mice (Study III, Suppl. Figure 2C). A substantial 
leakiness of the Cre-LoxP-induced deletion of HO-1 was observed in HO-1-deficient 
TEPMs subjected to treatment with CoPP and hemin. In the HO-1-deficient TEPMs Hmox1 
expression was reduced by only 60% on average, which may well have contributed to the 
persistent inhibitory effect (Study III, Suppl. Figure 2D). Therefore, it could not be concluded 
that the inhibitory effect of CoPP and hemin was mediated by the induction of Hmox1. 
 
Based on the results of the present study showing that 1) an enzymatic inhibitor of HO-1 
reversed the inhibitory effect of CoPP; 2) a degradation product of heme/hemin, CO, inhibited 
the secretion of IL-1β; 3) Nrf2 partly reversed the inhibitory effects of hemin and CoPP; and 
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4) the deletion of Hmox1 increased the secretion of IL-1β in response to nigericin activation, 
it seems plausible to propose that the inhibitory effect of hemin and CoPP on the activation 
of the NLRP3 inflammasome is partially mediated by HO-1. However, the inhibitory effect 
of CoPP and hemin was not affected by the deletion of HO-1. In addition, the expression of 
HO-1 was not fully upregulated at the 4 h time point, when the prominent inhibition of the 
inflammasome had already been established. In conclusion, the inhibitory effect of hemin 
and CoPP on the activation of the NLRP3 inflammasome was possibly mediated by HO-1, 
but the induction of HO-1 certainly seems to not be the only contributing factor.
6.3 Hemin inhibits the NLRP3 inflammasome via autophagy
Autophagy regulates the activation and outcome of inflammasome activation at multiple 
levels. Autophagy is an important gatekeeper of inflammasome activation because it 
reduces the generation and release of mitochondrial ROS and DNA by degrading damaged 
mitochondria (Zhou et al. 2011, Nakahira et al. 2011, Shimada et al. 2012). Furthermore, 
enhanced autophagy has been shown to lead to the degradation of inflammasome components, 
including ASC and IL-1β (Shi et al. 2012, Harris et al. 2011). In the present study, we have 
confirmed that CoPP and hemin reduce the levels of ASC in nonactivated and activated 
THP-1 cells. Because the decrease in the amount of intracellular ASC was not caused by the 
enhanced secretion or reduced expression of ASC, the involvement of autophagy was studied. 
During autophagosome formation, the conjugation of PE to cytosolic LC3-I is required 
for the expansion of the autophagosomal membranes, and if the rate of autophagosomal 
degradation remains unchanged, the increased ratio of PE-conjugated LC3-II to LC3-I 
reflects an increase in autophagosome formation (Kabeya et al. 2000, Mizushima 2004, 
Yang & Klionsky 2010). Compared to untreated cells, human primary macrophages treated 
with CoPP and hemin exhibited increased ratio of LC3-II to LC3-I, indicating that CoPP and 
hemin possibly increased autophagosome formation (Study III, Figure 5G, Suppl. Figure 
3F). 
Because the increased ratio of LC3-II to LC3-I may have also resulted from reduced 
degradation of autophagosomes (Klionsky et al. 2012), the level of cellular SQSTM1, 
which is a substrate of autophagosomal degradation, was measured. The cellular level of 
SQSTM1 reflects the degradation of autophagosomal content because it is constitutively 
expressed and it is degraded in autophagosomes (Klionsky et al. 2012). CoPP and hemin 
significantly reduced the level of SQSTM1 compared to control cells (Study III, Figure 
5I, Suppl. Figure 3G). Furthermore, ATP-activated cells treated with CoPP exhibited a 
statistically nonsignificant reduction in SQSTM1 compared to ATP-activated cells. These 
results indicate that CoPP and hemin induce both autophagosome formation and degradation. 
Consistent with our results, HO-1 was previously reported to be required for the autophagy 
induced by cecal ligation and puncture and LPS in mouse hepatic tissue in vivo and in 
hepatocytes in vitro (Carchman et al. 2011). In addition, CO has been shown to increase 
autophagosome formation and the levels of cellular LC3 in mouse lung and cultured human 
alveolar and bronchial epithelial cells by increasing ROS generation (Lee et al. 2011). The 
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general ROS scavenger NAC and a scavenger of mitochondrial ROS prevented the CO-
induced increase in the ratio of LC3-II to LC3-I (Lee et al. 2011).
To further confirm that the observed reduction in intracellular ASC was mediated by 
autophagy, a widely used pharmacological inhibitor of autophagy, 3-methyladenine (3-MA), 
was used to inhibit PI3K activity, which is necessary for autophagosome formation. As 
expected, 3-MA significantly inhibited the conversion of LC3-I to LC3-II in THP-1 cells 
at the timepoint used in the experiments (Study III, Suppl. Figure 4C,D). Importantly, the 
inhibition of autophagy by 3-MA reversed the CoPP-induced reduction in intracellular 
ASC (Study III, Figure 5J, Suppl. Figure 4E). In agreement with the results of Shi et al., 
3-MA increased the secretion of IL-1β both alone and in nigericin-activated THP-1 cells, 
and it reversed the inhibitory effect of CoPP (Figure 15). The increased secretion of IL-1β 
in response to 3-MA may have been due to increased ROS formation and the subsequent 
inflammasome activation caused by the inhibition of autophagy (Zhou et al. 2011). The 
induction of autophagy has also been shown to not inhibit but, instead, to be required for the 
secretion of IL-1β (Dupont et al. 2011). These discrepant results may be explained by the 
different time points used in the experiments (1 h starvation in the study by Dupont et al. and 
6 h starvation in the study by Shi et al.) (Dupont et al. 2011, Deretic et al. 2012). Thus, the 
induction of autophagy is hypothesized to be necessary for the secretion of IL-1β at the early 
time point, whereas at the later time point, the degradation of the activated inflammasomes 
and IL-1β result in the reduced secretion of IL-1β (Deretic et al. 2012). According to the 
model presented by Deretic et al., autophagy is necessary for the secretion of IL-1β while 
simultaneously acting to limit the activity of the inflammasome (Deretic et al. 2012).
Figure 15. Inhibition of autophagy reverses 
the inhibitory effect of CoPP. THP-1 cells were 
incubated first in the presence of the autophagy 
inhibitor 3-MA (5 mM, 23 h) and then in the 
presence of CoPP (5 µM, 3 h) before finally being 
activated with nigericin (4 µM, 1 h). The secretion 
of mature IL-1β was determined using ELISA. The 
data represent the means of ±SEM of 3 individual 
experiments. CoPP, cobalt protoporphyrin; IL, 
interleukin; 3-MA, 3-methyl adenine; Nig, nigericin.
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Lastly, we stained CoPP-treated THP-1 cells with antibodies against ASC and SQSTM1. 
At the 2 h and 4 h time points, CoPP promoted the oligomerization of SQSTM1 as shown 
by the increased formation of SQSTM1 specks (Study III, Figure 5H). The recruitment 
of SQSTM1 to ULK1 is an early step in the process of autophagosome formation, and 
the oligomerization of SQSTM1 in connection with ULK1 may define the autophagosome 
formation site (Itakura & Mizushima 2011). Untreated cells exhibited diffuse cytosolic 
ASC staining, but in the presence of CoPP, cytosolic ASC staining was reduced and ASC 
staining appeared to colocalize with DAPI staining in the nucleus. Recently, the nuclear 
localization of ASC was connected with the resting state of mBMDMs (Martin et al. 2014). 
Upon inflammasome activation the resting state was reversed and ASC was relocalized to 
the perinuclear area (Martin et al. 2014). Taken together, the results suggest that hemin and 
CoPP induced autophagosome formation and the degradation of autophagosomal contents, 
i.e., autophagic flux. Thus, the increased autophagic flux inhibited inflammasome activation 
by degrading the adaptor protein ASC. 
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VI Conclusions
1. Summary and conclusions
In this study, the mechanisms that contribute to the regulation of innate immune functions 
were explored. The observed inhibitory mechanisms may form a basis for the discovery of 
novel means of treating chronic inflammatory diseases. 
Ethanol has well-acknowledged cardioprotective properties. Thus, an aim of this study was 
to elucidate the underlying mechanisms of this cardioprotective effect. Furthermore, hemin 
was identified as an immunoregulatory compound that strongly inhibits the activation of the 
inflammasome. The main findings from publications I-III and the Discussion section are 
summarized as follows:
1. Ethanol dose-dependently reduces the viability and proliferation of mast cells. Decreased 
mast cell viability and reduced proliferative potential could diminish mast cell numbers in 
response to acute alcohol exposure, especially in the mucosa of the alimentary tract, where 
the highest ethanol concentrations are encountered. The diminished mast cell viability was 
caused by the induction of immunologically silent cell death, apoptosis. Ethanol, but not 
its metabolite acetaldehyde, contributed to the reduction in viability and the increase in 
apoptosis. The induction of apoptosis proceeded via the activation of both the intrinsic and 
the extrinsic pathways, as modest inductions of the activities of both caspase-8 and caspase-9 
were observed. The cellular pathways that mediate the induction of apoptosis in response to 
ethanol clearly warrant further study. In addition, a decline in TNFα secretion was observed 
in activated mast cells. It is feasible that the reduction in mast cell numbers slows the 
initiation of local immune responses and contributes to the immunosuppression associated 
with alcohol abuse. Because activated mast cells are considered mediators of cardiovascular 
events, the beneficial cardioprotective effects of moderate alcohol consumption could partly 
be explained by a decline in the numbers of coronary mast cells. 
2. Ethanol, but not its metabolite acetaldehyde, dose-dependently inhibited the secretion of IL-
1β and IL-18 induced by the activation of the NLRP3 inflammasome in human macrophages. 
Two activating signals are required for the activation of the NLRP3 inflammasome: the 
priming signal induces the expression of NLRP3 and proIL-1β, and the activating signal 
induces the assembly and activation of the NLRP3 inflammasome. Ethanol did not reduce 
TLR-induced priming. Therefore it was concluded that ethanol specifically inhibited the 
activation of the NLRP3 inflammasome. Ethanol inhibited lysosomal destabilization and the 
release of cathepsin B from disrupted and seemingly intact lysosomes. However, ethanol had 
no effect on potassium efflux, nor did the inhibition of ROS production reverse the inhibitory 
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effect of ethanol. Thus, the inhibitory effect of ethanol seems general, as the secretion of IL-
1β induced by several NLRP3 inflammasome activators (ATP, cholesterol crystals, SAA, 
and nigericin) was inhibited in ethanol-treated cells despite differences in the mechanisms 
that mediate the inflammasome activation. Additionally, the secretion of IL-1β induced by 
AIM2 inflammasome activation was inhibited by ethanol. Ethanol inhibited inflammasome 
assembly and activation, which was reflected by the reduced oligomerization of ASC and 
the activation of caspase-1. However, ethanol did not inhibit the activation of the apoptotic 
caspase-8, thereby directing inflammasome-induced cell death toward apoptosis. Excessive 
NLRP3 inflammasome activation contributes to the pathogenesis of several common chronic 
inflammatory diseases. Thus, the reduced inflammasome activation may partly explain the 
reduced risk of RA associated with the moderate consumption of ethanol. Furthermore, the 
potential ethanol-induced inhibition of cholesterol crystal-induced inflammasome activation 
in atherosclerotic arteries may be partly responsible for the reduced risk of cardiovascular 
diseases associated with moderate ethanol consumption. These findings are presented in 
Figure 16. 
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Figure 16. Schematic representation of the inhibitory effects of ethanol on NLRP3 inflammasome 
activation. The inflammasome activators used in Study II are illustrated; some steps are omitted for clarity. 
Priming is shown on the left and inflammasome activation on the right. (1) First, the activation of TLRs by LPS 
or SAA initiates the expression of NLRP3 and proIL-1β, which is called the priming step. (2) Second, stimuli 
induced by extracellular ATP, nigericin, SAA or cholesterol crystals induce NLRP3 inflammasome activation. 
Extracellular ATP binds P2X7, which induces potassium efflux. Additionally, nigericin functions as an H+/K+ 
antiporter to induce potassium efflux. Furthermore, nigericin induces the release of cathepsin B from seemingly 
intact lysosomes (intact lysosomes are omitted for clarity) and ROS formation. SAA induces the release of 
cathepsin B from seemingly intact lysosomes by the activation of P2X7 receptors. Phagocytosed cholesterol 
crystals induce lysosomal disruption, which results in the leakage of cathepsin B from lysosomes. Cholesterol 
crystals also induce potassium efflux. Decreased intracellular potassium concentration, increased ROS 
production, and the release of cathepsin B each alone or in combination induce the activation of the NLRP3 
inflammasome. Caspase-1 is activated in the NLRP3 inflammasome, and it processes proIL-1β to its mature, 
secreted form. Ethanol reduces the activation of caspase-1 and the secretion of mature IL-1β by inhibiting the 
activation of the inflammasome. Two mechanisms were described: a) Ethanol inhibits lysosomal disruption and 
the release of active cathepsin B from disrupted and seemingly intact lysosomes, and b) ethanol inhibits the 
assembly of the inflammasome. ASC, apoptosis-associated speck-like protein containing a caspase-recruitment 
domain; ATP, adenosine triphosphate; IL-1β, interleukin 1β; LPS, lipopolysaccharide; NLRP3, nucleotide-binding 
domain and leucine-rich repeat-containing family, pyrin domain-containing 3; P2X7, P2X purinergic receptor 7; 
ROS, reactive oxygen species; SAA, Serum amyloid A; TLR, Toll-like receptor. Figure adapted from  
(Nurmi et al. 2013). 
3. Hemin and its derivative CoPP inhibited the secretion of IL-1β and IL-18 in human and 
mouse macrophages in response to several NLRP3 inflammasome activators. Additionally, 
the IL-1β secretion induced by the AIM2 inflammasome was inhibited, although the 
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exact mechanism of AIM2 inflammasome inhibition remains to be elucidated. The local 
NLRP3-induced secretion of IL-1β was further inhibited in vivo in mice. Hemin and CoPP 
specifically inhibited NLRP3 inflammasome activation because no reduction in priming 
was observed. CoPP did not affect potassium efflux but instead inhibited the release of 
active cathepsin B, which may reflect the diminished secretion of IL-1β along with other 
inflammasome components from autophagosomes. The inhibitory effect of hemin and CoPP 
was partially dependent on the induction of HO-1 by Nrf2 and the enzymatic activity of HO-
1. Additionally, the degradation product of heme/hemin, CO, dose-dependently inhibited 
NLRP3 inflammasome activation. Hemin and CoPP blocked the assembly of the NLRP3 
inflammasome by reducing the cellular level of the inflammasome adaptor protein ASC, 
which is required for the recruitment and activation of caspase-1. The reduction in ASC was 
caused by enhanced autophagy, which induced its degradation. In conclusion, the results 
of this part of the study indicate that endogenous hemin may function as an important 
negative regulator of the NLRP3 inflammasome. Thus, it is conceivable that hemin inhibits 
inflammasome activation under certain pathologic conditions that involve excessive 
hemolysis. The main findings of the study are illustrated in Figure 17.
Figure 17. Hemin and CoPP enhance autophagy, which subsequently results in inhibition of the 
NLRP3 inflammasome. Hemin and CoPP induce the expression of HO-1 at least partially via the activation 
of Nrf2. Hemin and CoPP, or HO-1, enhance autophagosome formation, which sequesters ASC (and possibly 
other inflammasome components) for degradation in autolysosomes. Enhanced autophagic process results 
in the degradation of inflammasome components and thereby diminishes the secretion of mature IL-1β. The 
colocalization of the NLRP3 inflammasome with mitochondria (orange-yellow ellipse shape with cristae) was 
demonstrated by Zhou et al. and Misawa et al. (Zhou et al. 2011, Misawa et al. 2013). ASC, apoptosis-associated 
speck-like protein containing a caspase-recruitment domain; CoPP, cobalt protoporphyrin; IL-1β, interleukin 1β; 
HO-1, heme oxygenase-1; Nrf2, NF-E2-related factor-2; SQSTM1, sequestosome 1. 
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2. Future prospects
Excessive inflammation is a key factor in the pathogenesis of several common diseases that 
are not limited to autoimmune diseases, such as RA and inflammatory bowel disease, but 
also include chronic inflammatory diseases, such as atherosclerosis and type 2 diabetes. 
A more thorough understanding of the function and regulation of the immune system is 
needed for the development of new therapeutic strategies to treat chronic inflammation. In 
the present study, the regulation of innate immune cell functions was studied, particularly 
the mechanisms that inhibit the inflammatory actions of two key players of innate immunity, 
i.e., mast cells and macrophages. Two novel factors, ethanol and hemin, were demonstrated 
to limit the proinflammatory actions of mast cells and macrophages.
Increases in the number and activation of mast cells in atherosclerotic coronary arteries 
contribute to the recruitment of immune defense cells and to cardiovascular events, such 
as plaque rupture (Bot et al. 2013, Laine et al. 1999). Chronic inflammation directs the 
progression of atherosclerosis. IL-1β is a prototypical proinflammatory cytokine that mediates 
the accumulation of phagocytes in atherosclerotic plaques, thereby indirectly contributing to 
foam cell formation and the further enhancement of plaque progression (Young et al. 2002, 
Kirii et al. 2003).  In the present study, ethanol was shown to reduce mast cell viability 
by inducing immunologically silent apoptotic cell death. Further, the ability of ethanol 
to directly inhibit the activation of the NLRP3 inflammasome and the secretion of IL-1β 
from macrophages suggests that reductions in the functions of macrophages and mast cells 
may contribute to the cardioprotective effects of ethanol. Targeting chronic inflammation 
in atherosclerotic arteries could be a potent therapeutic strategy for the treatment of CHD. 
Indeed, the well-acknowledged cardioprotective effects of statins may be mediated in part 
by reduction in inflammation, and several anti-inflammatory drugs are currently being 
tested for their potential to reduce cardiovascular risk (Golia et al. 2014). 
In the present study, we discovered that hemin prevents the assembly of the NLRP3 
inflammasome and the secretion of mature IL-1β in macrophages. Highly proinflammatory 
conditions and the release of free heme/hemin caused by massive hemolysis induce the 
periodic fever observed during malarial infection (Olivier et al. 2014). Malaria is a severe 
infection caused by several species of the protozoan parasite Plasmodium. Plasmodium 
produces hemozoin, which is released to the circulation by the lysis of red blood cells. 
Hemozoin is further phagocytosed by macrophages, eliciting the strong activation of 
the NLRP3 inflammasome and the secretion of the pyrogenic cytokine IL-1β (Shio et al. 
2009). In light of our results, it is conceivable that evolutionary pressure has induced the 
development of a negative regulatory loop in which enhanced levels of free heme/hemin 
inhibit NLRP3 inflammasome activation during malarial infection. 
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Our results suggest that hemin inhibits inflammasome activation by enhancing autophagy. 
However, the contribution of HO-1 in the inhibiton of inflammasome activation and 
enhancement of autophagy has yet to be fully elucidated. Another intriguing question is the 
role of autophagy during inflammasome activation. How does the induction of autophagy 
first drive the secretion of IL-1β? At which point does autophagic degradation become 
dominant and block the secretion of IL-1β by the degradation of inflammasome components 
(Deretic et al. 2012)? Based on our results, we propose a model in which hemin enhances the 
autophagic degradation of the critical inflammasome adaptor protein ASC. This inhibitory 
pathway also holds potential for the development of novel therapeutic approaches for the 
treatment both of severe autoinflammatory diseases and of more common chronic diseases 
characterized by excessive NLRP3 inflammasome activation.
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